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CHAPTER-1 
 
GENERAL INTRODUCTION TO CHROMATOGRAPHY 
VARIOUS CHROMATOGRAPHIC TECHNIQUES AND 
ITS APPLICATION IN PHARMACEUTICAL AND 
CHEMICAL INDUSTRUES 
 
Chapter – 1                                                                                                                                                    General Introduction 
1. CHROMATOGRAPHY 
 
Chromatography, although primarily a separation technique, is mostly employed in 
chemical analysis. Nevertheless, to a limited extent, it is also used for preparative 
purposes, particularly for the isolation of relatively small amounts of materials that have 
comparatively high intrinsic value. Chromatography is probably the most powerful and 
versatile technique available to the modern analyst. In a single step process it can 
separate a mixture into its individual components and simultaneously provide a 
quantitative estimate of each constituent. Samples may be gaseous, liquid or solid in 
nature and can range in complexity from a simple blend of two entantiomers to a multi 
component mixture containing widely differing chemical species. Furthermore, the 
analysis can be carried out, at one extreme, on a very costly and complex instrument, and 
at the other, on a simple, inexpensive thin layer plate. The first scientist to recognize 
chromatography as an efficient method of separation was the Russian botanist Tswett [1], 
who used a simple form of liquid-solid chromatography to separate a number of plant 
pigments. The colored bands he produced on the adsorbent bed evoked the term 
chromatography for this type of separation (color writing). Although color has little to do 
with modern chromatography, the name has persisted and, despite it irrelevance, is still 
used for all separation techniques that employ the essential requisites for a 
chromatographic separation, viz. a mobile phase and a stationary phase.  
 
The technique, as described by Tswett was largely ignored for a long time and it was not 
until the late 1930s and early 1940s that Martin and Synge [2] introduced liquid-liquid 
chromatography by supporting the stationary phase, in this case water, on silica in a 
packed bed and used it to separate some acetyl amino acids. In their paper, they 
recommended replacing the liquid mobile phase by a suitable gas, as the transfer of 
sample between the two phases would be faster, and thus provide more efficient 
separations. In this manner, the concept of gas chromatography was created but again, 
little notice was taken of the suggestion and it was left to Martin himself and A. T. James 
to bring the concept to practical reality nearly a decade later. In the same publication in 
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1941, the essential requirements for HPLC (High Performance Liquid Chromatography) 
were unambiguously defined, 
"Thus, the smallest HETP (the highest efficiency) should be obtainable by using very 
small particles and a high pressure difference across the column". 
Despite his recommendations, however, it was nearly four decades before this concept 
were taken seriously and the predicted high efficiency liquid chromatography columns 
became a reality. By the mid 1960s the development of all aspects of chromatography 
were virtually complete and since then, despite the plethora of publications that have 
appeared on the subject, the vast majority has dealt with applications of the technique and 
only a minority with fundamental aspects of the subject and novel instrumentation 
concepts. Today, chromatography is an extremely versatile technique; it can separate 
gases, and volatile substances by GC, in-volatile chemicals and materials of extremely 
high molecular weight (including biopolymers) by LC and if necessary very 
inexpensively by TLC. All three techniques, (GC), (LC) and TLC have common features 
that classify them as chromatography systems. Chromatography has been defined as 
follows,  
“Chromatography is a separation process that is achieved by distributing the 
components of a mixture between two phases, a stationary phase and a mobile phase. 
Those components held preferentially in the stationary phase are retained longer in the 
system than those that are distributed selectively in the mobile phase. As a consequence, 
solutes are eluted from the system as local concentrations in the mobile phase in the 
order of their increasing distribution coefficients with respect to the stationary phase; 
ipso facto a separation is achieved” [3]. 
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2. VARIOUS TYPES OF CHROMATOGRAPHY 
 
Chromatography can be classified by various ways (I) On the basis of interaction of 
solute to the stationary phase [4], (II) On the basis of chromatographic bed shape [5, 6], 
(III) Techniques by physical state of mobile phase and (V) Few Special Chromatographic 
Techniques.  
 
2.1. ON THE BASIS OF INTERACTION OF SOLUTE TO STATIONARY 
PHASE 
2.1.1. ADSORPTION CHROMATOGRAPHY 
 
Adsorption chromatography is probably one of the oldest types of chromatography 
around. It utilizes a mobile liquid or gaseous phase that is adsorbed onto the surface of a 
stationary solid phase. The equilibration between the mobile and stationary phase 
accounts for the separation of different solutes. 
 
Figure 1: Schematic figure for adsorption phenomenon in chromatography 
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2.1.2. PARTITION CHROMATOGRAPHY 
This form of chromatography is based on a thin film formed on the surface of a solid 
support by a liquid stationary phase. Solute equilibrates between the mobile phase and the 
stationary liquid. 
 
 
Figure 2: Schematic figure for Partition phenomenon in chromatography 
2.1.3. ION EXCHANGE CHROMATOGRAPHY 
In this type of chromatography, the use of a resin (the stationary solid phase) is used to 
covalently attach anions or cations onto it. Solute ions of the opposite charge in the 
mobile liquid phase are attracted to the resin by electrostatic forces. 
 
 
 
Figure 3: Schematic figure for Ion Exchange phenomenon in chromatography 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                              Page 4 
 
 
Chapter – 1                                                                                                                                                    General Introduction 
2.1.4. MOLECULAR EXCLUSION CHROMATOGRAPHY 
Also known as gel permeation or gel filtration, this type of chromatography lacks an 
attractive interaction between the stationary phase and solute. The liquid or gaseous 
phase passes through a porous gel which separates the molecules according to its size. 
The pores are normally small and exclude the larger solute molecules, but allow smaller 
molecules to enter the gel, causing them to flow through a larger volume. This causes the 
larger molecules to pass through the column at a faster rate than the smaller ones. 
 
 
Figure 4: Schematic figure for Molecular Exchange phenomenon in chromatography 
2.2. ON THE BASIS OF CHROMATOGRAPHIC BED SHAPE  
2.2.1. COLUMN CHROMATOGRAPHY 
Column chromatography is a separation technique in which the stationary bed is within a 
tube. The particles of the solid stationary phase or the support coated with a liquid 
stationary phase may fill the whole inside volume of the tube (packed column) or be 
concentrated on or along the inside tube wall leaving an open, unrestricted path for the 
mobile phase in the middle part of the tube (open tubular column). Differences in rates of 
movement through the medium are calculated to different retention times of the sample 
[7]. 
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In 1978, W.C.Still introduced a modified version of column chromatography called flash 
column chromatography [8] [9]. The technique is very similar to the traditional column 
chromatography, except for that the solvent is driven through the column by applying 
positive pressure. This allowed most separations to be performed in less than 20 minutes, 
with improved separations compared to the old method. Modern flash chromatography 
systems are sold as pre-packed plastic cartridges, and the solvent is pumped through the 
cartridge. Systems may also be linked with detectors and fraction collectors providing 
automation. The introduction of gradient pumps resulted in quicker separations and less 
solvent usage. 
In expanded bed adsorption, a fluidized bed is used, rather than a solid phase made by a 
packed bed. This allows omission of initial clearing steps such as centrifugation and 
filtration, for culture broths or slurries of broken cells. 
 
2.2.2. PLANAR CHROMATOGRAPHY 
Planar chromatography is a separation technique in which the stationary phase is present 
as or on a plane. The plane can be a paper, serving as such or impregnated by a substance 
as the stationary bed (paper chromatography) or a layer of solid particles spread on a 
support such as a glass plate (thin layer chromatography). Different compounds in the 
sample mixture travel different distances according to how strongly they interact with the 
stationary phase as compared to the mobile phase. The specific Retention factor (Rf) of 
each chemical can be used to aid in the identification of an unknown substance. 
 
2.2.2.1. PAPER CHROMATOGRAPHY 
Paper chromatography is a technique that involves placing a small dot or line of sample 
solution onto a strip of chromatography paper. The paper is placed in a jar containing a 
shallow layer of solvent and sealed. As the solvent rises through the paper, it meets the 
sample mixture which starts to travel up the paper with the solvent. This paper is made of 
cellulose, a polar substance, and the compounds within the mixture travel farther if they 
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are non-polar. More polar substances bond with the cellulose paper more quickly, and 
therefore do not travel as far. 
 
2.2.2.2. THIN LAYER CHROMATOGRAPHY 
Thin layer chromatography (TLC) is a widely employed laboratory technique and is 
similar to paper chromatography. However, instead of using a stationary phase of paper, 
it involves a stationary phase of a thin layer of adsorbent like silica gel, alumina, 
or cellulose on a flat, inert substrate. Compared to paper, it has the advantage of faster 
runs, better separations, and the choice between different adsorbents. For even better 
resolution and to allow for quantification, high-performance TLC can be used. 
 
2.2.2.3. DISPLACEMENT CHROMATOGRAPHY 
The basic principle of displacement chromatography is, “A molecule with a high affinity 
for the chromatography matrix (the displacer) will compete effectively for binding sites, 
and thus displace all molecules with lesser affinities”.[10]  
There are distinct differences between displacement and elution chromatography. In 
elution mode, substances typically emerge from a column in narrow, Gaussian peaks. 
Wide separation of peaks, preferably to baseline, is desired in order to achieve maximum 
purification. The speed at which any component of a mixture travels down the column in 
elution mode depends on many factors. But for two substances to travel at different 
speeds, and thereby be resolved, there must be substantial differences in some interaction 
between the biomolecules and the chromatography matrix. Operating parameters are 
adjusted to maximize the effect of this difference. In many cases, baseline separation of 
the peaks can be achieved only with gradient elution and low column loadings. Thus, two 
drawbacks to elution mode chromatography, especially at the preparative scale, are 
operational complexity, due to gradient solvent pumping, and low throughput, due to low 
column loadings.  
Displacement chromatography has advantages over elution chromatography in that 
components are resolved into consecutive zones of pure substances rather than “peaks”. 
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Because the process takes advantage of the nonlinearity of the isotherms, a larger column 
feed can be separated on a given column with the purified components recovered at 
significantly higher concentrations. 
 
2.3. TECHNIQUES BY PHYSICAL STATE OF MOBILE PHASE 
2.3.1. GAS CHROMATOGRAPHY 
Gas chromatography (GC), also sometimes known as Gas-Liquid chromatography, 
(GLC), is a separation technique in which the mobile phase is a gas. Gas chromatography 
is always carried out in a column, which is typically "packed" or "capillary". 
Gas chromatography (GC) is based on a partition equilibrium of analyte between a solid 
stationary phase (often a liquid silicone-based material) and a mobile gas (most often 
Helium). 
The stationary phase is adhered to the inside of a small-diameter glass tube (a capillary 
column) or a solid matrix inside a larger metal tube (a packed column). It is widely used 
in analytical chemistry; though the high temperatures used in GC make it unsuitable for 
high molecular weight biopolymers or proteins (heat will denature them), frequently 
encountered in biochemistry, it is well suited for use in the petrochemical, environmental 
monitoring, and industrial chemical fields. It is also used extensively in chemistry 
research. 
 
2.3.2. LIQUID CHROMATOGRAPHY 
Liquid chromatography (LC) is a separation technique in which the mobile phase is a 
liquid. Liquid chromatography can be carried out either in a column or a plane. Present 
day liquid chromatography that generally utilizes very small packing particles and a 
relatively high pressure is referred as high performance liquid chromatography (HPLC). 
In the HPLC technique, the sample is forced through a column that is packed with 
irregularly or spherically shaped particles or a porous monolithic layer (stationary phase) 
by a liquid (mobile phase) at high pressure. HPLC is historically divided into two 
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different sub-classes based on the polarity of the mobile and stationary phases. Technique 
in which the stationary phase is more polar than the mobile phase (e.g. toluene as the 
mobile phase, silica as the stationary phase) is called normal phase liquid 
chromatography (NPLC) and the opposite (e.g. water-methanol mixture as the mobile 
phase and C18 = octadecylsilyl as the stationary phase) is called reversed phase liquid 
chromatography (RPLC). Ironically the "normal phase" has fewer applications and RPLC 
is therefore used considerably more. 
Specific techniques which come under this broad heading are listed below. It should also 
be noted that the following techniques can also be considered fast protein liquid 
chromatography if no pressure is used to drive the mobile phase through the stationary 
phase.  
 
2.3.2.1. AFFINITY CHROMATOGRAPHY 
Affinity chromatography [11] is based on selective non-covalent interaction between an 
analyte and specific molecules. It is very specific, but not very robust. It is often used in 
biochemistry in the purification of proteins bound to tags. These fusion proteins are 
labeled with compounds such as His-tags, biotin or antigens, which bind to the stationary 
phase specifically. After purification, some of these tags are usually removed and the 
pure protein is obtained. Affinity chromatography often utilizes a biomolecule's affinity 
for a metal (Zn, Cu, Fe, etc.). Columns are often manually prepared. Traditional affinity 
columns are used as a preparative step to flush out unwanted biomolecules. However, 
HPLC techniques exist that do utilize affinity chromatography properties. Immobilized 
Metal Affinity Chromatography (IMAC) is useful to separate aforementioned molecules 
based on the relative affinity for the metal (I.e. Dionex IMAC). Often these columns can 
be loaded with different metals to create a column with a targeted affinity. 
 
2.3.2.2. SUPERCRITICAL FLUID CHROMATOGRAPHY 
Supercritical fluid chromatography is a separation technique in which the mobile phase is 
a fluid above and relatively close to its critical temperature and pressure. 
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2.4. FEW SPECIAL CHROMATOGRAPHIC TECHNIQUES  
2.4.2 TWO-DIMENSIONAL CHROMATOGRAPHY 
In some cases, the chemistry within a given column can be insufficient to separate some 
analytes. It is possible to direct a series of unresolved peaks onto a second column with 
different physico-chemical (Chemical classification) properties. Since the mechanism of 
retention on this new solid support is different from the first dimensional separation, it 
can be possible to separate compounds that are indistinguishable by one-dimensional 
chromatography. The sample is spotted at one corner of a square plate, developed, air-
dried, then rotated by 90° and usually redeveloped in a second solvent system. 
 
2.4.2. SIMULATED MOVING-BED CHROMATOGRAPHY 
In chromatography, the simulated moving bed (SMB) technique is a variant of high 
Performance liquid chromatography; it is used to separate particles and/or chemical 
compounds that would be difficult or impossible to resolve otherwise. This increased 
separation is brought about by a valve-and-column arrangement that is used to lengthen 
the stationary phase indefinitely. In the moving bed technique of preparative 
chromatography the feed entry and the analyte recovery are simultaneous and continuous, 
but because of practical difficulties with a continuously moving bed in the simulated 
moving bed technique instead of moving the bed the sample inlet and the analyte exit 
positions are moved continuously, giving the impression of a moving bed.[12] [13].  
True moving bed chromatography (MBC) is only a theoretical concept. Its 
simulation, SMBC is achieved by the use of a multiplicity of columns in series and a 
complex valve arrangement, which provides for sample and solvent feed, analyte and 
waste take off at appropriate locations of any column, whereby it allows switching at 
regular intervals the sample entry in one direction the solvent entry in the opposite 
direction, whilst changing the analyte and waste takeoff positions appropriately as wells. 
The advantage of the SMBC is high speed, because a system could be near continuous, 
whilst its disadvantage is that it only separates binary mixtures. It does not say, but 
perhaps it can be assumed that this is equivalent with the separation of a single 
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component from a group of compounds. With regard to efficiency it compares with 
simple chromatography technique like continuous distillation does with batch distillation. 
 
2.4.3. PYROLYSIS GAS CHROMATOGRAPHY 
Pyrolysis is the thermal dissociation of materials in an inert atmosphere or a vacuum. The 
sample is put into direct contact with a platinum wire, or placed in a quartz boat inside a 
platinum coil, and rapidly heated to 600 – 800 C. Large molecules cleave at their weakest 
points and produce smaller, more volatile fragments. Various methylating reagents, 
which increase the volatility of polar fragments, can be added to a sample before 
pyrolysis. These fragments can then it can be easily separated by gas chromatograph 
(GC). 
Not as well-known is the pyrolysis inside a Programmable Temperature Vaporizer (PTV) 
injector. The reason this technique is relatively unknown is that PTV injectors in general 
are of yet not often used. With some of the latest versions it is now possible to heat the 
sample very quickly until an end temperature of 600°C is reached. Some PTV's have a 
ramp rate of 30°C/sec. The fast ramp rate and the end temperature of 600°C are enough 
to make good pyrolysis. There are many advantages to using the injector as a pyrolyser. 
There is a price advantage, and switching from pyrolysing to normal GC injections can 
be done without changing the configuration of the hardware. Both liquid as well solid 
samples can be used when a PTV injector with a relative big liner is used. Real 
quantitative data can be acquired, and good results of derivatization inside the PTV 
injector are published. 
 
2.4.4. FAST PROTEIN LIQUID CHROMATOGRAPHY 
Fast protein liquid chromatography (FPLC) is a term applied to several chromatography 
techniques which are used to purify proteins. Many of these techniques are identical to 
those carried out under high performance liquid chromatography, however use of FPLC 
techniques are typically for preparing large scale batches of a purified product. 
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2.4.5. COUNTERCURRENT CHROMATOGRAPHY 
Countercurrent chromatography (CCC) is a type of liquid-liquid chromatography, where 
both the stationary and mobile phases are liquids. It involves mixing a solution of liquids, 
allowing them to settle into layers and then separating the layers. 
 
2.4.6. CHIRAL CHROMATOGRAPHY 
Chiral chromatography involves the separation of stereoisomers. In the case of 
enantiomers, these have no chemical or physical differences apart from being three-
dimensional mirror images. Conventional chromatography or other separation processes 
are incapable of separating them. To enable chiral separations to take place, either the 
mobile phase or the stationary phase must themselves be made chiral, giving differing 
affinities between the analytes. Chiral chromatography HPLC columns (with a chiral 
stationary phase) in both normal and reversed phase are commercially available. 
Pyrolysis gas chromatography is very useful for the identification of synthetic polymeric 
media, such as acrylics or alkyds, and synthetic varnishes [14]. It can also be used for 
environmental samples [15], including fossils [16]. 
Most Known Chromatographic equipments are [17], 
(1) High Performance Liquid Chromatography(HPLC) 
(2) Ultra Performance Liquid Chromatography(UPLC, upgraded version of HPLC ) 
(3) High Performance Thin  Layer Chromatography(HPTLC) 
(4) Ion Chromatography(IC) 
(5) Gas Chromatography(GC) 
(6) Flash Chromatography 
(7) Preparative High Performance Liquid Chromatography (Prep. HPLC) 
(8) Capillary Chromatography. 
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3. INTRODUCTION TO HIGH PERFORMANCE LC[18] 
 
The acronym HPLC, coined by the late Prof. Csaba Horvath for his 1970 Pittcon paper, 
originally indicated the fact that high pressure was used to generate the flow required for 
liquid chromatography in packed columns. In the beginning, pumps only had a pressure 
capability of 500 psi. This was called high pressure liquid chromatography, or HPLC.  
The early 1970s saw a tremendous leap in technology. These new HPLC instruments 
could develop up to 6,000 psi of pressure, and incorporated improved injectors, detectors, 
and columns. HPLC really began to take hold in the mid-to late-1970s. With continued 
advances in performance during this time (smaller particles, even higher pressure), the 
acronym HPLC remained the same, but the name was changed to high 
performance liquid chromatography. 
 
Figure 5: Schematic Diagram of HPLC system 
High performance liquid chromatography is now one of the most powerful tools in 
analytical chemistry. It has the ability to separate, identify, and quantitate the compounds 
that are present in any sample that can be dissolved in a liquid. Today, compounds in 
trace concentrations as low as parts per trillion (ppt) may easily be identified. HPLC can 
be, and has been, applied to just about any sample, such as pharmaceuticals, food, 
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nutraceuticals, cosmetics, environmental matrices, forensic samples, and industrial 
chemicals [18].The components of a basic high-performance liquid chromatography 
(HPLC) system are shown in the simple diagram in Figure 5 (Schematic Diagram). 
A reservoir (Solvent Delivery) holds the solvent (called the mobile phase, because it 
moves). A high-pressure pump solvent manager is used to generate and meter a specified 
flow rate of mobile phase, typically milliliters per minute.  
An injector (sample manager or auto sampler) is able to introduce (inject) the sample into 
the continuously flowing mobile phase stream that carries the sample into the HPLC 
column. The column contains the chromatographic packing material needed to effect the 
separation. This packing material is called the stationary phase because it is held in place 
by the column hardware. A detector is needed to see the separated compound bands as 
they elute from the HPLC column (most compounds have no color, so we cannot see 
them with our eyes).  
The mobile phase exits the detector and can be sent to waste, or collected, as desired. 
When the mobile phase contains a separated compound band, HPLC provides the ability 
to collect this fraction of the eluate containing that purified compound for further study. 
This is called preparative chromatography. The high-pressure tubing and fittings are used 
to interconnect the pump, injector, column, and detector components to form the conduit 
for the mobile phase, sample, and separated compound bands. 
The detector is wired to the computer data station, the HPLC system component that 
records the electrical signal needed to generate the chromatogram on its display and to 
identify and quantitate the concentration of the sample constituents. Since sample 
compound characteristics can be very different, several types of detectors have been 
developed. For example, if a compound can absorb ultraviolet light, a UV-absorbance 
detector is used. If the compound fluoresces, a fluorescence detector is used. If the 
compound does not have either of these characteristics, a more universal type of detector 
is used, such as an evaporative-light-scattering detector (ELSD). The most powerful 
approach is the use multiple detectors in series. For example, a UV and/or ELSD detector 
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may be used in combination with a mass spectrometer (MS) to analyze the results of the 
chromatographic separation. This provides, from a single injection, more comprehensive 
information about an analyte. The practice of coupling a mass spectrometer to an HPLC 
system is called LC/MS. 
 
3.1. HPLC OPERATION 
The compounds contained in a sample are given in Figure 6. Mobile phase enters the 
column from the left, passes through the particle bed, and exits at the right. Flow 
direction is represented by green arrows. First, consider the top image; it represents the 
column at time zero (the moment of injection), when the sample enters the column and 
begins to form a band.  
The sample shown here, a mixture of yellow, red, and blue dyes, appears at the inlet of 
the column as a single black band. (This sample could be anything that can be dissolved 
in a solvent; typically the compounds would be colorless and the column wall opaque, so 
it would need a detector to see the separated compounds as they elute.) After a few 
minutes (lower image), during which mobile phase flows continuously and steadily past 
the packing material particles, the individual dyes have moved in separate bands at 
different speeds. This is because there is a competition between the mobile phase and the 
stationary phase for attracting each of the dyes or analytes. Notice that the yellow dye 
band moves the fastest and is about to exit the column. The yellow dye likes (is attracted 
to) the mobile phase more than the other dyes. Therefore, it moves at a faster speed, 
closer to that of the mobile phase. The blue dye band likes the packing material more 
than the mobile phase. Its stronger attraction to the particles causes it to move 
significantly slower. In other words, it is the most retained compound in this sample 
mixture. The red dye band has an intermediate attraction for the mobile phase and 
therefore moves at an intermediate speed through the column. Since each dye band 
moves at different speed, we are able to separate it chromatographically. 
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Figure 6: Understanding How a Chromatographic Column Works – Bands 
As the separated dye bands leave the column, they pass immediately into the detector. 
The detector contains a flow cell that detects each separated compound band against a 
background of mobile phase (Figure 7). (Solutions of many compounds at typical HPLC 
analytical concentrations are colorless.) An appropriate detector has the ability to sense 
the presence of a compound and send its corresponding electrical signal to a computer 
data station. A choice is made among many different types of detectors, depending upon 
the characteristics and concentrations of the compounds that need to be separated and 
analyzed. A chromatogram is a representation of the separation that has chemically 
(chromatographically) occurred in the HPLC system. A series of peaks rising from a 
baseline is drawn on a time axis. Each peak represents the detector response for a 
different compound. The chromatogram is plotted by the computer data station (Figure 
7). 
 
 
 
 
 
 
Figure 7: How Peaks Are Created 
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In Figure 7, the yellow band has completely passed through the detector flow cell; the 
electrical signal generated has been sent to the computer data station. The resulting 
chromatogram has begun to appear on screen. The chromatogram begins when the 
sample was first injected and starts as a straight line set near the bottom of the screen. 
This is called the baseline; it represents pure mobile phase passing through the flow cell 
over time. As the yellow analyte band passes through the flow cell, a stronger signal is 
sent to the computer. The line curves, first upward, and then downward, in proportion to 
the concentration of the yellow dye in the sample band. This creates a peak in the 
chromatogram. After the yellow band passes completely out of the detector cell, the 
signal level returns to the baseline; the flow cell now has, once again, only pure mobile 
phase, it is the first peak drawn. 
A little while later, the red band reaches the flow cell. The signal rises up from the 
baseline as the red band first enters the cell, and the peak representing the red band 
begins to be drawn. The blue band, the most strongly retained, travels at the slowest rate 
and elutes after the red band. The dotted line shows that a completed chromatogram’s 
appearance if the run continue to its conclusion. It is interesting that the width of the blue 
peak will be the broadest because the width of the blue analyte band, while narrowest on 
the column, becomes the widest as it elutes from the column. This is because it moves 
more slowly through the chromatographic packing material bed and requires more time 
(and mobile phase volume) to be eluted completely. Since mobile phase is continuously 
flowing at a fixed rate, this means that the blue band widens and is more dilute. Since the 
detector responds in proportion to the concentration of the band, the blue peak is lower in 
height, but larger in width. 
In Figure 7, three dye compounds are represented by three peaks separated in time in the 
chromatogram. Each elutes at a specific location, measured by the elapsed time between 
the moment of injection (time zero) and the time when the peak maximum elutes. By 
comparing each peak’s retention time (tR) with that of injected reference standards in the 
same chromatographic system (same mobile and stationary phase), a chromatographer 
may be able to identify each compound. 
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3.2. ISOCRATIC AND GRADIENT LC SYSTEM OPERATION 
Two basic elution modes are used in HPLC. The first is called isocratic elution. In this 
mode, the mobile phase, either a pure solvent or a mixture, remains the same throughout 
the run. A typical system is outlined in Figure 8. 
In the simplest case, shown in Figure 9, there are two bottles of solvents and two pumps. 
The speed of each pump is managed by the gradient controller to deliver more or less of 
each solvent over the course of the separation. The two streams are combined in the 
mixer to create the actual mobile phase composition that is delivered to the column over 
time. At the beginning, the mobile phase contains a higher proportion of the weaker 
solvent (Solvent A). Over time, the proportion of the stronger solvent (Solvent B) is 
increased, according to a predetermined timetable. In Figure 9, the mixer is downstream 
of the pumps; thus the gradient is created under high pressure. Other HPLC systems are 
designed to mix multiple streams of solvents under low pressure, ahead of a single pump. 
A gradient proportioning valve selects from the four solvent bottles, changing the 
strength of the mobile phase over time (Figure 10). 
 
 
 
 
 
 
 
Figure 8: Isocratic LC System 
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Figure 9: High-Pressure-Gradient System 
 
 
Figure 10: Low-Pressure-Gradient System 
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3.3. HPLC SCALE [ANALYTICAL, PREPARATIVE AND PROCESS] 
HPLC can also be used to purify and collect desired amounts of each compound, using a 
fraction collector downstream of the detector flow cell. This process is called preparative 
chromatography (Figure 11).In preparative chromatography, the scientist is able to collect 
the individual analytes as they elute from the column (e.g., in this example: yellow, then 
red, then blue). The fraction collector selectively collects the eluate that now contains a 
purified analyte, for a specified length of time. The vessels are moved so that each 
collects only a single analyte peak. A scientist determines goals for purity level and 
amount. Coupled with knowledge of the complexity of the sample and the nature and 
concentration of the desired analytes relative to that of the matrix constituents, these 
goals, in turn, determine the amount of sample that needs to be processed and the 
required capacity of the HPLC system.  
In general, as the sample size increases, the size of the HPLC column will become larger 
and the pump will need higher volume-flow-rate capacity. Determining the capacity of an 
HPLC system is called selecting the HPLC scale. Table 1 lists various HPLC scales and 
their chromatographic objectives. 
 
 
Figure 11: HPLC System for Purification: Preparative Chromatography 
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Scale Chromatographic Objective 
Analytical Information (Compound Identity and Concentration) 
Semi-Preparative Small amount of purified compound (less than 0.5 gm) 
Preparative Larger amount of purified compound (more than 0.5 gm) 
Process (Industrial) Manufacturing Quantities (Gram to Kilograms) 
Table 1: Chromatographic Scale and its objective 
 
3.4. HPLC SEPARATION MODES 
In general, three primary characteristics of chemical compounds can be used to create 
HPLC separations. They are as under. 
 
3.4.1. SEPARATION BASED ON: POLARITY 
A molecule’s structure, activity, and physicochemical characteristics are determined by 
the arrangement of its constituent atoms and the bonds between them. Within a molecule, 
a specific arrangement of certain atoms that is responsible for special properties and 
predictable chemical reactions is called a functional group. This structure often 
determines whether the molecule is polar or non-polar. Organic molecules are sorted into 
classes according to the principal functional group(s) each contains. Using a separation 
mode based on polarity, the relative chromatographic retention of different kinds of 
molecules is largely determined by the nature and location of these functional groups. As 
shown in Figure 12, classes of molecules can be ordered by their relative retention into a 
range or spectrum of chromatographic polarity from highly polar to highly non-polar. 
 
Figure 12: Chromatographic Polarity Spectrum by Analyte Functional Group 
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Water (a small molecule with a high dipole moment) is a polar compound. Benzene (an 
aromatic hydrocarbon) is a non-polar compound. Molecules with similar 
chromatographic polarity tend to be attracted to each other; those with dissimilar polarity 
exhibit much weaker attraction, if any, and may even repel one another. This becomes the 
basis for chromatographic separation modes based on polarity. 
Another way to think of this is by the familiar analogy: oil (non-polar) and water (polar). 
Unlike in magnetism where opposite poles attract each other, chromatographic 
separations based on polarity depend upon the stronger attraction between likes and the 
weaker attraction between opposites. Remember, “Like attracts like” in polarity-based 
chromatography. 
Figure 13, 14, and 15 display typical chromatographic polarity ranges for mobile phases, 
stationary phases, and sample analytes, respectively. Let’s consider each in turn to see 
how a chromatographer chooses the appropriate phases to develop the attraction 
competition needed to achieve a polarity-based HPLC separation. 
 
Figure 13: Mobile Phase Chromatographic Polarity Spectrum 
 
A scale, such as that shown in Figure 13, upon which some common solvents are placed 
in order of relative chromatographic polarity is called an eluotropic series. Mobile phase 
molecules that compete effectively with analyte molecules for the attractive stationary 
phase sites displace these analytes, causing them to move faster through the column 
(weakly retained). Water is at the polar end of mobile-phase-solvent scale, while hexane, 
an aliphatic hydrocarbon, is at the non-polar end. In between, single solvents, as well as 
miscible-solvent mixtures (blended in proportions appropriate to meet specific separation 
requirements), can be placed in order of elution strength. Which end of the scale 
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represents the ‘strongest’ mobile phase depends upon the nature of the stationary phase 
surface where the competition for the analyte molecules occurs. 
Silica has an active, hydrophilic (water-loving) surface containing acidic silanol (silicon-
containing analog of alcohol) functional groups. Consequently, it falls at the polar end of 
the stationary-phase scale shown in Figure 14. The activity or polarity of the silica 
surface may be modified selectively by chemically bonding to it less polar functional 
groups (bonded phase). Examples shown here include, in order of decreasing polarity, 
cyanopropylsilyl- (CN), n-octylsilyl- (C8), and n-octadecylsilyl- (C18, ODS)moieties on 
silica. The latter is a hydrophobic (water-hating), very non-polar packing. 
 
Figure 14: Stationary Phase Particle Chromatographic Polarity Spectrum 
 
 
 
Figure 15: Compound/Analyte Chromatographic Polarity Spectrum 
Figure 15 repeats the chromatographic polarity spectrum of our sample. After considering 
the polarity of both phases, then, for a given stationary phase, a chromatographer must 
choose a mobile phase in which the analytes of interest are retained, but not so strongly 
that they cannot be eluted. Among solvents of similar strength, the chromatographer 
considers which phase combination may best exploit the more subtle differences in 
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analyte polarity and solubility to maximize the selectivity of the chromatographic system. 
Like attracts like, but, as you probably can imagine from the discussion so far, creating a 
separation based upon polarity involves knowledge of the sample and experience with 
various kinds of analytes and retention modes.  
To summarize, the chromatographer will choose the best combination of a mobile phase 
and particle stationary phase with appropriately opposite polarities. Then, as the sample 
analytes move through the column, the rule like attracts like will determine which 
analytes slow down and which proceed at a faster speed. 
3.4.1.1. HYDROPHILIC-INTERACTION CHROMATOGRAPHY[HILIC] 
HILIC may be viewed as a variant of normal-phase chromatography. In normal-phase 
chromatography, the mobile phase is 100% organic. Only traces of water are present in 
the mobile phase and in the pores of the polar packing particles. Polar analytes bind 
strongly to the polar stationary phase and may not elute. Adding some water (< 20%) to 
the organic mobile phase (typically an aprotic solvent like acetonitrile) makes it possible 
to separate and elute polar compounds that are strongly retained in the normal-phase 
mode (or weakly retained in the reversed-phase mode), Water, a very polar solvent, 
competes effectively with polar analytes for the stationary phase. HILIC may be run in 
either isocratic or gradient elution modes. 
Polar compounds that are initially attracted to the polar packing material particles can be 
eluted as the polarity (strength) of the mobile phase is increased (by adding more water). 
Analytes are eluted in order of increasing hydrophilicity (chromatographic polarity 
relative to water). Buffers or salts may be added to the mobile phase to keep ionizable 
analytes in a single form. 
3.4.1.2. HYDROPHOBIC-INTERACTION CHROMATOGRAPHY[HIC]  
HIC is a type of reversed-phase chromatography that is used to separate large 
biomolecules, such as proteins. It is usually desirable to maintain these molecules intact 
in an aqueous solution, avoiding contact with organic solvents or surfaces that might 
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denature them. HIC takes advantage of the hydrophobic interaction of large molecules 
with a moderately hydrophobic stationary phase, e.g., butyl-bonded (C4), rather than 
octadecyl-bonded (C18), silica. Initially, higher salt concentrations in water will 
encourage the proteins to be retained (salted out) on the packing. Gradient separations are 
typically run by decreasing salt concentration. In this way, biomolecules are eluted in 
order of increasing hydrophobicity. 
 
4. INTRODUCTION TO ULTRA PERFORMANCE LC[18][19] 
In 2004, further advances in instrumentation and column technology were made to 
achieve very significant increases in resolution, speed, and sensitivity in liquid 
chromatography. Columns with smaller particles (1.7 micron) and instrumentation with 
specialized capabilities designed to deliver mobile phase at 15,000 psi (1,000 bars) were 
needed to achieve a new level of performance. A new system had to be holistically 
created to perform ultra-performance liquid chromatography, now known as UPLC 
technology. 
Basic research is being conducted today by scientists working with columns containing 
even smaller 1-micron-diameter particles and instrumentation capable of performing at 
100,000 psi. This provides a glimpse of what we may expect in the future. UPLC refers 
to Ultra Performance Liquid Chromatography. It improves in three areas: 
chromatographic resolution, speed and sensitivity analysis. It uses fine particles and saves 
time and reduces solvent consumption [20-24].  UPLC is comes from HPLC. HPLC has 
been the evolution of the packing materials used to effect the separation. An underlying 
principle of HPLC dictates that as column packing particle size decreases, efficiency and 
thus resolution also increases. As particle size decreases to less than 2.5μm, there is a 
significant gain in efficiency and it’s doesn’t diminish at increased linear velocities or 
flow rates according to the common Van Deemter equation [25]. By using smaller 
particles, speed and peak capacity (number of peaks resolved per unit time) can be 
extended to new limits which is known as Ultra Performance.  
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The classic separation method is of HPLC (High Performance Liquid Chromatography) 
with many advantages like robustness, ease of use, good selectivity and adjustable 
sensitivity. Its main limitation is the lack of efficiency compared to gas chromatography 
or the capillary electrophoresis [26, 27] due to low diffusion coefficients in liquid phase, 
involving slow diffusion of analytes in the stationary phase. The Van Deemter equation 
shows that efficiency increases with the use of smaller size particles but this leads to a 
rapid increase in back pressure, while most of the HPLC system can operate only up to 
400 bar. That is why short columns filled with particles of about 2μm are used with these 
systems, to accelerate the analysis without loss of efficiency, while maintaining an 
acceptable loss of load.  
To improve the efficiency of HPLC separations, the following can be done, 
 
(1) Work at higher temperatures  
(2) Use of monolithic columns 
 
4.1. USE OF THE UPLC SYSTEM  
 
Elevated-temperature chromatography also allows for high flow rates by lowering the 
viscosity of the mobile phase, which significantly reduces the column backpressure [28, 
29]. Monolithic columns contain a polymerized porous support structure that provides 
lower flow resistances than conventional particle-packed columns [30-32].  
 
4.1.1. PRINCIPLE 
 
The UPLC is based on the principal of use of stationary phase consisting of particles less 
than 2 μm (while HPLC columns are typically filled with particles of 3 to 5 μm). The 
underlying principles of this evolution are governed by the van Deemter equation, which 
is an empirical formula that describes the relationship between linear velocity (flow rate) 
and plate height (HETP or column efficiency). The Van Deemter curve, governed by an 
equation with three components shows that the usable flow range for a good efficiency 
with small diameter particles is much greater than for larger diameters [33-36]  
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H=A+B/v+Cv  
Where A, B and C are constants and v is the linear velocity, the carrier gas flow rate. The 
A term is independent of velocity and represents "eddy" mixing. It is smallest when the 
packed column particles are small and uniform. The B term represents axial diffusion or 
the natural diffusion tendency of molecules. This effect is diminished at high flow rates 
and so this term is divided by v. The C term is due to kinetic resistance to equilibrium in 
the separation process.  
The kinetic resistance is the time lag involved in moving from the gas phase to the 
packing stationary phase and back again. The greater the flow of gas, the more a 
molecule on the packing tends to lag behind molecules in the mobile phase. Thus this 
term is proportional to v.  
Therefore it is possible to increase throughput, and thus the speed of analysis without 
affecting the chromatographic performance. The advent of UPLC has demanded the 
development of a new instrumental system for liquid chromatography, which can take 
advantage of the separation performance (by reducing dead volumes) and consistent with 
the pressures (about 8000 to 15,000 PSI, compared with 2500 to 5000 PSI in HPLC). 
Efficiency is proportional to column length and inversely proportional to the particle size 
[37]. Therefore, the column can be shortened by the same factor as the particle size 
without loss of resolution. The application of UPLC resulted in the detection of additional 
drug metabolites, superior separation and improved spectral quality [38, 39]. 
 
4.1.2. SAMPLE INJECTION 
In UPLC, sample introduction is critical. Conventional injection valves, either automated 
or manual, are not designed and hardened to work at extreme pressure. To protect the 
column from extreme pressure fluctuations, the injection process must be relatively 
pulse-free and the swept volume of the device also needs to be minimal to reduce 
potential band spreading. A fast injection cycle time is needed to fully capitalize on the 
speed afforded by UPLC, which in turn requires a high sample capacity. Low volume 
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injections with minimal carryover are also required to increase sensitivity [40]. There are 
also direct injection approaches for biological samples [41, 42]. 
4.1.3. UPLC COLUMNS 
 
Resolution is increased in a 1.7 μm particle packed column because efficiency is better. 
Separation of the components of a sample requires a bonded phase that provides both 
retention and selectivity. Four bonded phases are available for UPLC separations: 
ACQUITY UPLCTM BEH C18 and C8 (straight chain alkyl columns), ACQUITY UPLC 
BEH Shield RP18 (embedded polar group column) and ACQUITY UPLC BEH Phenyl 
(phenyl group tethered to the silyl functionality with a C6 alkyl) [43]. Column chemistry 
provides a different combination of hydrophobicity, silanol activity, hydrolytic stability 
and chemical interaction with analytes. 
  
ACQUITY UPLC BEH C18 and C8 columns are considered the universal columns of 
choice for most UPLC separations by providing the widest pH range. They incorporate 
trifunctional ligand bonding chemistries which produce superior low pH stability. This 
low pH stability is combined with the high pH stability of the 1.7 μm BEH particle to 
deliver the widest usable pH operating range. ACQUITY UPLC BEH Shield RP18 
columns are designed to provide selectivities that complement the ACQUITY UPLC 
BEH C18
 
and C8
 
phases.  
 
ACQUITY UPLC BEH Phenyl columns utilize a trifunctional C6
 
alkyl tether between 
the phenyl ring and the silyl functionality. This ligand, combined with the same 
proprietary endcapping processes as the ACQUITY UPLC BEH C18
 
and C8
 
columns, 
provides long column lifetimes and excellent peak shape. This unique combination of 
ligand and endcapping on the 1.7 μm BEH particle creates a new dimension in selectivity 
allowing a quick match to the existing HPLC column. An internal dimension (ID) of 2.1 
mm column is used. For maximum resolution, choose a 100 mm length and for faster 
analysis, and higher sample throughput, choose 50 mm column. 
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Figure 17: Different column chemistry available for UPLC 
Half-height peak widths of less than one second are obtained with 1.7μm particles, which 
gives significant challenges for the detector. In order to integrate an analyte peak 
accurately and reproducibly, the detector sampling rate must be high enough to capture 
enough data points across the peak. The detector cell must have minimal dispersion 
(volume) to preserve separation efficiency. Conceptually, the sensitivity increase for 
UPLC detection should be 2-3 times higher than HPLC separations, depending on the 
detection technique. MS detection is significantly enhanced by UPLC; increased peak 
concentrations with reduced chromatographic dispersion at lower flow rates promote 
increased source ionization efficiencies. 
The ACQUITY UPLC System consists of a binary solvent manager, sample manager 
including the column heater, detector, and optional sample organizer. The binary solvent 
manager uses two individual serial flow pumps to deliver a parallel binary gradient. 
There are built-in solvent select valves to choose from up to four solvents. There is a 
15,000-psi pressure limit (about 1000 bar) to take full advantage of the sub-2μm particles. 
The sample manager also incorporates several technology advancements. Using pressure 
assisted sample introduction, low dispersion is maintained through the injection process, 
and a series of pressures transducers facilitate self-monitoring and diagnostics. It uses 
needle-in-needle sampling for improved ruggedness and a needle calibration sensor 
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increases accuracy. Injection cycle time is 25 seconds without a wash and 60 sec with a 
dual wash used to further decrease carry over. A variety of microtiter plate formats (deep 
well, mid height, or vials) can also be accommodated in a thermostatically controlled 
environment. Using the optional sample organizer, the sample manager can inject from 
up to 22 microtiter plates. The sample manager also controls the column heater. Column 
temperatures up to 65°C can be attained. To minimize sample dispersion, a “pivot out” 
design allows the column outlet to be placed in closer proximity to the source inlet of an 
MS detector [44].  
For UPLC detection, the tunable UV/Visible detector is used which includes new 
electronics and firmware to support Ethernet communications at the high data rates. 
Conventional absorbance-based optical detectors are concentration sensitive detectors, 
and for UPLC use, the flow cell volume would have to be reduced in standard 
UV/Visible detectors to maintain concentration and signal. According to Beer’s Law, 
smaller volume conventional flow cells would also reduce the path length upon which the 
signal strength depends. A reduction in cross-section means the light path is reduced, and 
transmission drops with increasing noise. Therefore, if a conventional HPLC flow cell 
were used, UPLC sensitivity would be compromised. The ACQUITY Tunable 
UV/Visible detector cell consists of a light guided flow cell equivalent to an optical fiber. 
Light is efficiently transferred down the flow cell in an internal reflectance mode that still 
maintains a 10mm flow cell path length with a volume of only 500mL. Tubing and 
connections in the system are efficiently routed to maintain low dispersion and to take 
advantage of leak detectors that interact with the software to alert the user to potential 
problems [45]. 
4.1.4.  ADVANTAGES 
1. Decreases run time and increases sensitivity. 
2. Provides the selectivity, sensitivity, and dynamic range of LC analysis. 
3. Maintaining resolution performance.  
4. Expands scope of Multiresidue Methods. 
5. UPLC’s fast resolving power quickly quantifies related and unrelated compounds. 
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6. Faster analysis through the use of a novel separation material of small particle size. 
7. Operation cost is reduced. 
8. Less solvent consumption. 
9. Reduces process cycle times, so that more product can be produced with existing 
resources. 
10. Increases sample throughput and enables manufacturers to produce more material that 
consistently meet or exceeds the product specifications, potentially eliminating 
variability, failed batches, or the need to re-work material [46, 47]. 
11.  Delivers real-time analysis in step with manufacturing processes. 
12.  Assures end-product quality, including final release testing. 
 
4.1.5.  DISADVANTAGES 
 
Due to increased pressure requires more maintenance and reduces the life of the columns 
of this type. So far performance similar or even higher has been demonstrated by using 
stationary phases of size around 2 μm without the adverse effects of high pressure. In 
addition, the phases of less than 2 μm are generally non-regenerable and thus have 
limited use [48, 49]. 
 
 
5. APPLICATIONS OF CHROMATOGRAPHY 
 
In recent times chromatography is most widely used analytical tool for various 
applications. Hence it could not be possible for include all of it but some of very 
important and recently developed applications are discussed here, 
5.1.  AFFINITY CHROMATOGRAPHY: CLINICAL APPLICATIONS [50] 
Affinity chromatography is a type of liquid chromatography that makes use of biological-
like interactions for the separation and specific analysis of sample components. This 
work describes the basic principles of affinity chromatography and examines its use in 
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the testing of clinical samples, with an emphasis on HPLC-based methods. Some 
traditional applications of this approach include the use of boronate, lectin, protein A or 
protein G, and immunoaffinity supports for the direct quantification of solutes. Newer 
techniques that use antibody-based columns for on- or off-line sample extraction are 
examined in detail, as are methods that use affinity chromatography in combination with 
other analytical methods, such as reversed-phase liquid chromatography, gas 
chromatography, and capillary electrophoresis. Indirect analyte detection methods are 
also described in which immunoaffinity chromatography is used to perform flow-based 
immunoassays. Other applications that are include affinity-based chiral separations and 
the use of affinity chromatography for the study of drug or hormone interactions with 
binding proteins. Some areas of possible future developments are then considered, such 
as tandem affinity methods and the use of synthetic dyes, immobilized metal ions, 
molecular imprints, or aptamers as affinity ligands for clinical analyte. 
5.2.  PROTEIN PURIFICATION : MEMBRANE CHROMATOGRAPHY [51] 
Adsorption chromatography is increasingly used for protein purification and medical 
applications. Synthetic membranes have advantages as support matrices in comparison to 
conventional bead supports because they are not compressible and they eliminate 
diffusion limitations. As a result, higher throughput and faster processing times are 
possible in membrane systems. In this paper, there are various applications of membrane 
chromatography by focusing on affinity, ion exchange, hydrophobic interaction, 
reversed-phase and multistage chromatography. The prospects of further development of 
membrane chromatography are massive. 
5.3. CHROMATOGRAPHIC AND ELECTROPHORETIC METHODOLOGY 
TO THE SPECIATION OF ORGANOMERCURY COMPOUNDS IN 
FOOD ANALYSIS [52] 
Trace metals such as mercury, especially its organic compounds, are an important risk to 
the environment and to man due to their accumulation in the food chain. For this reason, 
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the routine determination of the very toxic methylmercury and of other organic and 
inorganic mercury compounds in marine and land animals, vegetables, fruits and fresh 
water is of increasing importance in health and environmental control programmes 
throughout the world. The majority of speciation methods for organomercurials involve a 
series of fundamental steps for the identification and quantification of samples of 
biological origin: extraction or isolation from the matrix; derivatisation and 
concentration; detection; separation of different species of interest and of interference. 
Each of these steps, as part of the chromatographic analysis of MeHg and of other 
organomercurials is revised using food samples. 
 
5.4. ENANTIOSELECTIVE CHROMATOGRAPHY AS A ALTERNATIVE 
FOR THE PREPARATION OF DRUG ENANTIOMERS [53] 
The preparative separation of enantiomers by chromatography on chiral stationary phases 
(CSPs) has been recognized as being a useful alternative to the more conventional 
approaches such as enantioselective synthesis and enzymatically catalyzed 
transformations. The possible contribution of enantioselective chromatography with 
respect to the preparation of enantiomerically pure compounds is reviewed in the context 
of the competitive approaches and depending on the application scale, with a special 
emphasis on the recent progresses achieved in this particular field of separation. 
 
5.5. MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY [54] 
Compared to MEKC, the presence of a water-immiscible oil phase in the microemulsion 
droplets of microemulsion EKC (MEEKC) gives rise to some special properties, such as 
enhanced solubilization capacity and enlarged migration window, which could allow for 
the improved separation of various hydrophobic and hydrophilic compounds, with 
reduced sample pretreatment steps, unique selectivities and/or higher efficiencies. 
Typically, stable and optically clear oil-in-water microemulsions containing a surfactant 
(SDS), oil (octane or heptane), and cosurfactant (1-butanol) in phosphate buffer are 
employed as separation media in conventional MEEKC. However, in recent years, the 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                              Page 33 
 
 
Chapter – 1                                                                                                                                                    General Introduction 
applicability of reverse MEEKC (water-in-oil microemulsions) has also been 
demonstrated, such as for the enhanced separation of highly hydrophobic substances. 
Also, during the past few years, the development and application of MEEKC for the 
separation of chiral molecules has been expanded, based on the use of enantioselective 
microemulsions that contained a chiral surfactant or chiral alcohol.  
On the other hand, the application of MEEKC for the characterization of the lipophilicity 
of chemical substances remains an active and important area of research, such as the use 
of multiplex MEEKC for the high-throughput determination of partition coefficients 
(log P values) of pharmaceutical compounds. Emphases are placed on the discussion of 
MEEKC in the separation of chiral molecules and highly hydrophobic substances, as well 
as in the determination of partition coefficients, followed by a survey of recent 
applications of MEEKC in the analysis of pharmaceuticals, cosmetics and health-care 
products, biological and environmental compounds, plant materials, and foods. 
 
5.6. LC–MS IN FORENSIC & CLINICAL TOXICOLOGY [55] 
Liquid chromatographic–mass spectrometric (LC–MS) procedures are available for the 
identification and/or quantification of drugs of abuse, therapeutic drugs, poisons and/or 
their metabolites in biosamples (whole blood, plasma, serum, urine, cerebrospinal fluid, 
vitreous humor, liver or hair) of humans or animals (cattle, dog, horse, mouse, pig or rat). 
This is relevant to clinical toxicology, forensic toxicology, doping control or drug 
metabolism and pharmacokinetics. 
 
5.7. LC–MS TO THE CHARACTERIZATION OF FOOD PROTEINS AND 
DERIVED PEPTIDES [56] 
This review describes the development of mass spectrometry off-line and on-line coupled 
with liquid chromatography to the analysis of food proteins. It includes the significant 
results recently obtained in the field of milk, egg and cereal proteins. This paper also 
outlines the research carried out in the area of food protein hydrolysates, which are 
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important components in foodstuffs due to their functional properties. Liquid 
chromatography and mass spectrometry have been particularly used for the 
characterization of food peptides and especially in dairy products. 
 
5.8. AFFINITY CHROMATOGRAPHY IN PROTEOMICS [57] 
Affinity chromatography is a powerful protein separation method that is based on the 
specific interaction between immobilized ligands and target proteins. Peptides can also be 
separated effectively by affinity chromatography through the use of peptide-specific 
ligands. Both two-dimensional electrophoresis (2-DE) - and non-2-DE-based proteomic 
approaches benefit from the application of affinity chromatography. Before protein 
separation by 2-DE, affinity separation is used primarily for preconcentration and 
pretreatment of samples. Those applications entail the removal of one protein or a class 
of proteins that might interfere with 2-DE resolution, the concentration of low-abundance 
proteins to enable them to be visualized in the gel, and the classification of total protein 
into two or more groups for further separation by gel electrophoresis. Non-2-DE-based 
approaches have extensively employed affinity chromatography to reduce the complexity 
of protein and peptide mixtures. Prior to mass spectrometry (MS), preconcentration and 
capture of specific proteins or peptides to enhance sensitivity can be accomplished by 
using affinity adsorption.  Affinity purification of protein complexes followed by 
identification of proteins by MS serves as a powerful tool for generating a map of 
protein–protein interactions and cellular locations of complexes. Affinity 
chromatography of peptide mixtures, coupled with mass spectrometry, provides a tool for 
the study of protein posttranslational modification (PTM) sites and quantitative 
proteomics.  
 
Quantitation of proteomes is possible via the use of isotope-coded affinity tags and 
isolation of proteolytic peptides by affinity chromatography. An emerging area of 
proteomics technology development is miniaturization. Affinity chromatography is 
becoming more widely used for exploring PTM and protein–protein interactions, 
especially with a view toward developing new general tag systems and strategies of 
chemical derivatization on peptides for affinity selection. More applications of affinity-
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based purification can be expected, including increasing the resolution in 2-DE, 
improving the sensitivity of MS quantification, and incorporating purification as part of 
multidimensional liquid chromatography  
 
5.9. CLINICAL APPLICATIONS OF GAS CHROMATOGRAPHY AND GAS 
CHROMATOGRAPHY–MASS SPECTROMETRY OF STEROIDS [58] 
This review article underlines the importance of gas chromatography–mass spectrometry 
(GC–MS) for determination of steroids in man. The use of steroids labelled with stable 
isotopes as internal standard and subsequent analysis by GC–MS yields up to now the 
only reliable measurement of steroids in serum. Isotope dilution GC–MS is the reference 
method for evaluation of routine analysis of serum steroid hormones. GC–MS is an 
important tool for detection of steroid hormone doping and combined with a combustion 
furnace and an isotope ratio mass spectrometer the misuse of testosterone by athletes can 
be discovered. Finally the so called urinary steroid profile by GC and GC–MS is the 
method of choice for detection of steroid metabolites in health and disease. 
 
5.10. LC-MS/MS FOR THE ANALYSIS OF PHARMACEUTICAL RESIDUES 
IN ENVIRONMENTAL SAMPLES [59] 
 
Pharmaceutical residues are environmental contaminants of recent concern and the 
requirements for analytical methods are mainly dictated by low concentrations found in 
aqueous and solid environmental samples. This can be determined by LC-MS/MS. 
Pharmaceuticals included are antibiotics, non-steroidal anti-inflammatory drugs, β-
blockers, lipid regulating agents and psychiatric drugs. This can deal by advanced aspects 
of current LC–MS/MS methodology. 
 
5.11. CHROMATOGRAPHY AS A TOOL FOR SELECTED ANTIBIOTIC 
CLASSES: PHARMACOKINETIC APPLICATIONS [60] 
The first antibiotic discovered, penicillin, appeared on the market just after the Second 
World War. Intensive research in subsequent years led to the discovery and development 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                              Page 36 
 
 
Chapter – 1                                                                                                                                                    General Introduction 
of cephalosporins, aminoglycosides, tetracyclines and rifamycin. The chemotherapeutic 
quinolones and the more recently discovered fluoroquinolones have added promising new 
therapeutic weapons to fight the microbial challenge.  
The major role pharmacokinetics has played in developing these compounds should be 
highlighted. Plasma concentration–time profiles and the therapeutic activity evoked by 
these compounds allow the therapeutic window, doses and dose turnovers to be 
appropriately defined, as well as possible dose adjustment to be made in renal failure. 
The pharmacokinetics of antimicrobial agents was initially explored by using 
microbiological methods, but these lack specificity. The HPLC technique with UV, 
fluorimetric, electrochemical and, in some cases, mass spectrometry detection has 
satisfactorily solved the problem of antimicrobial agent assay for pharmacokinetic, 
bioavailability and bioequivalence purposes alike. Indeed, in these studies, plasma 
concentrations of the given analyte must be followed up for a period ≥3 times the half-
life, which calls for specific sensitive assays. 
 
5.12. LC-MASS SPECTROMETRY IN ANALYTICAL TOXICOLOGY [61] 
 
Liquid chromatography-mass spectrometry (LC-MS), after long-term development that 
has introduced seven major interfacing techniques, is finally suitable for application in 
the field of analytical toxicology. Various compound classes can be analyzed, and 
sensitivities for more or less polar analytes that are as good as or better than those of gas 
chromatography-mass spectrometry can be obtained with modern interfaces. In addition, 
because ionization is often softer than classical electron impact, some LC-MS interfaces 
are able to handle fragile species that are otherwise not amenable to MS. 
 
5.13. DETERMINATION OF PESTICIDE RESIDUES IN BIO SAMPLES [62] 
 
The use of hyphenated technique, liquid chromatography/mass spectrometry (LC–MS) 
for the identification and quantification of pesticides and their metabolites in human 
biosamples are very well known. The first applications of LC–MS in this field began in 
the early 1990s. Since then, increasing interest has been shown in applying this powerful 
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technique, with most applications dealing with the determination of a variety of 
chemically diverse metabolites in urine. The use of different LC–MS interfaces and mass 
spectral detection modes are discussed. Special attention is given to tandem mass 
spectrometry (MS/MS) due to its inherent advantages of increased sensitivity and 
selectivity, as well as its advantages for identification and confirmation of analytes in 
samples. 
 
5.14. MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 
TO THE ANALYSIS OF ILLICIT DRUG SEIZURES [63] 
Micellar electrokinetic capillary chromatography (MECC) is used for the analysis of 
illicit drug seizures. Quantitative analysis of various drugs, including heroin, opium, 
cocaine, amphetamines, LSD and anabolic steroids are available. Due to its high 
efficiency, high selectivity and general applicability, MECC is well suited for forensic 
drug analyses. 
 
5.15. ENVIRONMENTAL ANALYSIS USING MULTIDIMENSIONAL GAS 
CHROMATOGRAPHY AND COMPREHENSIVE GC [64] 
 
Developments in coupled-column gas chromatography methods for qualitative analysis 
of selected environmental toxicants such as dioxin, polychlorinated biphenyls (PCBs), 
polycyclic aromatic hydrocarbons (PAHs), etc are easily available. In particular, the new 
technique of GC×GC will be introduced, and its role, and the promise it offers to this 
field is discussed. The benefits of enhanced separation to quantitative analysis are 
considered. In order to perform an accurate risk assessment, both the dose and biological 
effects of environmental toxicants have to be determined with a high degree of certainty. 
This is most often achieved by using chromatographic methods. Given the complexity of 
most environmental sample extracts, single-column gas chromatography is unable to 
fully resolve all the components of interest frequently leading to a positive bias in the 
reported concentrations. Advanced separation tools, such as multidimensional gas 
chromatography (MDGC), were investigated quite early and demonstrated improvements 
in separation. 
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5.16. THE DETERMINATION OF AMINES BY GAS CHROMATOGRAPHY 
AND THEIR APPLICATIONS IN ENVIRONMENTAL ANALYSIS [65] 
 
The environmental analysis of amines is important to preserve human health because 
these compounds often have toxic effects. Gas chromatography (GC) of free amines is 
generally unsatisfactory owing to the adsorption and decomposition of the solutes on the 
column. Derivatization of amines is employed to reduce the polarity and to improve the 
GC properties. Derivatization reactions for the determination of amines by GC could give 
the best results. Many other applications of chromatography as an important analytical 
tool are also available in literature. Only few of them are presented here, scientists are 
more concentrated on the unfolded area of chromatography and its applications. The vast 
area of chromatography is now the target for the analytical scientist to resolve the critical 
problems and also for the cost effective and hazardless analysis of different chemical 
entities. 
 
 
6. INTRODUCTION TO ANALYTICAL METHOD VALIDATION 
 
6.1. ANALYTICAL METHOD VALIDATION 
Validation of an analytical procedure is the process by which it is established, by 
laboratory studies, that the performance characteristics of the procedure meet the 
requirements for its intended use [66]. All analytical methods that are intended to be used 
for analyzing any clinical samples will need to be validated. Validation of analytical 
methods is an essential but time - consuming activity for most analytical development 
laboratories. It is therefore important to understand the requirements of method validation 
in more detail and the options that are available to allow for optimal utilization of 
analytical resources in a development laboratory   [67]. 
 
6.2.  REQUIREMENT TO VALIDATE ANALYTICAL PROCEDURES 
There are many reasons for the need to validate analytical procedures. Among them are 
regulatory requirements, good science, and quality control requirements. The Code of 
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Federal Regulations (CFR) 311.165c explicitly states that “the accuracy, sensitivity, 
specificity, and reproducibility of test methods employed by the firm shall be established 
and documented”. To apply good science to demonstrate that the analytical method used 
had demonstrated accuracy, sensitivity, specificity, and reproducibility. Finally 
management of the quality control unit would definitely want to ensure that the analytical 
methods that the department uses to release its products are properly validated for its 
intended use so the product will be safe for human use 
 
6.3.   TYPES OF ANALYTICAL PROCEDURES TO BE VALIDATED 
The discussion of the validation of analytical procedures is directed to the four most 
common types of analytical procedures [68] 
 
6.3.1. IDENTIFICATION TESTS 
 Identification tests are intended to ensure the identity of an analyte in a sample. This is 
normally achieved by comparison of a property of the sample (e.g., spectrum, 
chromatographic behavior, chemical reactivity, etc.) to that of a reference standard. 
 
6.3.2. QUANTITATIVE TESTS FOR IMPURITIE’S CONTENT 
Testing for impurities can be either a quantitative test or a limit test for the impurity in a 
sample. Either test is intended to accurately reflect the purity characteristics of the 
sample. Different validation characteristics are required for a quantitative test than for a 
limit test. 
 
6.3.3. LIMIT TESTS FOR THE CONTROL OF IMPURITIES. 
Assay procedures are intended to measure the analyte present in a given sample. In the 
context of this document, the assay represents a quantitative measurement of the major 
component(s) in the drug substance. For the drug product, similar validation 
characteristics also apply when assaying for the active or other selected component(s). 
The same validation characteristics may also apply to assays associated with other 
analytical procedures (e.g., dissolution). 
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6.3.4.  QUANTITATIVE TESTS OF THE ACTIVE MOIETY IN SAMPLES 
 Quantitative tests of the active moiety in samples of drug substance or drug product or 
other selected component(s) in the drug product. 
 
6.4. VALIDATION PARAMETERS 
The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated. Typical validation 
characteristics which should be considered are explained below. 
Furthermore Revalidation may be necessary in the following circumstances: 
(i) Changes in the synthesis of the drug substance. 
(ii) Changes in the composition of the finished product. 
(iii) Changes in the analytical procedure. 
The degree of revalidation required depends on the nature of the changes. Certain other 
changes may require validation as well. Additionally for acceptance of the data generated 
during the Method Validation the Solution Stability is also very significant role. Hence it 
is included in Method Validation or some time it performs prior to method validation. 
Validation applies to a defined protocol, for the determination of a specified analyte and 
range of concentrations in a particular type of test material, used for a specified purpose. 
In general, validation should check that the method performs adequately for the purpose 
throughout the range of analyte concentrations and test materials to which it is applied. It 
follows that these features, together with a statement of any fitness-for-purpose criteria, 
should be completely specified before any validation takes place. 
 
6.4.1.  SELECTIVITY (SPECIFICITY) 
 
Selectivity is the degree to which a method can quantify the analyte accurately in the 
presence of interferents. Ideally, selectivity should be evaluated for any important 
interferent likely to be present. It is particularly important to check interferents that are 
likely, on chemical principles, to respond to the test. For example, colorimetric tests for 
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ammonia might reasonably be expected to respond to primary aliphatic amines. It may be 
impracticable to consider or test every potential interferent; where that is the case, it is 
recommended that the likely worst cases are checked. As a general principle, selectivity 
should be sufficiently good for any interference to be ignored. In many types of analysis, 
selectivity is essentially a qualitative assessment based on the significance or otherwise of 
suitable tests for interference.  
However, there are useful quantitative measures. In particular, one quantitative measure 
is the selectivity index ban/bint where ban is the sensitivity of the method (slope of the 
calibration function) and bint the slope of the response independently roduced by a 
potential interferent, provides a quantitative measure of interference. bint can be 
determined approximately by execution of the procedure on a matrix blank and the same 
blank spiked with the potential interferent at one appropriate concentration.  
If a matrix blank is unavailable, and a typical material used instead, bint can be estimated 
from such a simple experiment only under the assumption that mutual matrix effects are 
absent. Note that bint is more easily determined in the absence of the analyte because the 
effect might be confused with another type of interference when the sensitivity of the 
analyte is itself affected by the interferent (a matrix effect) [69]. Specificity can be 
established in following ways [70], 
 
6.4.1.1. IDENTIFICATION 
 
Suitable identification tests should be able to discriminate between compounds of closely 
related structures which are likely to be present. The discrimination of a procedure may 
be confirmed by obtaining positive results (perhaps by comparison with a known 
reference material) from samples containing the analyte, coupled with negative results 
from samples which do not contain the analyte. In addition, the identification test may be 
applied to materials structurally similar to or closely related to the analyte to confirm that 
a positive response is not obtained. The choice of such potentially interfering materials 
should be based on sound scientific judgment with a consideration of the interferences 
that could occur.  
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6.4.1.2. ASSAY AND IMPURITY TEST(S) 
For chromatographic procedures, representative chromatograms should be used to 
demonstrate specificity and individual components should be appropriately labelled. 
Similar considerations should be given to other separation techniques. Critical 
separations in chromatography should be investigated at an appropriate level. For critical 
separations, specificity can be demonstrated by the resolution of the two components 
which elute closest to each other. In cases where a non-specific assay is used, other 
supporting analytical procedures should be used to demonstrate overall specificity. For 
example, where a titration is adopted to assay the drug substance for release, the 
combination of the assay and a suitable test for impurities can be used. The approach is 
similar for both assay and impurity tests. 
 
6.4.1.2.1. IMPURITIES ARE AVAILABLE 
For the assay, this should involve demonstration of the discrimination of the analyte in 
the presence of impurities and/or excipients; practically, this can be done by spiking pure 
substances (drug substance or drug product) with appropriate levels of impurities and/or 
excipients and demonstrating that the assay result is unaffected by the presence of these 
materials (by comparison with the assay result obtained on unspiked samples). For the 
impurity test, the discrimination may be established by spiking drug substance or drug 
product with appropriate levels of impurities and demonstrating the separation of these 
impurities individually and/or from other components in the sample matrix. 
 
6.4.1.2.2. IMPURITIES ARE NOT AVAILABLE 
If impurity or degradation product standards are unavailable, specificity may be 
demonstrated by comparing the test results of samples containing impurities or 
degradation products to a second well-characterized procedure e.g.: Pharmacopeial 
method or other validated analytical procedure (independent procedure). As appropriate, 
this should include samples stored under relevant stress conditions: light, heat, humidity, 
acid/base hydrolysis and oxidation. For the assay, the two results should be compared and 
for the impurity tests, the impurity profiles should be compared. 
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Peak purity tests may be useful to show that the analyte chromatographic peak is not 
attributable to more than one component (e.g., diode array, mass spectrometry). 
 
6.4.2. ACCURACY 
 
The accuracy of an analytical procedure expresses the closeness of agreement between 
the value which is accepted either as a conventional true value or an accepted reference 
value and the value found. This is sometimes termed trueness. Trueness is stated 
quantitatively in terms of “bias”, with smaller bias indicating greater trueness. Bias is 
typically determined by comparing the response of the method to a reference material 
with the known value assigned to the material. Significance testing is recommended. 
Where the uncertainty in the reference value is not negligible, evaluation of the results 
should consider the reference material uncertainty as well as the statistical variability. 
Accuracy of Method can determine by following ways [71]. 
 
6.4.2.1 ASSAY 
6.4.2.1.1. DRUG SUBSTANCE 
Several methods of determining accuracy are available: 
-  Application of an analytical procedure to an analyte of known purity (reference 
material). 
-  Comparison of the results of the proposed analytical procedure with those of a second 
well-characterized procedure, the accuracy of which is stated and/or defined.  
-   Accuracy may be inferred once precision, linearity and specificity have been 
established. 
 
6.4.2.1.2. DRUG PRODUCT 
- Application of the analytical procedure to synthetic mixtures of the drug product 
components to which known quantities of the drug substance to be analysed have 
been added. 
- In cases where it is impossible to obtain samples of all drug product components, it 
may be acceptable either to add known quantities of the analyte to the drug product or 
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to compare the results obtained from a second, well characterized procedure, the 
accuracy of which is stated and/or defined.  
- Accuracy may be inferred once precision, linearity and specificity have been 
established. 
 
6.4.2.1.3. IMPURITIES (QUANTITATION) 
- Accuracy should be assessed on samples (drug substance/drug product) spiked with 
known amounts of impurities. 
- In cases where it is impossible to obtain samples of certain impurities and/or 
degradation products, it is considered acceptable to compare results obtained by an 
independent procedure. The response factor of the drug substance can be used. 
- It should be clear how the individual or total impurities are to be determined e.g., 
weight/weight or area percent, in all cases with respect to the major analyte. 
- Accuracy should be assessed using a minimum of 9 determinations over a minimum 
of 3 concentration levels covering the specified range (e.g. 3 concentrations / 3 
Replicates each of the total analytical procedure). 
- Accuracy should be reported as percent recovery by the assay of known added 
amount of analyte in the sample or as the difference between the mean and the 
accepted true value together with the confidence intervals 
 
6.4.3. PRECISION 
 
The precision of an analytical procedure expresses the closeness of agreement (degree of 
scatter) between a series of measurements obtained from multiple sampling of the same 
homogeneous sample under the prescribed conditions. Precision may be considered at 
three levels: repeatability, intermediate precision and reproducibility. 
Precision should be investigated using homogeneous, authentic samples. However, if it is 
not possible to obtain a homogeneous sample it may be investigated using artificially 
prepared samples or a sample solution. The precision of an analytical procedure is usually 
expressed as the variance, standard deviation or coefficient of variation of a series of 
measurements [72]. 
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6.4.3.1.  REPEATABILITY (METHOD PRECISION) 
Repeatability expresses the precision under the same operating conditions over a short 
interval of time. Repeatability is also termed intra-assay precision. Repeatability should 
be assessed using minimum of 9 determinations covering the specified range for the 
procedure (e.g. 3 concentrations/3 replicates each) or a minimum of 6 determinations at 
100% of the test concentration. 
 
 
6.4.3.2. INTERMEDIATE PRECISION 
Intermediate precision expresses within laboratories variations: different days different 
analysts, different equipment, etc. The extent to which intermediate precision should be 
established depends on the circumstances under which the procedure is intended to be 
used. The applicant should establish the effects of random events on the precision of the 
analytical procedure. Typical variations to be studied include days, analysts, equipment, 
etc. It is not considered necessary to study these effects individually. The use of an 
experimental design (matrix) is encouraged. 
 
6.4.3.3. REPRODUCIBILITY 
Reproducibility expresses the precision between laboratories (collaborative studies 
usually applied to standardization of methodology). Reproducibility is assessed by means 
of an inter-laboratory trial. Reproducibility should be considered in case of the 
standardization of an analytical procedure, for instance, for inclusion of procedures in 
pharmacopoeias. These data are not part of the marketing authorization dossier. 
 
6.4.4. LINEARITY 
 
The linearity of an analytical procedure is its ability (within a given range) to obtain test 
results which are directly proportional to the concentration (amount) of analyte in the 
sample. It may be demonstrated directly on the drug substance (by dilution of a standard 
stock solution) and/or separate weighing of synthetic mixtures of the drug product 
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components, using the proposed procedure [73]. The latter aspect can be studied during 
investigation of the range. Linearity should be evaluated by visual inspection of a plot of 
signals as a function of analyte concentration or content.  
If there is a linear relationship, test results should be evaluated by appropriate statistical 
methods, for example, by calculation of a regression line by the method of least squares. 
In some cases, to obtain linearity between assays and sample concentrations, the test data 
may need to be subjected to a mathematical transformation prior to the regression 
analysis. Data from the regression line itself may be helpful to provide mathematical 
estimates of the degree of linearity. 
 
The correlation coefficient, y-intercept, slope of the regression line and residual sum of 
squares should be submitted. A plot of the data should be included. In addition, an 
analysis of the deviation of the actual data points from the regression line may also be 
helpful for evaluating linearity. Some analytical procedures, such as immunoassays, do 
not demonstrate linearity after any transformation. In this case, the analytical response 
should be described by an appropriate function of the concentration (amount) of an 
analyte in a sample. For the establishment of linearity, a minimum of 6 concentrations is 
recommended. Other approaches should be justified. 
 
6.4.5. RANGE 
 
The range of an analytical procedure is the interval between the upper and lower 
concentration (amounts) of analyte in the sample (including these concentrations) for 
which it has been demonstrated [74] that the analytical procedure has a suitable level of 
precision, accuracy and linearity. The specified range is normally derived from linearity 
studies and depends on the intended application of the procedure. It is established by 
confirming that the analytical procedure provides an acceptable degree of linearity, 
accuracy and precision when applied to samples containing amounts of analyte within or 
at the extremes of the specified range of the analytical procedure. The following 
minimum specified ranges should be considered, 
 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                              Page 47 
 
 
Chapter – 1                                                                                                                                                    General Introduction 
- For the assay of a drug substance or a finished (drug) product: normally from 80 to 
120 percent of the test concentration. 
-  For content uniformity, covering a minimum of 70 to 130 percent of the test 
concentration, unless a wider more appropriate range, based on the nature of the 
dosage form (e.g., metered dose inhalers), is justified. 
- For dissolution testing: +/-20 % over the specified range. 
 
e.g., if the specifications for a controlled released product cover a region from 20%, after 
1 hour, up to 90%, after 24 hours, the validated range would be 0-110% of the label 
claim. 
 
- For the determination of an impurity: from the reporting level of an impurity1 to 
120% of the specification; 
- For impurities known to be unusually potent or to produce toxic or unexpected 
pharmacological effects, the detection/quantitation limit should be commensurate 
with the level at which the impurities must be controlled. 
- If assay and purity are performed together as one test and only a 100% standard is 
used, linearity should cover the range from the reporting level of the impurities to 
120% of the assay specification. 
 
6.4.6. LIMIT OF DETECTION 
The detection limit of an individual analytical procedure is the lowest amount of analyte 
in a sample which can be detected but not necessarily quantitated as an exact value [75]. 
Several approaches for determining the detection limit are possible, depending on 
whether the procedure is a non-instrumental or instrumental. Approaches other than those 
listed below may be acceptable [76]. 
 
6.4.6.1. BASED ON VISUAL EVALUATION 
Visual evaluation may be used for non-instrumental methods but may also be used with 
Instrumental methods. The detection limit is determined by the analysis of samples with 
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known concentrations of analyte and by establishing the minimum level at which the 
analyte. 
6.4.6.2. BASED ON SIGNAL-TO-NOISE 
This approach can only be applied to analytical procedures which exhibit baseline noise. 
Determination of the signal-to-noise ratio is performed by comparing measured signals 
from samples with known low concentrations of analyte with those of blank samples and 
establishing the minimum concentration at which the analyte can be reliably detected. A 
signal-to-noise ratio between 3 or 2:1 is generally considered acceptable for estimating 
the detection limit. 
 
6.4.7. LIMIT OF QUANTIFICATION 
The quantitation limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be quantitatively determined with suitable precision and 
accuracy. The quantitation limit is a parameter of quantitative assays for low levels of 
compounds in sample matrices, and is used particularly [76]. 
 
6.4.7.1. BASED ON VISUAL EVALUATION 
Visual evaluation may be used for non-instrumental methods but may also be used with 
instrumental methods. The quantitation limit is generally determined by the analysis of 
samples with known concentrations of analyte and by establishing the minimum level at 
which the analyte can be quantified with acceptable accuracy and precision. 
 
6.4.7.2. BASED ON SIGNAL-TO-NOISE 
 
This approach can only be applied to analytical procedures that exhibit baseline noise. 
Determination of the signal-to-noise ratio is performed by comparing measured signals 
from samples with known low concentrations of analyte with those of blank samples and 
by establishing the minimum concentration at which the analyte can be reliably 
quantified. A typical signal-to-noise ratio is 10:1. 
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6.4.8.  ROBUSTNESS  
The robustness of an analytical procedure is a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage [77].  
The evaluation of robustness should be considered during the development phase and 
depend on the type of procedure under study. It should show the reliability of an analysis 
with respect to deliberate variation in method parameter if measurements are susceptible 
to variations in analytical condition, the analytical condition should be suitably controlled 
or precautionary statement should be included in the procedure. One consequence of the 
evaluation of robustness should be that a series of system suitability parameter (e.g. 
Resolution test) is established to ensure that the validity of the analytical procedure is 
maintained whenever used. Typical variations are, Stability of Solutions and Extraction 
time. In case of Liquid chromatography, examples of typical variations are, 
 
- Influence of variations of pH in mobile phase. 
- Influence of variations in mobile phase composition. 
- Different column (different lot and suppliers) 
- Temperature 
- Flow Rate 
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1.  INTRODUCTION 
 
Antidepressant drugs are medicines that relieve symptoms of depressive disorders. An 
antidepressant is a psychiatric medication used to alleviate mood disorders, such as major 
depression and dysthymia. Drugs including the monoamine oxidase inhibitors (MAOIs), 
tricyclic antidepressants (TCAs), tetracyclic antidepressants (TeCAs), selective serotonin 
reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs) 
are most commonly associated with the term. These medications are among those most 
commonly prescribed by psychiatrists and other physicians, and their effectiveness and 
adverse effects are the subject of many studies and competing claims. Many drugs 
produce an antidepressant effect, but restrictions on their use have caused controversy 
and off-label prescription a risk, despite claims of superior efficacy. Most typical 
antidepressants have a delayed onset of action (2–6 weeks) and are usually administered 
for anywhere from months to years. Despite the name, antidepressants are often used to 
treat other conditions, such as anxiety disorders, obsessive compulsive disorder, eating 
disorders, chronic pain, and some hormone-mediated disorders such as dysmenorrhea. 
Alone or together with anticonvulsants (e.g., Tegretol or Depakote), these medications 
can be used to treat attention-deficit hyperactivity disorder (ADHD) and substance abuse 
by addressing underlying depression. Also, antidepressants have been used sometimes to 
treat snoring and migraines. Other medications that are not usually called antidepressants, 
including antipsychotics in low doses and benzodiazepines, may be used to manage 
depression, although benzodiazepines may cause physical dependence if treatment is not 
properly monitored by a doctor. Stopping benzodiazepine (or SSRI) treatment abruptly 
can cause unpleasant withdrawal symptoms. An extract of the herb St John's Wort is 
commonly used as an antidepressant, although it is labeled as a dietary supplement in 
some countries. The term antidepressant is sometimes applied to any therapy (e.g., 
psychotherapy, electro-convulsive therapy, acupuncture) or process (e.g., sleep 
disruption, increased light levels, regular exercise) found to improve a clinically 
depressed mood. Inert placebos can have significant antidepressant effects, and so to 
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establish a substance as an "antidepressant" in a clinical trial it is necessary to show 
superior efficacy to placebo. 
Aripiprazole is chemically identified as 7-[4-[4-(2, 3-dichlorophenyl) piperazin-1-yl] 
butoxy]-3,4-dihydro-1H-quinolin-2-one,is an atypical antipsychotic used in the treatment 
of schizophrenia, bipolar disorder, and clinical depression. It was approved by the Food 
and Drug Administration (FDA) for schizophrenia on November 15, 2002, for 
acute manic and mixed episodes associated with bipolar disorder on October 1, 2004, and 
as an adjunct for major depressive disorder on November 20, 2007[1]. Aripiprazole was 
developed by Otsuka in Japan, and in the United States, Otsuka America markets it 
jointly with Bristol-Myers Squibb. 
 
 
Figure 1: Chemical Structure of Aripiprazole 
Aripiprazole's mechanism of action is different from those of the other FDA-
approved atypical antipsychotics (e.g., Clozapine, Olanzapine, Quetiapine, Ziprasidone 
and Risperidone). Rather than antagonizing the D2 receptor, aripiprazole acts as a 
D2 partial agonist [2] [3]. Aripiprazole is also a partial agonist at the 5-HT1A receptor, 
and like the other atypical antipsychotics displays an antagonist profile at the 5-
HT2Areceptor [4] [5]. It also antagonizes the 5-HT77 receptor and acts as a partial 
agonist at the 5-HT2C receptor, both with high affinity. The latter action may underlie the 
minimal weight gain seen in the course of therapy [6]. Aripiprazole has moderate affinity 
for histamine and α-adrenergic receptors and for the serotonin transporter, and no 
appreciable affinity for cholinergic muscarinic receptors [7]. 
D2 and D3 receptor occupancy levels are high, with average levels ranging between 71% 
at 2 mg/day to 96% at 40 mg/day [8] [9]. Most atypical antipsychotics bind preferentially 
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to extrastriatal receptors, but aripiprazole appears to be less preferential in this regard, as 
binding rates are high throughout the brain [10]. 
The molecular weight of Aripiprazole is 448.385 g/mole with molecular formula of 
C23H27Cl2H N3O2 and its dissociation constants (pKb) 7.29 and 5.6 are reported, the melting 
point of  Aripiprazole is 139°C to139.5°C [11]. 
 
1.1.  SYNTHETIC METHOD [12]  
 
The synthesis begins with acylation of 3- methoxy aniline followed by Fiedel- Craft ring 
closure to give quinolinone. Further hydrogenation provides Di-hydro quinolinone. 
Which is further treated with 1, 4 – di bromo butane in presence of K2CO3 to afford 
intermediate 5. Compound 5 was treated with NaI and then alkylated with 2, 3, diclholoro 
phenyl piprazine to produce aripiprazole 
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2.  LITERATURE REVIEW 
 
The literature reviews regarding Aripiprazole suggest that various analytical methods are 
reported for drug substance as well as in pharmaceutical formulation and also in various 
biological fluids. The literature reviews for analysis of Aripiprazole are as under. 
 
2.1.  Vijaya kumar M, Muley P.R. have describe the HPLC method for aripiprazole 
in bulk drug and in solid dosage form using the Grace Vydac (C18, 25cm, 4.6mm internal 
diameter, 5μ) column with mobile phase consisting of buffer (0.05M potassium 
phosphate pH adjusted to 3 with phosphoric acid), Methanol and Acetonitrile in the ratio 
of (50:25:25% v/v) in an isocratic mode was used. The detection wavelength was 250nm, 
flow rate 1ml/minute and Methylparaben was used as an internal standard, in the linear 
range of 25-50μg/ml. In addition to this they also did the force degradation analysis [13].  
 
2.2. Srinivas K. S. V, Buchireddy R , Madhusudhan G , Mukkanti K and 
Srinivasulu P  have reported the method for determination of Aripiprazole using Inertsil 
phenyl column, mixture of 0.2% Trifluoroacetic acid and acetonitrile (55:45, v/v) as a 
mobile phase in the linear range of 25–200 μg/ml. They have also applied the stress 
condition to the drug substance [14]. 
 
2.3.  Liu H, Jiang Y and Hao X has published a paper with the title; Determination 
of aripiprazole by nonaqueous reversed-phase high performance liquid chromatography 
[15]. 
 
2.4. Kirschbaum K. M, Muller M. J, Zernig G have given the method for 
Therapeutic Monitoring of Aripiprazole by HPLC with Column-Switching and 
Spectrophotometric Detection using LiChrospher CN 5 µm (MZ-Analysentechnik), and a 
[10 x 4 mm (i.d.)] CN column (20-µm particle size; MZ-Analysentechnik column with 
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mobile phase consisting of 500 ml/l acetonitrile in phosphate buffer in the linear range of 
50 to 500 µg/l, the detection was performed at 210 nm [16]. 
 
2.5.  Zuo1 X. C, Wang F, Xu P, Zhu R. H and Li H. D developed method for LC–
ESI–MS for Rapid and Sensitive Determination of Aripiprazole in Human Plasma using 
C18 column, with acetonitrile-30 mm ammonium acetate containing 0.1% formic acid, 
58:42 (v/v), as mobile phase, coupled with electrospray ionization mass spectrometry 
(ESI-MS) at linear range of19.9–1119.6 ng/ ml [17]. 
 
2.6. Lancelina F, Djebranib  K, Tabaoutia  K, Kraoula  L et al. have contributed 
with Development and validation of a high-performance liquid chromatography method 
using diode array detection for the simultaneous quantification of aripiprazole and 
dehydro-aripiprazole in human plasma using an ammonium buffer–acetonitrile mobile 
phase (40:60, v/v) and  reversed phase C18 column at linear range of 2–1000 ng/ml[18].  
 
2.7.  Musengaa A, Saracinoa M. A, Spinellib D, Rizzatob E et al have worked on 
the Analysis of the recent antipsychotic aripiprazole in human plasma by capillary 
electrophoresis and high-performance liquid chromatography with diode array detection 
using uncoated fused silica capillaries and a background electrolyte composed of 50 mM 
phosphate buffer at pH 2.5. With 20 kV voltages, aripiprazole was detectable at 214 nm 
within 5 min. The second analytical method based on HPLC with diode array detection, 
using a C8 reversed-phase column and a mixture of a 12.5 mM phosphate buffer, pH 3.5, 
containing triethylamine and acetonitrile as the mobile phase. Aripiprazole was detected 
at 254 nm [19]. 
 
2.8. Huang H. C, Liu C. H, Lan T. H, Hu T. M, Chiu H. J, Wu Y. C, Tseng Y. L 
have published a paper on Detection and quantify cation of aripiprazole and its 
metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood 
samples of psychiatric patients with sample preparation of extraction of aripiprazole and 
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its metabolite by N-methyl-N-trimethylsilytrifluoroacetamide (MSTFA) derivatization 
using solid phase technique [20].   
 
2.9.  Shimokawa Y, Akiyama H, Kashiyama E, Koga T, Miyamoto G have made 
impact by developing a High performance liquid chromatographic methods for the 
determination of aripiprazole with ultraviolet detection in rat plasma and brain: 
application to the pharmacokinetic study using the Nova-pak phenyl column; flow rate, 
1.0 ml/min; mobile phase, acetonitrile-methanol-20 mM sodium sulfate-acetic acid 
(27:25:48:1, v/v/v/v); UV detection at 254 nm at the linear range of 10.0-2000 ng/ml 
[21]. 
 
2.10. Sastry B. S, Gananadhamu S and Devala R. G has recently published paper 
with the title; RP-HPLC determination of aripiprazole in pharmaceutical formulations 
[22]. 
 
2.11. Rao DV Subba, Shetty Satheesh Kumar, Radhakrishnanand P and 
Himabindu V has also worked on the stability indicating method of aripiprazole [23]. 
 
2.12. Ravimathi S. P, Shrikumar S and Ravi T.K has developed the method for 
determination of aripiprazole by high performance thin layer chromatography which is 
the only HPTLC method in the literature [24]. 
 
2.13. Kalaichelvi R, Thangabalan B, Srinivasa rao D and Jayachandran E has 
reported UV Spectrophotometric Determination of Aripiprazole in Bulk and 
Pharmaceutical Formulation [25]. And Attri N. Yadav S and Goyal A have developed a 
method as visible Spectrophotometric methods for determination of aripiprazole in tablet 
formulation [26]. 
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3.  AIM OF THE PRESENT WORK 
 
The above literature reveals that there are many methods for the quantification of 
aripiprazole as a drug substance as well as in pharmaceutical dosage form, few of the 
methods are also which deals the bioanalytical study but very few methods are available 
describing the forced degradation. Furthermore these methods are not impressionable to 
achieve the high throughput study which can be possible by optimizing the method in 
such a way which includes shortest runtime with maximum selectivity. Hence, it can be 
maximum utilize for the analysis of formulation development and stability testing as well 
as at quality control laboratory for routine use. The aim and scope of the proposed work 
are as under. 
 
3.1. To develop rapid RP-HPLC method for quantification of the drug substance with 
highest selectivity, precision and accuracy. 
3.2. Forced Degradation Study to confirm the stability of the drug substance. 
3.3.  Perform analytical method validation for the proposed method as per ICH 
guideline [27]. 
 
 
4. EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS 
Torrent Research Centre (Gandhinagar, India) has provided Aripiprazole working 
standard. Aripiprazole tablets containing 10 mg Aripiprazole and the inactive ingredients 
used in the drug matrix has obtained from the commercial market. Analytical grade 
Ammonium Acetate, HPLC grade acetonitrile and water has purchased from 
Spectrochem Pvt. Ltd (Mumbai, India). Analytical grade hydrochloric acid, NaOH 
pellets, orthophosphoric acid and 30% hydrogen peroxide solution has procured from 
Ranbaxy Fine Chemicals (New Delhi, India). 
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4.2. INSTRUMENTATION 
The chromatographic system used to perform development and validation of this method 
consisted of an LC-IOATvp binary pump, SPD-M10Avp photodiode array detector, and 
Rheodyne manual injector Model 7725i with 20 μl loop (Shimadzu, Kyoto, Japan) 
connected to a multi-instrument data acquisition and processing system (Class-VP 6.13 
SP2, Shimadzu).Sartorius microbalance and Equiptronics branded balance and heating 
oven was used for the weighing and heating purpose while Spinco ultrasonic bath used 
for degassing purpose.   
4.3. METHOD DEVELOPMENT 
4.2.1. MOBILE PHASE SELECTION 
On the basis of literature survey, previous experience and several exploratory efforts, the 
chromatographic compatibility was achieved using 20 mM Ammonium Acetate: 
Acetonitrile (10:90) as an isocratic elution. This gives the best results as a mobile phase. 
4.2.2. COLUMN SELECTION 
Column selection is the most important part in the method development. Applying 
various column chemistry, the most suitable column was Phenominex Luna C8 (2) (250 
mm x 4.6 mm id, 5μ particle size). 
4.2.3. DETECTION WAVELENGTH SELECTION  
We screened the standard solution over 190 nm to 400 nm wavelength using the 
advantage of photo diode array detector. On the basis of peak absorption maxima of 
analyte and the degradation impurities, the 240 nm was decided as the detection 
wavelength. This gives the maximum chromatographic compatibility to the method. 
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4.2.4. MOBILE PHASE PREPARATION 
The mobile phase consist of Acetonitrile: 20 mM ammonium acetate (90:10) was 
prepared by dissolving 1.54 gm of ammonium acetate (AR grade) in 1000 ml of HPLC 
grade water which further mixed with acetonitrile in 90:10 (v/v) ratio and filtered through 
0.45µn filter followed by degassing in ultra sonic bath for 20 min. 
4.2.5. STANDARD SOLUTION PREPARATION 
An aripiprazole standard solution containing 100μg/ml was prepared in a 100 ml 
volumetric flask by dissolving 10 mg aripiprazole in 25 ml acetonitrile and then diluting 
to volume with acetonitrile.  
4.2.6. SAMPLE SOLUTION PREPARATION 
Twenty commercially available 10.0 mg label claimed tablets of aripiprazole have 
weighed, and the average weight of a tablet was determined. From these, 5 tablets were 
weighed and transferred into a 500 ml volumetric flask and added 50 ml acetonitrile 
followed by sonication of minimum 30 min with intermittent shaking. Then the solution 
has brought back to room temperature and diluted to volume with acetonitrile. The 
sample has filtered through a 0.45 μn nylon syringe filter. The available concentration 
was 100 μg/ml of analyte. 
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     Figure 2: Chromatogram of Working Standard and Commercial Sample of the analyte. 
 
 
 
 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                               Page 65 
 
 
Chapter – 2                                                             A Stability Indicating RP-HPLC method for quantification of Aripiprazole 
Finally after several experiment in method development, the best chromatography results 
were achieved in following chromatographic condition. 
 
Mobile Phase A  : 20 mM Ammonium Acetate in HPLC grade water 
Mobile Phase B  : Acetonitrile (HPLC grade) 
  Column   : Phenominex Luna C8 (2) (250 mm x 4.6 mm id, 5μ). 
Flow Rate   : 1.0 ml/min 
Detection   : 240 nm UV 
   Diluent    : Acetonitrile (HPLC grade) 
Injection Volume  : 20µl 
 
 
4.3. METHOD VALIDATION 
 
Method for the determination of aripiprazole in bulk drug as well as in pharmaceutical 
dosage form is further validated as per ICH Q2(R1) guideline [27]. To prove this method 
Stability Indicating, force degradation study has also performed and also included. 
Validation of analytical method was performed using Aripiprazole 10 mg tablet 
formulation as well as bulk drug substance equivalent to the formulation.  
 
4.3.1. SPECIFICITY  
 
The evaluation of the specificity of the method was determined against placebo and stress 
(forced degradation) application. The interference of the excipients of the claimed 
placebo present in the pharmaceutical dosage form was derived from placebo solution. 
Further the specificity of the method toward the drug was established by means of the 
interference of the degradation products against drug during the forced degradation study. 
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Blank preparation, 
Diluent was used as blank. 
 
Standard solution preparation, 
Stock solution: 25.00 mg of Aripiprazole working standard was accurately weighed and 
transferred into 25 ml volumetric flask. 20 ml of diluent was added into the volumetric 
flask and the standard substance was dissolved by sonication for one minute. Then, 
volume of the flask was made up with diluent. The concentration obtained was 1000 
μg/ml of Aripiprazole. 5 ml of above standard stock solution was pipette out and 
transferred into 50 ml volumetric flask followed by diluted to volume with diluent. The 
concentration obtained is 100 μg/ml of analyte.  
 
Test Preparation, 
Test stock solution: 10 Tablets were accurately weighed (1021.8 mg) and transferred into 
100 ml volumetric flask. 70 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal hand-shaking. Then, the 
flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
solution was filtered through 0.45 μn nylon syringe filter. The concentration obtained was 
about 1000 μg/ml of drug substance. 5.0 ml of above test stock solution was pipette out 
and transferred into 50 ml volumetric flask followed by diluted to volume with diluent. 
The concentration obtained is about 100 μg/ml of Aripiprazole 
 
Average weight of the tablets, 
Randomly selected 20 tablets were weighed accurately (2020.0 mg) and the mean weight 
was calculated for the same. This mean weight (101.0 mg) was used as average weight 
throughout all experiments. 
 
Placebo preparation, 
Stock solution: Placebo equivalent to 10 times of average placebo weight was weighed 
(900.0 mg) and transferred into 100 ml volumetric flask.70 ml of diluent was added into 
the volumetric flask and sonicate for 30 minutes with normal hand-shaking. The 
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volumetric flask was cooled to room temperature and diluted to volume with diluent. 10 
ml of this solution was filtered through 0.45 μm nylon syringe filter.5 ml of above 
placebo stock solution was pipette out and transferred into 50 ml volumetric flask 
followed by dilute up to volume with diluent. 
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Figure 3: Chromatogram of Diluent in Specificity Experiment. 
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Figure 4: Chromatogram of Placebo in Specificity Experiment. 
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Figure 5: Chromatogram Test preparation (commercial sample) 
 
Forced Degradation Study: 
The degradation samples were prepared by transferring intact tablets, samples were 
employed for acidic, alkaline and oxidant media and also for thermal and photolytic 
conditions. After the degradation treatments were completed, the stress content solutions 
were diluted with diluent to attain about 100µg/ml concentration. Specific conditions 
were described as follows. 
 
A) Acidic Degradation:  Acidic degradation study was performed by refluxing the 
drug content in 30 ml of 1 N HCl at about 100° C for 1 hour and after cooling to room 
temperature it was neutralized with 1 N NaOH solution. Further solution was diluted to 
achieve concentrations 100 µg/ml with diluent. 
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                     Figure 6: Chromatogram Test preparation (Acidic Degradation) 
 
B) Alkali Degradation: Alkaline degradation was performed by heating the drug 
content in 1 M NaOH at around 100˚ C for 1 hour and then the mixture was neutralized 
with 1 M HCl. It was further diluted with diluent to achieve 100 µg/ml concentrations. 
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     Figure 7: Chromatogram of Alkali Degradation Study 
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C) Oxidative Degradation Study: Oxidative degradation study was performed by 
refluxing the drug content in 3% v/v H2O2 at 100°C for 1 hour then diluted to 100µg/ml 
with diluent. 
 
 
 
 
 
 
 
 
 
 
Figure 8: Chromatogram of Oxidative Degradation Study 
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Figure 8: Chromatogram of Oxidative Degradation Study 
 
D) Thermal Degradation Study: Thermal degradation study was performing by 
keeping powdered drug content at around 80˚C for 72 hour. After this it was allowed to 
come at room temperature. 
 
This powdered drug was used for the stock solution preparation as per procedure on page 
67, then it was diluted to attain 100 µg/ml, the same was used in the forced degradation 
study by confirming against the freshly prepared standard solution. Aim of this 
experiment was to study the thermal liability of the drug as well as the formulated 
pharmaceutical dosage form.  
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Figure 9: Chromatogram of Thermal Degradation Study 
 
E) Photolytic Degradation Study: Photolytic degradation study was performed by 
exposing drug content in sun-light for 72 hour, further it diluted to 100 µg/ml using 
diluent. 
 
 
   
 
 
 
 
 
 
 
mAU
10987654321
0
100
200
300 Detector A-240 nm
PHOTOLYTIC DEGRADATION
7.072
  
  
5.5014.533
   3.1792.709      
2.432
2.091    
0
Minutes
Figure 10: Chromatogram of Photolytic Degradation Study 
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Observations: 
 
(1)  Any interference was not observed from blank or placebo to the peak of interest, 
in addition to this peak purity was also within the acceptance criteria proved by 
the photo diode detector. 
(2) From the above chromatogram it can be conclude that there is no interference of 
any degradation product to the peak of interest and impurity has been generated 
by each stress condition. 
 
Stress Condition Acidic Alkali Oxidative Thermal Photolytic
% Degradation 13.27 52.82 95.8 3.21 1.09 
    
Table 1: % Degradation observed by applying the stress condition 
 
4.3.2. LINEARITY AND RANGE  
 
The linearity plot was prepared with 8 concentration levels (40, 60, 80, 100, 120, 140, 
160 and 180 μg/ml of Aripiprazole). These concentration levels were respectively 
corresponding to 40, 60, 80, 100, 120, 140, 160 and 180% of standard solution 
concentration. The peak areas vs. concentration data were evaluated by linear regression 
analysis. 
Stock solution for Linearity study was prepared as per procedure on page 67 and further 
diluted to attain concentration of about 40, 60, 80, 100, 120, 140,160 and 180% of 
standard solution concentration. 
 
Linearity Standard Solution Preparation: 
From Standard Stock Solution of accurately 1000 µg/ml pipette out exact 0.4, 0.6, 0.8, 
1.0, 1.2, 1.4, 1.6 and 1.8 ml and dilute it up to 10 ml each with diluent to achieve 40-180 
µg/ml concentration range. 
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Linearity 
Level 
Concentration
(µg/ml) 
Peak Area 
1 180 5871033 
2 160 5181590 
3 140 4481048 
4 120 3886248 
5 100 3274823 
6 80 2696396 
7 60 2048711 
8 40 1460485 
 
Table 2: Linearity and Range - Concentration Vs Peak area response data 
 
 
 
 
 
 
 
 
 
 
 
 
 
X axis = Concentration (µg/ml) Y axis = Peak Area 
Chart 1: Regression Analysis chart of linearity Study 
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Correlation coefficient of the linearity study was found to R2 = 0.999 with linear 
regression equation y = 31252x + 17480, which proves the method is highly linear over 
the working range 40 – 180 µg/ml. 
 
4.3.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION STUDY 
LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) more than 3.3 for LOD and more 
than 10 for LOQ. On the basis of linearity data theoretically it can be also calculated by 
the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 67. From the stock 
solution of 1000 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent , assign this solution as Solution – A. 
Form the Solution – A, pipette out exact 0.5 ml to the 100 ml volumetric flask followed 
by dilution up to the mark with diluent to reach 0.05 µg/ml concentrations. 
 
LOQ Solution Preparation: 
Form the Solution – A, pipette out exact 1 ml to the 100 ml volumetric flask followed by 
dilution up to the mark with diluent to achieve 0.1 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
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Injection Peak Area 
1 5201 
2 5509 
3 4905 
4 6021 
5 5010 
6 5787 
Mean 5405.5 
Std. Dev. 443.6 
% RSD 8.2 
 
Table 3: Limit of Quantification - Precision data 
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Figure 11: Chromatogram of Limit of Detection 
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Figure 12: Chromatogram of Limit of Quantification 
 
LOQ of the analytical method can evaluated by establish linearity up to LOQ value. 
Hence linearity study is extended to LOQ value, 
 
 
 
X axis = Concentration (µg/ml) Y axis = Peak Area 
Chart 2: Regression Analysis chart of linearity Study included with LOQ level 
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All the results of LOD and LOQ data were within the acceptance criteria, hence it can be 
conclude that the LOD and LOQ of the method was 0.05 µg/ml and 0.1 µg/ml 
respectively which correspond to 0.05% and 0.1% of working concentration. 
 
4.3.4. PRECISION STUDY 
 
Precision study was established by evaluating method precision and intermediate 
precision study. Method precision of the analytical method was determined by analyzing 
six sets of sample solution preparation.  
Assay of all six replicate sample preparations was determined and mean % assay value, 
standard deviation and % relative standard deviation for the same was calculated. 
Intermediate precision of the analytical method was determined by performing same 
experiment as method precision on another day by another analyst using different make 
of raw materials under same experimental condition. Assay of all six replicate sample 
preparations was determined and mean % assay value, standard deviation and % relative 
standard deviation also calculated. Overall assay value of method precision and 
intermediate precision was compared and % difference and overall % relative standard 
deviation was calculated.  
 
Solution Preparation for Precision Study: 
 
Standard Solution Preparation: 
Standard Stock Solution prepared as per procedure on page 67 of 1000 µg/ml. pipette out 
exact 1.0 ml from this solution and dilute up to 10 ml to accomplish 100 µg/ml 
concentration.  
 
Sample Solution Preparation: 
Test stock solution: 10 Tablets were accurately weighed (1012.2 mg) and transferred into 
100 ml volumetric flask. 70 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal hand-shaking. Then, the 
flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
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solution was filtered through 0.45 μm nylon syringe filter. The concentration obtained 
was about 1000 μg/ml of Aripiprazole. 
 
5 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained is about 100 
μg/ml of Aripiprazole. This solution is assign as Test Preparation Set – 01. 
 
The same procedure was used for preparing the six Test preparation Sets. Same approach 
was applied for the intermediate precision study on the second day with different analyst 
and different make of raw materials. 
 
Method Precision Data 
Samples Replicates Peak Area Mean Area % Assay 
Set 01 
Injection 01 3128400 
3094474.3 99.84 Injection 02 3085926 
Injection 03 3069097 
Set 02 
Injection 01 3067987 
3091894.3 100.2 Injection 02 3088611 
Injection 03 3119085 
Set 03 
Injection 01 3079287 
3099486.3 98.95 Injection 02 3110092 
Injection 03 3109080 
Set 04 
Injection 01 3107151 
3096900.7 101.02 Injection 02 3090598 
Injection 03 3094153 
Set 05 
Injection 01 3099524 
3114039 98.34 Injection 02 3123404 
Injection 03 3119189 
Set 06 
Injection 01 3126685 
3120480.7 101.58 Injection 02 3109245 
Injection 03 3125512 
  
 
Table 4: Method Precision Data 
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Intermediate Precision Data 
Samples Replicates Peak Area Mean Area % Assay 
Set 01 
Injection 01 3122601 
3082463.7 101.23 Injection 02 3084289 
Injection 03 3040501 
Set 02 
Injection 01 3110861 
3102068 100.9 Injection 02 3063011 
Injection 03 3132332 
Set 03 
Injection 01 3084548 
3105804.7 100.19 Injection 02 3108545 
Injection 03 3124321 
Set 04 
Injection 01 3095322 
3137528.3 98.9 Injection 02 3117262 
Injection 03 3200001 
Set 05 
Injection 01 3113698 
3117058.3 99.97 Injection 02 3137565 
Injection 03 3099912 
Set 06 
Injection 01 3159538 
3158868.3 101.97 Injection 02 3171746 
Injection 03 3145321 
 
  Table 5: Intermediate Precision Data 
 
 
% Assay calculation is as under: 
 
  
 
Where, 
AT = Average Area of Test Preparation. 
AS = Average Area of Standard Preparation. 
W1 = Weight of Working Standard (mg). 
W2 = Weight of Test Sample (mg). 
AW = Average Weight of Formulation (mg). 
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LC = Label Claim Weight of Formulation (mg). 
P = Potency of Working Standard (%). 
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    Figure 13: Chromatograms of Sample Solution in Method Precision and Int. Precision 
Overall the data for the precision study suggest % Assay value for each Test Preparation 
is between 98 – 102% which is under the acceptance criteria while % RSD of all results 
are less than 2%. Hence from all the observation it can conclude that the proposed 
method is highly precise.  
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4.3.5.  ACCURACY STUDY    
This Experiment can be performed by the recovery test. Recovery of the method was 
evaluated at 3 different concentration levels (Generally corresponding to 50, 100 and 
150% of test solution concentration) by addition of known amounts of standard to 
placebo preparation. For each concentration level, 3 sets were prepared and injected in 
duplicate. 
 
Blank preparation: 
Diluent was used as blank. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 67. 
 
Sample preparations for accuracy levels are as under: 
 
Accuracy level 1 (50%)  
Test stock solution:  
100.0 mg of Aripiprazole reference standard was accurately weighed and transferred into 
200 ml volumetric flask. 900.0 mg placebo (equivalent of 10 average placebo weights) 
was weighed and transferred into the same 200 ml volumetric flask. Around 140 ml of 
diluent added into the volumetric flask. The volumetric flask was proceeding for 
sonication of 30 minutes with normal handshaking. Then, the flask was cooled to room 
temperature and diluted to volume with diluent. 10 ml of this solution was filtered 
through 0.45 μm nylon syringe filter. The concentration obtained was 500 μg/ml of 
Aripiprazole.  
5 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained is 50 μg/ml 
of Aripiprazole. The same procedure was applied for preparing the three sets. 
 
Accuracy level 2 (100 %) 
Test stock solution:  
100.0 mg of Aripiprazole working standard was accurately weighed and transferred into 
200 ml volumetric flask. 900.0 mg placebo (equivalent of 10 average weights) was 
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weighed and transferred into this 200 ml volumetric flask. 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking. 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.45 μm nylon syringe filter. The concentration 
obtained was 1000 μg/ml of Aripiprazole.  
5 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained was 100 
μg/ml of Aripiprazole. The same procedure was applied for preparing the three sets. 
 
Accuracy level 3 (150 %) 
Test stock solution: 
150.0 mg of Aripiprazole Working standard was accurately weighed and transferred into 
200 ml volumetric flask. 900 mg placebo (equivalent of 10 average placebo weights) was 
weighed and transferred into this 200 ml volumetric flask. 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking. 
 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.45 μm nylon syringe filter. The concentration 
obtained was 1500 μg/ml of Aripiprazole.  5 ml of above test stock solution was pipette 
out and transferred into 50 ml volumetric flask followed by diluted to volume with 
diluent. The concentration obtained is 150.0 μg/ml of Aripiprazole. The same procedure 
was applied for preparing the three sets. 
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Accuracy 
Replicates Area Mean Mean of each level 
Level-1 set 1 inj 01 1940738 
1911506 
1880782 
Level-1 set 1  inj 02 1882273 
Level-1 set 2  inj 01 1870417 
1864574 
Level-1 set 2 inj 02 1858731 
Level-1 set 3  inj 01 1862668 
1866267 
Level-1 set 3 inj 02 1869865 
Level-2 set 1 inj 01 3554754 
3574708 
3563145 
Level-2 set 1 inj 02 3594662 
Level-2 set 2 inj 01 3571942 
3567242 
Level-2 set 2 inj 02 3562542 
Level-2 set 3 inj 01 3542120 
3547486 
Level-2 set 3 inj 02 3552852 
Level-3 set 1 inj 01 5364250 
5307440 
5317133 
Level-3 set 1 inj 02 5250629 
Level-3 set 2 inj 01 5295559 
5286757 
Level-3 set 2 inj 02 5277954 
Level-3 set 3 inj 01 5357984 
5357203 
Level-3 set 3 inj 02 5356422 
 
  Table 6: Summery of Accuracy Data-01 
 
Calculation formulas for recovery study are as under: 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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From the above calculation the % Recovery was calculated which is given below. 
 
 
Accuracy (Recovery) Study 
Accuracy 
Level 
Set 
No 
Amount 
added 
(μg/ml ) 
Amount 
Found 
(μg/ml ) 
Recovery 
(%) 
Average 
recovery 
Std 
Dev. 
% 
RSD 
I (50%) 
1 50.12 50.08 99.9 
99.9 0.06 0.06 2 50.1 50.03 99.9 
3 50.2 50.1 99.8 
II (100%) 
1 100.01 99.9 99.9 
99.9 0.10 0.10 2 100.08 100.1 100.0 
3 100.3 100.12 99.8 
II (150%) 
1 150.04 149.96 99.9 
99.8 0.25 0.25 2 150.15 150.2 100.0 
3 149.95 149.3 99.6 
 
 
Table 7: Summary of Accuracy Data-02 
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Figure 14: Chromatograms of Accuracy level -1 (50 %) 
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Figure 15: Chromatograms of Accuracy level -2 (100 %) 
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Figure 16: Chromatograms of Accuracy level -3 (150 %) 
From the all above data it has been proven that the % recovery is within the limit of 98 to 
102 % this is in the limit of acceptance criteria and % RSD value of % recovery of 
replicate set is below 2 % .Hence this suggest that proposed method is highly accurate. 
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4.3.6. ROBUSTNESS STUDY 
 
Robustness of the method was evaluated by assaying test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in 
proportions of Buffer-Acetonitrile (08:92 and 88:12,v/v), and change in column-lot. 
 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 0.9 ml/min and 1.1 ml/min each and the results were observed in terms of assay 
value and chromatographic compatibility (System Suitability Test).Blank, Standards and 
Sample solutions were prepared as per the same procedure mentioned on page 67. A 
proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Flow Rate 0.9 
ml/min 
2 Standard  5 
3 Test 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 1.1 
ml/min 
6 Standard  5 
7 Test 2 
8 Bracketing Standard 1 
  
Table 8: Experimental HPLC sequence for the robustness study -01 
The calculation formula for the determination of assay is, 
 
  
 
Where, AT = Average Area of Test Preparation. 
AS = Average Area of Standard Preparation. 
W1 = Weight of Working Standard (mg). 
W2 = Weight of Test Sample (mg). 
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W2 = Weight of Test Sample (mg). 
AW = Average Weight of Formulation (mg). 
LC = Label Claim Weight of Formulation (mg). 
P = Potency of Working Standard (%). 
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Figure 17: Chromatogram of Aripiprazole at Flow Rate 0.9 and 1.1 ml/min. 
The assay value of test preparation was 101.01% and 100.23% at 0.9 and 1.1 ml/min 
respectively. The above chromatograms suggest that the flow rate affects on the retention 
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time of drug but it did not have any impact on the response so the peak area were not 
change too much hence the assay value remain unaffected.  
B) Mobile Phase Proportion Change: In this experiment the test samples were 
analyzed at the mobile phase proportion of 08:92 and 88:12, v/v (Buffer: Acetonitrile) 
each and the results were observed in terms of assay value and chromatographic 
compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 67.  A proto type chromatographic sequence of the robustness study is 
as under, 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
08:92  
Buffer : Acetonitrile 
2 Standard  5 
3 Test 2 
4 Bracketing Standard 1 
5 Blank 1 
12:88  
Buffer : Acetonitrile 
6 Standard  5 
7 Test 2 
8 Bracketing Standard 1 
 
Table 9: Experimental HPLC sequence for the robustness study – 02 
The calculation formula for the determination of assay is, 
 
  
 
Where, AT = Average Area of Test Preparation. 
AS = Average Area of Standard Preparation 
W1 = Weight of Working Standard (mg). 
W2 = Weight of Test Sample (mg). 
W2 = Weight of Test Sample (mg). 
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AW = Average Weight of Formulation (mg). 
LC = Label Claim Weight of Formulation (mg). 
P = Potency of Working Standard (%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Chromatogram of Aripiprazole at different mobile phase proportion. 
The assay value of test preparation was 99.89% and 98.34% at 08:92 (Buffer: 
Acetonitrile, v/v) and 12:88 (Buffer: Acetonitrile, v/v) respectively. The above  data and 
chromatograms suggesting that the Mobile Phase proportion made a impact  on the 
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retention time of drug but it did not have any significant change on the intensity so the 
peak area were not change too much hence the assay value remain unaffected  
 
C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of assay value and 
chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 67. A proto type chromatographic sequence of the robustness study is 
as under. 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections Chromatographic condition
1 Blank 1 
Different Column Lot 
2 Standard  5 
3 Test 2 
4 Bracketing Standard 1 
 
Table 10: Experimental HPLC sequence for the robustness study – 03 
 
The calculation formula for the Assay determination is as per given on the previous page 
89. The assay value is for the test preparation was 101.76%. 
The data and the chromatogram given below suggest that there is no considerable 
influence of the column lot change on the result of the analysis by this method or on 
chromatographic suitability of this method. Hence, it can be conclude from this 
experiment that the method is highly robust in terms of column lot change.  
 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                               Page 91 
 
 
Chapter – 2                                                             A Stability Indicating RP-HPLC method for quantification of Aripiprazole 
 
109876543210 
mAU 
0
100
200
300
Detector A-240 nm
Column Lot Change
  
 
5.52  
Minutes
 
 
 
 
 
 
 
 
 
Figure 19: Chromatogram of Aripiprazole at different column lot. 
 
Summary of Robustness Study 
Robust 
Condition % Assay 
Retention time 
(min.) 
System Suitability 
Theoretical 
Plates Asymmetry
Flow Change 0.9 
ml/min  101.01 6.144 14911 1.18 
Flow Change 1.1 
ml/min  100.23 5.045 15851 1.13 
MP Proportion 
Change 08:92 99.89 5.397 14991 1.14 
MP Proportion 
Change 12:88 98.34 5.696 15799 1.21 
Column Lot 
Change 101.76 5.52 15320 1.12 
   
Table 11: Summary of robustness study  
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4.3.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time of 
period, 
(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS: 25.00 mg of Aripiprazole working standard 
was accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substance was dissolved by sonication 
for one minute. Then, volume of the flask was making up with diluent. The concentration 
obtained is 1000 μg/ml of Aripiprazole. This solution was prepared on the first day of the 
validation and kept at the 2-4˚C temp. in refrigerator without any disturbance until 
performance of the LTSSS experiment. 
After 12 day the stock solution was bring out of the refrigerator and keep it as such till it 
attains the room temp. 5 ml of this solution was pipette out in 50 ml volumetric flask and 
dilute it up to the mark to reach 100 of Aripiprazole. This solution was assigned as 
LTSSS Standard solution. 
Preparation of Fresh Standard Solution: 25.00 mg of Aripiprazole working standard was 
accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substance was dissolved by sonication 
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for one minute. Then, volume of the flask was making up with diluent. The concentration 
obtained is 1000 μg/ml of Aripiprazole. Pipette out exactly 5 ml of this solution in 50 ml 
volumetric flask and dilute it up to the mark accurately to confirm the 100 μg/ml of 
Aripiprazole. This solution was assigned as Fresh Standard Solution. The proto-type 
experimental sequence is given below for LTSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard 5 
3 LTSSS-01( 12 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 ( 12 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 12 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 12 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 12 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for LTSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard         
Mean Area Ratio = 1.003 for this experiment. 
Preparation of Stock Solution for STSSS or Bench Top Solution Stability:  25.00 mg of 
Aripiprazole working standard was accurately weighed and transferred into 25 ml 
volumetric flask. 20 ml of diluent was added into the volumetric flask and the standard 
substance was dissolved by sonication for one minute. Then, volume of the flask was 
making up with diluent. The concentration obtained is 1000 μg/ml of Aripiprazole. This 
solution was prepared before the 12 hour and kept on bench at ambient temperature 
without any disturbance until performance of the STSSS experiment. After 12 hour on 
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the bench. 5 ml of this solution was pipette out in 50 ml volumetric flask and dilute it up 
to the mark to reach 100 of Aripiprazole. This solution was assigned as STSSS Standard 
solution Preparation of Fresh Standard Solution: 25.00 mg of Aripiprazole working 
standard was accurately weighed and transferred into 25 ml volumetric flask. 20 ml of 
diluent was added into the volumetric flask and the standard substance was dissolved by 
sonication for one minute. Then, volume of the flask was making up with diluent. The 
concentration obtained is 1000 μg/ml of Aripiprazole. Pipette out exactly 5 ml of this 
solution in 50 ml volumetric flask and dilute it up to the mark accurately to confirm the 
100 μg/ml of Aripiprazole. This solution was assigned as Fresh Standard Solution. The 
proto-type experimental sequence is given below for STSSS. 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 STSSS-01( 12.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 12.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour) 1 
8 STSSS-03 ( 12.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 12.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 12.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 13: Sequence for STSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 0.998 for this experiment. 
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The Mean Area Ratio is within the acceptance criteria of 0.95 to 1.05, hence it can be 
concluded from this experiment that the Stock Solution is stable for the 12 days at 2 - 4˚ 
C in refrigerator, while Standard solution is remain unaffected on bench at ambient 
temperature and in normal light for 12 hour. In addition to this it confirms the reliability 
of the data generated during the method validation.  
 
4.3.8.  SYSTEM SUITABILITY STUDY 
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
 
The Theoretical plates should be more than 5000, Asymmetry should be less than 2.0 and 
% RSD should be less than 2.0. As the data suggest the system suitability was within the 
criteria in each validation experiment.  Hence the system was found suitable to perform 
the validation experiment which confirms the reliability of the data generated during the 
method validation. 
Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity 15302 1.16 0.92 
Linearity and Range 15411 1.15 0.81 
LOD and LOQ 15210 1.13 1.21 
Method Precision 15902 1.19 1.03 
Int. Precision 15545 1.19 0.98 
Accuracy 15698 1.15 0.67 
Robustness 14900 1.12 0.42 
Solution Stability 15320 1.18 1.23 
 
Table 14: Results of System Suitability Test after each Validation Experiment 
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5.  CONCLUSION 
The surveillance and outcome obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria. Since, all the 
results are with-in the limit, the developed Analytical method is considered as validated 
and suitable for anticipated use.   
 
 
6. APPLICATION OF CURRENT WORK  AND  FURTHER 
AREA OF EXTENSION 
 
6.1. This method can be used for the quantification of aripiprazole in bulk drug as well 
as in pharmaceutical dosage form in routine or as a special test. 
6.2. As the stress condition analysis also did here it can be appropriately use for the 
stability study of Aripiprazole. 
6.3. This method has also application over the chromatographic purity of Aripiprazole. 
6.4. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation of Aripiprazole and its related compound. 
 
Further Area of Development, 
 
6.5. This method can be transferred to RP-UPLC which is highly useful for the high 
throughput analysis. 
6.6. It is highly specific over the degradation product hence it has scope for the 
isolation, characterization of impurity and their analysis. 
6.7. This method can be used for the analogue structure of the aripiprazole, 
additionally a general method can be develop and validate for the analogs of this 
molecule. 
6.8. Further the method for the determination of aripiprazole and its intermediate 
during the preparation of the molecule can be developed and validate.   
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1. INTRODUCTION 
 
We have already discussed and introduce Aripiprazole, biological importance as 
antipsychotic medicine and its unique mechanism pharmacokinatically as well as 
pharmacodynamically in previous chapter.  
Now we confer and introduce here briefly a fastest liquid chromatography: Ultra 
Performance Liquid Chromatography, Theory behind it and scale up process. 
In recent years, significant technological advances have been made in particle chemistry 
performance, system optimization, detector design, and data processing and control. 
When brought together, the individual achievements in each discipline have created a 
step-function improvement in chromatographic performance. Ultra Performance Liquid 
Chromatography (UPLC) is a new category of analytical separation science that retains 
the practicality and principles of HPLC, while increasing the overall interlaced attributes 
of speed, sensitivity and resolution.   
 
During the past 30 or so years, high performance liquid chromatography (HPLC) has 
proven to be the predominant technology used in laboratories worldwide. One of the 
primary drivers for the growth of this technique has been the evolution of the packing 
materials used to effect the separation. The underlying principles of this evolution are 
governed by the van Deemter equation, which any chromatographer is familiar with [1]. 
The van Deemter equation is an empirical formula that describes the relationship between 
linear velocity (flow rate) and plate height (HETP or column efficiency). Since particle 
size is one of the variables, a van Deemter curve can be used to investigate 
chromatographic performance, as illustrated in Figure 1. 
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Chart 1: van Deemter plot illustrating the evolution of particle sizes over the last 3 
decades. 
 
Figure 1 demonstrates that as the particle size decreases to less than 2.5 μm, not only is 
there a significant gain in efficiency, but the efficiency does not diminish at increased 
flow rates or linear velocities. By using smaller particles, speed and peak capacity 
(number of peaks resolved per unit time) can be extended to new limits, termed Ultra 
Performance Liquid Chromatography, or UPLC. Using UPLC, it is now possible to take 
full advantage of chromatographic principles to run separations using shorter columns, 
and/or higher flow rates for increased speed, with superior resolution and sensitivity. 
 
To truly take advantage of the increased speed, superior resolution and sensitivity 
afforded by small particles, instrument technology also had to keep pace. A completely 
new system design with advanced technology in the pump, autosampler, detector, data 
system, and service diagnostics was required. The UPLC system has been holistically 
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designed for low system and dwell volume to take full advantage of low dispersion and 
small particle technology [2]. 
Efficiency (N) is inversely proportional to particle size dp,  
 
N ∞ 1/dp 
 
Efficiency (N) is also inversely proportional to the square of peak width w, 
 
N ∞ 1/w2 
 
Peak height (H) is inversely proportional to the peak width w, 
 
 H ∞ 1/w 
 
From the above all formula it can be conclude that that by decreasing the particle size it is 
possible to increase the efficiency. In addition to this it is also possible to achieve the 
sharpen peak and more response in terms of the height. Overall by decrement in the 
particle size of stationary phase achieves the speed, sensitivity and resolution.  All 
introduction part raised the following question and its answer solves the whole query. 
 
Why HPLC methods are converted to UPLC methods? 
 
- To get faster results by applying new technology with more reliability 
- Achieves more information 
- Results more robust methods 
- Better situational response time (stat sample faster, research decision with more 
information, process monitoring, product release) 
- More sample analyzed per system, per scientist 
 
Overall increased productivity with best compatibility compare to earlier techniques [3]. 
Scale Up Process: 
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(A)  Injection Volume  
 
Target Inj. Vol. = Original Inj. Vol. X Target Column Vol. / Original Column Vol. 
 
(B)  Flow Rate 
   
Target Flow Rate = Original Flow Rate X Target Column Vol. / Original Column Vol. 
 
(C) Gradient Program 
 
Express gradient duration in percent change per column volume in (cv) unit. Calculate each 
segment as a number of column volumes. Calculate time required to deliver the same 
number of column volumes to the target column at the chosen flow rate. 
 
Gradient Duration (cv) = Gradient Volume/ Column Volume 
Gradient Step Volume = Duration (cv) X Target Column Volume 
Gradient Step Time = Gradient Step Volume/Flow Rate  
In addition to all this many research papers have already published which gives the idea 
about the benefit of UPLC and small particles in liquid chromatography compare to earlier 
methods and technology in literature using certain analysis using both [4-10]. 
 
2. LITERATURE REVIEW 
Many methods have been published for the determination of Aripiprazole by HPLC but 
According to our knowledge there is no method in literature for determination of 
aripiprazole by UPLC-PDA. We can only come across one investigative method in literature 
via all sources which describe UPLC-MS/MS method for determination of aripiprazole and 
its metabolite in vitro samples. 
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2.1. Li Kun Yan, Zhou Yan Gang, Re Hua Yi, Wang  Feng, Zhang Bi Kui, Li  Huan 
De have reported a method  using an Acquity UPLC BEH C18 column (100 mm × 2.1 mm 
i.d., 1.7 μm particle size) The UPLC system was coupled to a Waters Micromass Quattro 
Premier XE tandem quadruple mass spectrometer. The determination was performed in 
multiple reaction monitoring (MRM) mode. This method is for determination of aripiprazole 
and some other antipsychotic molecule with its metabolite from biological matrix [11]. 
 
3. AIM OF THE PRESENT WORK 
 The above literature reveals that there is no methods for the quantification of aripiprazole 
as a drug substance as well as in pharmaceutical dosage by UPLC-PDA, only one method 
available which deals the bioanalytical study but very few methods are available 
describing the forced degradation. Furthermore the present method has the advantage 
over the speed as well as the selectivity and it can be maximum utilize for the analysis of 
formulation development and stability testing as well as at quality control laboratory for 
routine use. The aim and scope of the proposed work are as under. 
 
3.1. To develop (transfer) fastest method for quantification of the drug substance with 
highest selectivity, precision and accuracy using the latest technology in liquid 
chromatography. 
3.2. Comparison of the validation results of previous HPLC method to present UPLC 
method for proving the efficiency of equipment and as well as the present method. 
3.3. Elaborate the technology suggesting the various applications.   
3.4. To perform analytical method validation for the proposed method as per ICH 
guideline [12]. 
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4. EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS 
Torrent Research Centre (Gandhinagar, India) provided Aripiprazole working standard. 
Aripiprazole tablets containing 10 mg Aripiprazole and the inactive ingredients used in 
the drug matrix has obtained from the commercial market. Analytical grade Ammonium 
Acetate, HPLC grade Acetonitrile and water has purchased from Spectrochem Pvt. Ltd 
(Mumbai, India). Analytical grade hydrochloric acid, NaOH pellets, Orthophosphoric 
acid and 30% hydrogen peroxide solution has procured from Ranbaxy Fine Chemicals 
(New Delhi, India). 
4.2. INSTRUMENTATION 
The Waters AcquityTM UPLC chromatographic system used to perform development and 
validation. This system consist of a binary solvent manager (pump), photodiode array 
detector, sample manager(Auto sampler) and column oven connected to a multi-
instrument data acquisition and processing system Empower 2.1 version. Sartorius 
microbalance and Equiptronics branded balance and heating oven was used for the 
weighing and heating purpose while Spinco ultrasonic bath used for degassing purpose.   
4.3. METHOD DEVELOPMENT (TECHNOLOGY TRANSFER) 
As the term technology transfer suggests that here the earlier method (developed and 
validated in previous chapter) was optimized to achieve the more speed, sensitivity and 
resolution. The HPLC technology was scale down to attain better chromatographic 
compatibility in order to using smaller particle size column and UPLC equipment. 
4.3.1. MOBILE PHASE SELECTION 
On the basis of literature survey, previous experience and chromatographic suitability 
achieved by several exploratory efforts suggest 20 mM Ammonium Acetate: Acetonitrile 
(10:90) this also been proven in HPLC method (in chapter-2). 
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4.3.2. COLUMN SELECTION 
Column selection is the most important part in the method development. Matching the 
column chemistry with Phenominex C8 which was used earlier for HPLC method, here 
we used the Acquity BEH C8 (50X2.1, 1.7µ particle size) column.  
4.3.3. DETECTION WAVELENGTH SELECTION  
nm220.00
240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
223.7
254.9
1.55
1.545
 
Figure 1: PDA absorption graph at each wavelength  
We have screened the standard solution over 190 nm to 400 nm using the advantage of 
photo diode array detector. On the basis of peak absorption maxima and peak purity 
index of analyte, the 240 nm was decided as the detection wavelength which also gives 
the maximum chromatographic compatibility to the method. The absorption is shown in 
the figure 1 for aripiprazole at each wavelength. 
4.3.4. MOBILE PHASE PREPARATION 
The mobile phase consist of Acetonitrile: 20 mM ammonium acetate (90:10, v/v) was 
prepared by dissolving 1.54 gm of ammonium acetate (AR grade) in 1000 ml of HPLC 
grade water which further mixed with acetonitrile at ratio (90:10, v/v) and filtered 
through 0.45µn filter followed by degassing in ultra sonic bath for 20 min. 
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4.3.5. STANDARD SOLUTION PREPARATION 
An aripiprazole standard solution containing 100μg/ml was prepared in a 100 ml 
volumetric flask by dissolving 10 mg aripiprazole in 25 ml acetonitrile and then diluting 
to volume with acetonitrile.  
4.3.6. SAMPLE SOLUTION PREPARATION 
Twenty commercially available 10.0 mg label clamed tablets of aripiprazole have 
weighed, and the average weight of a tablet was determined. From these, 5 tablets were 
weighed and transferred into a 500 ml volumetric flask and added 50 ml Acetonitrile 
followed by sonication of minimum 30 min with intermittent shaking. Then the solution 
has brought back to room temperature and diluted to volume with Acetonitrile. The 
sample has filtered through a 0.45 μn nylon syringe filter. Now the available 
concentration was 100 μg/ml aripiprazole. 
 
 
Figure 2: Chromatogram of Aripiprazole Working Standard 
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Figure 2: Chromatogram of Aripiprazole Working Standard Solution 
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Figure 3: Chromatogram of Aripiprazole Sample Solution 
 
Finally after few exploratory runs in Technology Transfer (method development) 
following chromatographic condition suits the most. 
 
 
Mobile Phase A  : 20 mM Ammonium Acetate in HPLC grade water 
Mobile Phase B  : Acetonitrile (HPLC grade) 
  Column   : Acquity BEH C8 (100 X 2.1 mm id, 1.7µn) 
Flow Rate   : 0.250 ml/min 
Detection   : 240 nm UV 
Diluent    : Acetonitrile (HPLC grade) 
Injection Volume  : 05 µl 
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4.4. METHOD VALIDATION 
 
Method for the determination of aripiprazole in bulk drug as well as in pharmaceutical 
dosage form is further validated as per ICH Q2(R1) guideline [12]. Validation of 
analytical method was performed using Aripiprazole 10 mg tablet formulation as well as 
bulk drug substance equivalent to the formulation.  
 
4.4.1. SPECIFICITY STUDY 
 
The evaluation of the specificity of the method was determined against placebo and 
diluent application. The interference of the excipients of the claimed placebo present in 
the pharmaceutical dosage form was derived from placebo solution. Further the 
specificity of the method toward the drug was established by means of the interference of 
diluent at the retention time of the drug peak. 
 
Blank preparation: 
Diluent was used as blank. 
 
Standard solution preparation, 
Stock solution: 25.00 mg of Aripiprazole working standard was accurately weighed and 
transferred into 25 ml volumetric flask. 20 ml of diluent was added into the volumetric 
flask and the standard substance was dissolved by sonication for one minute. Then, 
volume of the flask was making up with diluent. The concentration obtained was 1000 
μg/ml of Aripiprazole. 5 ml of above standard stock solution was pipette out and 
transferred into 50 ml volumetric flask followed by diluted to volume with diluent. The 
concentration obtained is 100 μg/ml of Aripiprazole  
 
Test Preparation, 
Test stock solution: 10 Tablets were accurately weighed (1021.8 mg) and transferred into 
100 ml volumetric flask. 70 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal hand-shaking. Then, the 
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flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
solution was filtered through 0.45 μn nylon syringe filter. The concentration obtained was 
about 1000 μg/ml of Aripiprazole. 5 ml of above test stock solution was pipette out and 
transferred into 50 ml volumetric flask followed by diluted to volume with diluent. The 
concentration obtained is about 100 μg/ml of Aripiprazole 
 
Average weight of the tablets: 
Randomly selected 20 tablets were weighed accurately (2020.0 mg) and the mean weight 
was calculated for the same. This mean weight (101.0 mg) was used as average weight 
throughout all experiments. 
 
Placebo preparation: 
Stock solution: Placebo equivalent to 10 times of average placebo weight was weighed 
(900.0 mg) and transferred into 100 ml volumetric flask.70 ml of diluent was added into 
the volumetric flask and sonicated of 30 minutes with normal hand-shaking. The 
volumetric flask was cooled to room temperature and diluted to volume with diluent. 10 
ml of this solution was filtered through 0.45 μm nylon syringe filter.5 ml of above 
placebo stock solution was pipette out and transferred into 50 ml volumetric flask 
followed by dilute to volume with diluent. 
 
 
 
 
 
 
 
 
 
 
 3.002.50 2.001.501.000.500.00 Minutes
0.020
0.015
0.010
0.000
-0.005
-0.010
AU
0.005
 
Diluent 
Figure 4: Chromatogram of Diluent in Specificity experiment 
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Figure 5: Chromatogram of Placebo in Specificity experiment 
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Figure 6: Chromatogram of Sample solution in Specificity experiment 
 
From the specificity experiment and subsequently achieved above chromatograms it has 
proven that any interference was not observed from blank or placebo to the peak of 
interest, in addition to this peak purity was also within the acceptance criteria confirmed 
by the photo diode detector. 
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Hence it authenticate that the proposed method is highly specific with respect to the 
diluent and excipients in the commercial sample. 
 
4.4.2. LINEARITY & RANGE  
 
The linearity curve was prepared with 8 concentration levels (40, 60, 80, 100, 120, 140, 
160 and 180 μg/ml of Aripiprazole). These concentration levels were respectively 
corresponding to 40, 60, 80, 100, 120, 140, 160 and 180% of standard solution 
concentration. The peak areas vs. concentration data were evaluated by linear regression 
analysis. Stock solution for Linearity study was prepared as per procedure on page 110 
and further diluted to attain concentration of about 40, 60, 80, 100, 120, 140,160 and 
180% of standard solution concentration. 
 
Linearity Standard Solution Preparation: From Standard Stock Solution of accurately 
1000 µg/ml pipette out exactly 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6 and 1.8 ml and dilute it up 
to 10 ml each with diluent to achieve 40-180 µg/ml concentration range. 
 
Linearity 
Level 
Concentration 
(µg/ml) Peak Area 
1 180 5621333 
2 160 4922169 
3 140 4270240 
4 120 3636078 
5 10 2993655 
6 80 2364282 
7 60 1709619 
8 40 1192202 
 
 Table 1: Linearity and Range - Concentration Vs Peak area response data 
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X axis = Concentration (µg/ml) Y axis = Peak Area 
Chart 2: Regression Analysis chart of linearity Study 
Above data and the chart suggest that correlation coefficient of the linearity study was 
found to R2 = 0.999 with linear regression equation y = 32511x - 25877, which proves the 
method is highly linear over the working range of 40 – 180 µg/ml. 
 
4.4.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION STUDY 
LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) should be more than 3.3 for LOD 
and more than 10 for LOQ. On the basis of linearity data theoretically it can be also 
calculated by the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
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Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 110. From the stock 
solution of 1000 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent, assign this solution as Solution – A. Form the 
Solution - A pipette out exact 0.1 ml to the 100 ml volumetric flask followed by dilution 
up to the mark with diluent to reach 0.01 µg/ml concentrations. 
LOQ Solution Preparation: 
Form the Solution - A pipette out exact 0.5 ml to the 100 ml volumetric flask followed by 
dilution up to the mark with diluent to achieve 0.05 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
 
LOQ 
Injection Peak Area 
1 1220 
2 1326 
3 1272 
4 1152 
5 1232 
6 1211 
Mean 1235.5 
Std. Dev. 58.9 
% RSD 4.8 
 
Table 2: Limit of Quantification – Summary of Replicate Injections 
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Figure 7: Chromatogram of Limit of Detection 
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        Figure 8: Chromatogram of Limit of Quantification 
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LOQ of the analytical method can evaluated by establish linearity up to LOQ value. For 
that linearity study is extended to LOQ value, 
 
 
 
X axis = Concentration (µg/ml) Y axis = Peak Area 
Chart 2: Regression Analysis chart of linearity Study included with LOQ level 
 
All the results of LOD and LOQ data were within the acceptance criteria, hence it can be 
conclude that the LOD and LOQ of the method was 0.01 µg/ml and 0.05 µg/ml 
respectively which correspond to 0.01% and 0.05% of working concentration. The signal 
to noise ratio for the LOD was well within the acceptance criteria it means more than 3.3 
and for the LOQ it was more than 10.0. Furthermore the % RSD of the six replicate 
injection of LOQ preparation was 4.8 and the data of linearity extension chart up to LOQ 
level also suggest that the aripiprazole can be quantified up to 0.05 µg/ml well precisely 
and accurately.  
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4.4.4. PRECISION STUDY 
 
Precision study was established by evaluating method precision and intermediate 
precision study.  
Method precision of the analytical method was determined by analyzing six sets of 
sample solution preparation. Assay of all six replicate sample preparations was 
determined and mean % assay value, standard deviation and % relative standard 
deviation for the same was calculated. Intermediate precision of the analytical method 
was determined by performing method precision on another day by another analyst using 
different make of raw materials under same experimental condition. Assay of all six 
replicate sample preparations was determined and mean % assay value, standard 
deviation and % relative standard deviation also calculated. Overall assay value of 
method precision and intermediate precision was compared and % difference and overall 
% relative standard deviation was calculated.  
 
Solution Preparation for Precision Study: 
Standard Solution Preparation: 
Standard Stock Solution prepared as per procedure on page 110 of 1000 µg/ml. pipette 
out exact 1.0 ml from this solution and dilute up to 10 ml to accomplish 100 µg/ml 
concentration.  
 
Sample Solution Preparation: 
Test stock solution: 10 Tablets were accurately weighed (1012.2 mg) and transferred into 
100 ml volumetric flask. 70 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal hand-shaking. Then, the 
flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
solution was filtered through 0.45 μm nylon syringe filter. The concentration obtained 
was about 1000 μg/ml of Aripiprazole. 5 ml of above test stock solution was pipette out 
and transferred into 50 ml volumetric flask followed by diluted to volume with diluent. 
The concentration obtained is about 100 μg/ml of Aripiprazole. This solution is assign as 
Test Preparation Set – 01. The same procedure was used for preparing the six Test 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                            Page 118 
 
 
Chapter – 3                                                  Method Development and Validation for Quantification of Aripiprazole by UPLC 
preparation Sets. Same approach was applied for the intermediate precision study on the 
second day with different analyst and different make of raw materials. 
 
 
 
Method Precision  
Sample Replicates Peak Area Mean % Assay  
 Set 01 
Injection 01 2834014 
2841993 99.12 Injection 02 2841274 
Injection 03 2850691 
 Set 02 
Injection 01 2843736 
2852594 100.21 Injection 02 2856643 
Injection 03 2857402 
 Set 03 
Injection 01 2854463 
2850746 99.45 Injection 02 2842640 
Injection 03 2855136 
 Set 04 
Injection 01 2861257 
2855496 100.21 Injection 02 2855174 
Injection 03 2850056 
 Set 05 
Injection 01 2840211 
2818446 98.9 Injection 02 2794121 
Injection 03 2821005 
 Set 06 
Injection 01 2891033 
2891758 98.27 Injection 02 2884230 
Injection 03 2900012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Method Precision Data 
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Intermediate Precision 
Sample Replicates Peak Area Mean % Assay 
Set 01 
Injection 01 2939495 
2900666 101.7 Injection 02 2945158 
Injection 03 2817346 
Set 02 
Injection 01 3160748 
3014019 100.23 Injection 02 2939764 
Injection 03 2941545 
Set 03 
Injection 01 2950295 
2957254 100.9 Injection 02 2924975 
Injection 03 2996491 
Set 04 
Injection 01 3012125 
2979361 98.81 Injection 02 2971717 
Injection 03 2954241 
Set 05 
Injection 01 2945611 
2968674 99.75 Injection 02 2871091 
Injection 03 3089321 
Set 06 
Injection 01 2933564 
2980279 100.45 Injection 02 3019823 
Injection 03 2987451 
 
Table 4: Intermediate Precision Data 
% Assay calculation is as under: 
 
  
 
Where, AT = Average Area of Test Preparation, AS = Average Area of Standard 
Preparation, W1 = Weight of Working Standard (mg), W2 = Weight of Test Sample (mg), 
AW = Average Weight of Formulation (mg), LC = Label Claim Weight of Formulation 
(mg), P = Potency of Working Standard (%) 
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Figure 9: Chromatograms of Method Precision study (Sample Solution) 
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Figure 10: Chromatograms of intermediate Precision study (Sample Solution) 
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Overall the data for the precision study suggest % Assay value for each Test Preparation 
is between 98 – 102% which is under the acceptance criteria while % RSD of all results 
are less than 2%. Hence from all the observation it can conclude that the proposed 
method is highly precise.  
 
4.4.5.  ACCURACY STUDY    
This Experiment can be performed by the recovery test. Recovery of the method is 
evaluated at 3 different concentration levels (corresponding to 40, 100 and 160% of test 
solution concentration) by addition of known amounts of standard to placebo preparation. 
For each concentration level, 3 sets were prepared and injected in duplicate. 
 
Blank preparation: 
Diluent was used as blank. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 110. 
 
Sample preparations for accuracy levels are as under: 
 
Accuracy level 1 (40%)  
Test stock solution:  
80.0 mg of Aripiprazole reference standard was accurately weighed and transferred into 
200 ml volumetric flask. 900.0 mg placebo (equivalent of 10 average placebo weights) 
was weighed and transferred into the same 200 ml volumetric flask. Around 140 ml of 
diluent added into the volumetric flask. The volumetric flask was proceeding for 
sonication of 30 minutes with normal handshaking. Then, the flask was cooled to room 
temperature and diluted to volume with diluent. 10 ml of this solution was filtered 
through 0.45 μm nylon syringe filter. The concentration obtained was 400 μg/ml of 
Aripiprazole. 5 ml of above test stock solution was pipette out and transferred into 50 ml 
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volumetric flask followed by diluted to volume with diluent. The concentration obtained 
is 40 μg/ml of Aripiprazole. The same procedure was applied for preparing the three sets. 
 
Accuracy level 2 (100 %) 
Test stock solution:  
100.0 mg of Aripiprazole working standard was accurately weighed and transferred into 
200 ml volumetric flask. 900.0 mg placebo (equivalent of 10 average weights) was 
weighed and transferred into this 200 ml volumetric flask. 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking. 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.45 μm nylon syringe filter. The concentration 
obtained is 1000 μg/ml of Aripiprazole. 5 ml of above test stock solution was pipette out 
and transferred into 50 ml volumetric flask followed by diluted to volume with diluent. 
The concentration obtained is 100 μg/ml of Aripiprazole. The same procedure was 
applied for preparing the three sets. 
 
Accuracy level 3 (150 %) 
Test stock solution: 
160.0 mg of Aripiprazole Working standard was accurately weighed and transferred into 
200 ml volumetric flask. 900 mg placebo (equivalent of 10 average placebo weights) was 
weighed and transferred into this 200 ml volumetric flask. 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking. 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.45 μm nylon syringe filter. The concentration 
obtained was 1600 μg/ml of Aripiprazole. 5 ml of above test stock solution was pipette 
out and transferred into 50 ml volumetric flask followed by diluted to volume with 
diluent. The concentration obtained is 160.0 μg/ml of Aripiprazole.  
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Accuracy 
Replicates Area Mean Mean of each level 
Leval-1 set 1 inj 01 4664795 
4675148 
4672478.2 
 Leval-1 set 1  inj 02 4685501 
 Level-1 set 2  inj 01 4674074 
4665354 
Level-1 set 2 inj 02 4656634 
 Level-1 set 3  inj 01 4661618 
4676932.5 
Level-1 set 3 inj 02 4692247 
Level-2 set 1 inj 01 2869915 
2867498 
2873661 
Level-2 set 1 inj 02 2865081 
Level-2 set 2 inj 01 2877644 
2874919.5 
Level-2 set 2 inj 02 2872195 
Level-2 set 3 inj 01 2884024 
2878565.5 
Level-2 set 3 inj 02 2873107 
Level-3 set 1 inj 01 1198889 
1157103.5 
1141707.7 
Level-3 set 1 inj 02 1115318 
Level-3 set 2 inj 01 1202799 
1159447.5 
Level-3 set 2 inj 02 1116096 
Level-3 set 3 inj 01 1109673 
1108572 
Level-3 set 3 inj 02 1107471 
 
Table 5: Summery of Accuracy Data-01 
 
Calculation formulas for recovery study are as under: 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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From the above calculation the % Recovery was calculated which is given below. 
 
Accuracy (Recovery) Study 
Accuracy 
Level 
Set 
No 
Amount 
Added 
(μg/ml ) 
Amount 
Found 
(μg/ml ) 
Recovery 
(%) 
Average 
Recovery 
Std. 
Dev. 
% RSD 
I (40%) 
1 40.1 40.02 99.8 
99.8 0.08 0.08 2 40.4 40.33 99.8 
3 40.23 40.1 99.7 
II (100%) 
1 100.1 99.1 99.0 
99.6 0.54 0.55 2 100.23 100.2 100.0 
3 100.54 100.45 99.9 
II (160%) 
1 160.5 159.96 99.7 
100.0 0.47 0.47 2 160.43 160.25 99.9 
3 159.2 160.1 100.6 
 
Table 6: Summery of Accuracy Data-02 
 
 
 
 
 
 
 
 
Figure 11: Chromatogram of Accuracy level -1 (160 %) 
3.002.502.001.501.000.500.00
Minutes
2.00
1.50
1.00
0.50
0.00
AU
 
Accuracy Level 1 (160%)  
1.546
 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                            Page 125 
 
 
Chapter – 3                                                  Method Development and Validation for Quantification of Aripiprazole by UPLC 
 
 
3.002.502.001.501.000.500.00
Minutes
 
Accuracy Level 2 (100%)  
 
1.545AU 
1.40
1.20
1.00
0.80
0.60
0.40
0.20
0.00
 
 
 
 
 
 
 
Figure 12: Chromatogram of Accuracy level -2 (100 %) 
 
 
 
 
3.002.50 2.001.501.000.500.00
Minutes
0.60
0.50
0.40
0.20
0.10
0.00
AU0.30
 
Accuracy Level 3 (40%)  
 
1.544 
 
 
 
 
Figure 13: Chromatogram of Accuracy level -1 (40 %) 
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From the all above data and chromatograms  it has been confirmed that the % recovery is 
within 98 to 102 % this is in the limit of acceptance criteria and % RSD value of % 
recovery of replicate sets is below 2 % .consequently this suggest that proposed method 
is highly accurate. 
 
4.4.6. ROBUSTNESS STUDY 
 
Robustness of the method was evaluated by assaying test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in 
proportions of Buffer-Acetonitrile (08:92 and 88:12,v/v), and change in column-lot. 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 0.38 ml/min and 0.42 ml/min each and the results were observed in terms of assay 
value and chromatographic compatibility (System Suitability Test). Blank, Standards and 
Sample solutions were prepared as per the same procedure mentioned on page 110. 
 A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. No. Sample Name No. of Injections 
Chromatographic 
condition 
1 Blank 1 
Flow Rate 0.38 
ml/min 
2 Standard 5 
3 Test 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 0.42 
ml/min 
6 Standard 5 
7 Test 2 
8 Bracketing Standard 1 
  
Table 7: Experimental UPLC sequence for the robustness study -01 
 
The calculation formula for the determination of assay is, 
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Where, AT = Average Area of Test Preparation, AS = Average Area of Standard 
Preparation, W1 = Weight of Working Standard (mg), W2 = Weight of Test Sample (mg), 
W2 = Weight of Test Sample (mg), AW = Average Weight of Formulation (mg), LC = 
Label Claim Weight of Formulation (mg), P = Potency of Working Standard (%) 
 
 
 
3.002.501.000.500.00 
Minutes
2.001.50
 
Robustness 0.42 ml/min 
 
AU 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
1.403
 
 
 
 
 
 
 
Figure 10: Chromatogram of Aripiprazole at Flow Rate 0.42 and 0.38 ml/min. 
3.002.502.001.501.000.500.00 
Minutes
 
Robustness 0.38 ml/min 
 
AU 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
1.40 
1.543
 
 
 
 
 
Figure 14: Chromatogram of Aripiprazole at Flow Rate 0.42 and 0.38 ml/min. 
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The assay value of test preparation was 99.5% and 98.9% at 0.42 and 0.38 ml/min 
respectively. The above chromatograms suggest that the flow rate affects on the retention 
time of drug but it did not have any impact on the response so the peak area were not 
change too much hence the assay value remain unaffected. 
B) Mobile Phase Proportion Change: In this experiment the test samples were 
analyzed at the mobile phase proportion of 08:92 and 12:88, v/v (Buffer: Acetonitrile) 
each and the results were observed in terms of assay value and chromatographic 
compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 110. 
 A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. No. Sample Name No. of Injections 
Chromatographic 
condition 
1 Blank 1 08:92 
2 Standard 5 Buffer : Acetonitrile 
3 Test 2 
4 Bracketing Standard 1 
5 Blank 1 12:88 
6 Standard 5 Buffer : Acetonitrile 
7 Test 2 
8 Bracketing Standard 1 
 
Table 8: Experimental UPLC sequence for the robustness study – 02 
 
The calculation formula for the determination of assay is, 
 
  
 
Where, AT = Average Area of Test Preparation, AS = Average Area of Standard 
Preparation, W1 = Weight of Working Standard (mg), W2 = Weight of Test Sample (mg), 
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W2 = Weight of Test Sample (mg), AW = Average Weight of Formulation (mg), LC = 
Label Claim Weight of Formulation (mg), P = Potency of Working Standard (%). 
 
 
 
 
 
 
 
 
 
Minutes
0.00  0.50 1.00 1.50 2.00 2.50 3.00
 
2.50 3.002.001.501.000.500.00 
Minutes
1.40
1.20
1.00
0.60
0.40
0.20
0.00
AU 
0.80
Robustness 12:88 
  1.55
1.40
1.20
1.00
0.60
0.40
0.20
0.00
AU
0.80
 
Robustness 08:92 
  1.52
 
 
 
 
 
 
Figure 11: Chromatogram of Aripiprazole at different mobile phase proportion 
The assay value of test preparation was 101.21% and 99.32% at 08:92 (Buffer: 
Acetonitrile, v/v) and12:88 (Buffer: Acetonitrile, v/v) respectively. The above  data and 
chromatograms signifying that the Mobile Phase proportion made a impact  on the 
retention time of drug but it did not have any significant change on the intensity so the 
peak area were not change too much hence the assay value remain unaltered  
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C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of assay value and 
chromatographic compatibility (System Suitability Test). Blank, Standards and Sample 
solutions were prepared as per the same procedure mentioned on page 110. A proto type 
chromatographic sequence of the robustness study is as under, 
  
Experimental Sequence 
Sr. No. Sample Name No. of Injections 
Chromatographic 
condition 
1 Blank 1 
Different Column 
Lot 
2 Standard 5 
3 Test 2 
4 Bracketing Standard 1 
 
 
 
Table 9: Experimental UPLC sequence for the robustness study – 03 
The calculation formula for the Assay determination is as per given on the previous page 
129. The assay value is for the test preparation was 101.21%.  The data and the 
chromatogram given below suggest that there is no considerable influence of the column 
lot change on the result of the analysis by this method or on chromatographic suitability 
of this method. Hence, it can be conclude from this experiment that the method is highly 
robust in terms of column lot change. 
 
 
      
 
 
 
 
 
3.002.50 2.001.501.000.500.00 
Minutes
 
Robustness Column lot change 
 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
1.40 
1.545
Figure 12: Chromatogram of Aripiprazole at different column lot. 
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Summary of Robustness Study 
Robust 
Condition % Assay 
Retention 
Time (min.) 
System Suitability 
Theoretical 
Plates Asymmetry 
Flow Change 0.42 
ml/min  99.5 1.403 25026 1.08 
Flow Change 0.38 
ml/min  98.9 1.543 24987 1.08 
MP Proportion 
Change 08:92 101.21 1.52 25622 1.06 
MP Proportion 
Change 12:88 99.32 1.55 24866 1.1 
Column Lot 
Change 101.21 1.545 25964 1.05 
Table 10: Summary of robustness study  
 
4.4.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time of 
period, 
(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
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standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS:  
25.00 mg of Aripiprazole working standard was accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substance was dissolved by sonication for one minute. Then, volume of the flask 
was making up with diluent. The concentration obtained was 1000 μg/ml of Aripiprazole. 
This solution was prepared on the first day of the validation and kept at the 2-4˚C temp. 
in refrigerator without any disturbance until performance of the LTSSS experiment. After 
12 day the stock solution was bring out of the refrigerator and keep it as such till it attains 
the room temp. 5 ml of this solution was pipette out in 50 ml volumetric flask and dilute 
it up to the mark to reach 100 μg/ml of Aripiprazole.  This solution was assigned as 
LTSSS Standard solution. 
 
Preparation of Fresh Standard Solution:  
25.00 mg of Aripiprazole working standard was accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substance was dissolved by sonication for one minute. Then, volume of the flask 
was making up with diluent. The concentration obtained was 1000 μg/ml of Aripiprazole. 
Pipette out exactly 5 ml of this solution in 50 ml volumetric flask and dilute it up to the 
mark accurately to confirm the 100 μg/ml of Aripiprazole. This solution was assigned as 
Fresh Standard Solution. 
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The proto-type experimental sequence is given below for LTSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard 5 
3 LTSSS-01( 12 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 ( 12 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 12 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 12 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 12 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 11: Sequence for LTSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 0.952 of analyte in this experiment. 
Preparation of Stock Solution for STSSS or Bench Top Solution Stability:  
25.00 mg of Aripiprazole working standard was accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substance was dissolved by sonication for one minute. Then, volume of the flask 
was making up with diluent. The concentration obtained was 1000 μg/ml of Aripiprazole. 
This solution was prepared before the 12 hour and kept on bench at ambient temperature 
without any disturbance until performance of the STSSS experiment. After 12 hour on 
the bench. 5 ml of this solution was pipette out in 50 ml volumetric flask and dilute it up 
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to the mark to reach 100 μg/ml of Aripiprazole.  This solution was assigned as STSSS 
Standard solution 
Preparation of Fresh Standard Solution:  
25.00 mg of Aripiprazole working standard was accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substance was dissolved by sonication for one minute. Then, volume of the flask 
was making up with diluent. The concentration obtained was 1000 μg/ml of Aripiprazole. 
Pipette out exactly 5 ml of this solution in 50 ml volumetric flask and dilute it up to the 
mark accurately to confirm the 100 μg/ml of Aripiprazole. This solution was assigned as 
Fresh Standard Solution. The Mean peak area ratio of five LTSSS standard injections and 
Fresh Standard solution was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 1.04 of analyte in this experiment. The proto-type experimental 
sequence is given below for STSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 STSSS-01( 12.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 12.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour) 1 
8 STSSS-03 ( 12.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 12.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 12.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for STSSS. 
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The Mean Area Ratio is within the acceptance criteria of 0.95 to 1.05, hence it can be 
concluded from this experiment that the Stock Solution is stable for the 12 days at 2 - 4˚ 
C in refrigerator, while Standard solution is remain unaffected on bench at ambient 
temperature and in normal light for 12 hour. In addition to this it confirms the reliability 
of the data generated during the method validation.  
 
4.4.8. SYSTEM SUITABILITY STUDY 
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
 
Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity  15302 1.16 0.92 
Linearity and Range 15411 1.15 0.81 
LOD and LOQ  15210 1.13 1.21 
Method Precision  15902 1.19 1.03 
Int. Precision 15545 1.19 0.98 
Accuracy 15698 1.15 0.67 
Robustness 14900 1.12 0.42 
Solution Stability 15320 1.18 1.23 
 
Table 13: Results of System Suitability Test after each Validation Experiment 
The Theoretical plates should be more than 5000, Asymmetry should be less than 2.0 and 
% RSD should be less than 2.0. As the data suggest the system suitability was within the 
criteria in each validation experiment.  Hence the system was found suitable to perform 
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the validation experiment which confirms the reliability of the data generated during the 
method validation. 
 
5. CONCLUSION 
The observation and upshots obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria. Since, all the 
results are with-in the limit, the developed Analytical method is considered as validated 
and suitable for projected use. 
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6. COMPARISON WITH HPLC METHOD 
To evaluate the accomplishment of the technology transfer of the HPLC method to newer 
improved technique and subsequently advantage of the same can only ascertain by 
compare the validation results of the both developed methods, hence here we produce the 
validation result comparative in tabular form. 
 
Validation 
Experiment HPLC Method UPLC Method 
Specificity No Interference to analyte peak 
No Interference to analyte 
peak 
LOQ 0.1 µg/ml 0.05 µg/ml 
LOD 0.05 µg/ml 0.01 µg/ml 
Linearity and Range      
Co-relation Coefficient R2 = 0.999 R2 = 0.999 
Regression equation Y = 31252x + 17480 Y = 32511x - 25877 
Method Precision  
(n = 6) % RSD = 1.07 % RSD = 0.77 
Int. Precision  
(n = 6) % RSD = 0.23 % RSD = 0.98 
Accuracy (Recovery %) 99 - 101 99 - 100 
Robustness Highly Robust method Highly Robust method 
Total Analysis Time 10.0 min 3.0 min 
LTSS Stability 12 days 12 days 
STSS Stability 12 hours 12 hours 
 
Table 14: Comparison of Validation Results of Methods  
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Summary of System Suitability Test 
Method Average Theoretical Plates Average Asymmetry 
By HPLC 15302 1.16 
By UPLC 25981 1.03 
 
Table 15: Comparison of System Suitability Results of Developed Methods 
Above all validation data and additionally system suitability results suggest that ultra 
performance liquid chromatographic method not only gives the rapid analysis but it also 
provide more consistent and dependable method. 
 
7. APPLICATION OF CURRENT FINDINGS 
 
7.1. This method can be used for the quantification of aripiprazole in bulk drug as well 
as in pharmaceutical dosage form in routine or as a special test. 
7.2. This method has also application over the chromatographic purity of Aripiprazole. 
7.3. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation of Aripiprazole and its related compound. 
7.4. Since the suggested method is based on fastest liquid chromatographic 
technology, it is useful for the high throughput screening of Aripiprazole in bulk 
drug as well as in pharmaceutical combination dosage form  
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1. INTRODUCTION 
 
Valproic acid (by its official name 2-propylvaleric acid) was first synthesized in 1882 by 
Burton as an analogue of valeric acid, found naturally in valerian [1]. A clear liquid fatty 
acid at room temperature, for many decades its only use was in laboratories as a 
"metabolically inert" solvent for organic compounds. In 1962, the French researcher 
Pierre Eymard serendipitously discovered the anticonvulsant properties of valproic acid 
while using it as a vehicle for a number of other compounds that were being screened for 
anti-seizure activity. He found that it prevented pentylenetetrazol-induced convulsions in 
rodents [2]. It was approved as an antiepileptic drug in 1967 in France and has become 
the most widely prescribed antiepileptic drug worldwide [3]. Valproic acid has also been 
used for migraine prophylaxis and bipolar disorder [4].  
Valproate is believed to affect the function of the neurotransmitter GABA in the human 
brain, making it an alternative to lithium salts in treatment of bipolar disorder. Its 
principal mechanism of action is believed to be the inhibition of the transamination of 
GABA (by inhibiting GABA transaminase). Valproate is also believed to reverse the 
transamination process to form more GABA. Hence, Valproate indirectly acts as a 
GABA agonist. However, several other mechanisms of action in neuropsychiatric 
disorders have been proposed for valproic acid in recent years [5]. Valproic acid also 
blocks the voltage-gated sodium channels and T-type Calcium channels. These 
mechanisms make Valproic Acid a Broad Spectrum Anticonvulsant drug. Valproic acid 
is an inhibitor of the enzyme histone deacetylase 1 (HDAC1) hence it is a histone 
deacetylase inhibitor. 
As an anticonvulsant, valproic acid is used to control absence seizures, tonic-clonic 
seizures (grand mal), complex partial seizures, juvenile myoclonic epilepsy and the 
seizures associated with Lennox-Gastaut syndrome. It is also used in treatment of 
myoclonus. In some countries, parenteral (administered intravenously) preparations of 
valproate are used also as second-line treatment of status epilepticus, as an alternative to 
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phenytoin. Valproate is one of the most common drugs used to treat post-traumatic 
epilepsy [6].  
 
 
 
 
 
 
             
 
 
Figure 1: Chemical Structure of Valproic Acid 
 
The molecular weight of Valproic Acid is 144.21 g/mole with molecular formula of 
C8H16H O2 and its dissociation constant (pKa) 4.8 reported, the boiling  point of  Valproic 
Acid is 220°C. 
1.1. SYNTHETIC METHOD  
There are many synthesis of valproic acid in literature [7- 13] few important syntheses 
are given below.  
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1.2. PROCESS RELATED IMPURITIES 
Preparation of valproic acid by different routes yields many impurities; there are 
possibilities of generation of many process related impurities depending upon the process 
route, which is also mention in the pharmacopeia [14] and other literature given below. 
 
 
 
 
A. R = R1 = H: Pentanoic acid (valeric acid),   
B. R = H, R1 = CH2-CH3: (2RS)-2-ethylpentanoic acid,  
C. R = H, R1 = CH (CH3)2: (2RS)-2-(1-methylethyl) Pentanoic acid,  
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D. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanoic acid, 
 
 
 
 
 
E. R = R1 = H: pentanamide (valeramide),  
F. R = H, R1 = CH2-CH2-CH3: 2-propylpentanamide,  
G. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanamide, 
 
 
 
 
 
H. R = R1 = H: pentanenitrile (Valeronitrile),  
I. R = H, R1 = CH2-CH2-CH3: 2-propylpentanenitrile,  
J. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanenitrile.  
 
Reviewing the above reaction scheme there is possibility of generation of only three 
process related impurities namely, Pentanoic Acid, 2-Ethyl Pentanoic acid, 2-(1-Methyl, 
ethyl) Pentanoic acid. These three molecules were considered in proposed work. 
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Figure 2: Chemical Structure of Possible process related impurities 
 
2. LITERATURE REVIEW 
The literature reviews regarding Valproic acid recommends that various analytical 
methods are reported for drug substance as well as in pharmaceutical formulation and 
also in various biological fluids. The literature reviews for analysis of Valproic acid are 
as under. 
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2.1. Ioffe V, Kalendarev T, Rubinstein I, Zupkovitz G. have developed methods for 
phospholipids-based derivatives of valproic acid and various non-steroidal anti-
inflammatory drugs evaporative light scattering and MS-detectors[15]. 
 
2.2. Steijns L. S. W, Bouw J, Van der Weide J has worked on Fluorescence 
Polarization Assays for measuring Valproic Acid, Phenytoin, Carbamazepine and 
Phenobarbital in serum [16]. 
 
2.3. Lau Cam C. A, Roos R. W. Have published a paper titled ”HPLC method with 
precolumn phenacylation for the assay of valproic acid and its salts in pharmaceutical 
dosage forms” using Microsorb-MV C18 column with a mobile phase composed of 
acetonitrile-methanol-water (50:20:30) and detection at 245 nm. At a flow rate of 2 
ml/min [17]. 
 
2.4. Liu H, Forman L. J, Montoya J, Eggers C, Barham C and Delgado M has 
developed a method for determination of Valproic Acid by high-performance liquid 
chromatography with photodiode-array and fluorescence detection [18]. 
 
Many gas chromatographic methods have been also in literature with head space 
application and electro capture detection or mass spectrometric detection from biological 
matrix [19-22].which is the significant analytical technique for determination of valproic 
acid or its salt derivative. 
 
2.5. Czarnecki W and Halczynska B has reports the quantification of valproic acid 
by colorimetric technique [23]. 
 
2.6. Matsuura K, Ohmori  T, Nakamura  M, Itoh  Y, Hirano K. and Jain  D. S, 
Subbaiah G, Sanyal M, Shrivastav P have describe the method for determination of  
valproic acid from human plasma using the tandem mass spectrometry[24, 25]. 
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Many papers are already in literature which provides the methods for analysis of the 
valproic acid from biological fluid using HPLC, Tandem mass spectrometry and 
fluorescence detection and ultra-violet detection [26 - 33]. 
 
2.7. Van der Horst F. A. L, Eikelboom G. G have develop a method which deals 
with High-performance liquid chromatographic determination of Valproic Acid in plasma 
using a micelle-mediated pre-column derivatization[34]. 
 
Many capillary electrophoresis methods are also available for ready references which are 
also useful analytical effort [35-38]. 
 
 
3. AIM OF THE PRESENT WORK 
 
The above literature recommends that there are no methods for the quantification of 
valproic acid and its related known impurities by UPLC-PDA. Available methods deals 
with the bioanalytical study of valproic acid and some methods deal with the metabolite 
of the same. Furthermore the present method has the advantage over the speed as well as 
the selectivity. It can be maximum utilize for the analysis and it could be also functional 
of quality control laboratory for routine use. The aim and scope of the proposed work are 
as under, 
 
3.1. To develop method for quantification of the drug substance with its process 
related impurities using the latest technology in liquid chromatography. 
3.2. To optimized the method at a maximum level to gain high throughput screening. 
3.3. Elaborate the technology suggesting the various applications.   
3.4. To perform analytical method validation for the proposed method as per ICH 
guideline [39]. 
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4. EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS. 
Parth Laboratories Pvt. Ltd. (Rajkot, India) provided Valproic Acid working standard and 
its related impurities working standards. Hexane sulphonic acid sodium salt anhydrous 
for HPLC, HPLC grade Acetonitrile has purchased from Spectrochem Pvt Ltd. HPLC 
grade water used was purified by Milli-Q Elix-3 water purification system. 
4.2. INSTRUMENTATION  
The Waters AcquityTM UPLC chromatographic system used to perform development and 
validation. This system consist of a binary solvent manager (pump), photodiode array 
detector, sample manager(Auto sampler) and column oven connected to a multi-
instrument data acquisition and processing system Empower 2.1 version. Sartorius 
microbalance and Equiptronics branded balance and heating oven was used for the 
weighing and heating purpose while Spinco ultrasonic bath used for degassing purpose. 
4.3. METHOD DEVELOPMENT 
Analytical Method development is consist of following steps which can be shore up by 
the literature survey, previous experience and chemical nature of the reagents used in the 
development. 
4.3.1. MOBILE PHASE SELECTION 
On the basis of literature survey, several exploratory runs have been performed but 
initially proper selectivity and resolution between the drug substance and its impurities 
not achieved. After furnishing more importance to the literature it was concluded that 
since one impurity specifically 2-(1-Methyl, ethyl) Pentanoic acid is a structural isomer 
of the drug component, the resolution accomplishment could be unusual. In such case the 
ion pair reagent can be the elucidation. Hexane sulphonic acid sodium salt anhydrous has 
given the best results and 5 mM concentration was fulfilling the requirements. Above all 
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5 mM hexane sulphonic acid sodium salt used with acetonitrile as an organic component 
with 1:1 ratio at isocratic elution provides the desired outcome. 
4.3.2. COLUMN SELECTION 
Column selection is the most important part in the method development. In this case most 
suitable column chemistry was silica C18. Among the column chemistry available with 
us the symmetry (250 mm x 4.6 mm id, 5μ particle size) gives the best consequences. 
4.3.3. DETECTION WAVELENGTH SELECTION  
We have screened the standard solution over 190 nm to 400 nm using the advantage of 
photo diode array detector. On the basis of peak absorption maxima and peak purity 
index the 215 nm was decided as the detection wavelength which also gives the 
maximum chromatographic compatibility to the method. The absorption is shown in the 
figure 1 for valproic acid and its related impurities at each wavelength. 
3.154 Peak 1
5.142 Peak 2
6.706 Peak 3
7.451 Peak 4
212.1
212.7
212.1
AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
 
Figure 3: UV absorption of valproic acid and its related substance 
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4.3.4. MOBILE PHASE PREPARATION 
The mobile phase consist of Acetonitrile: 5 mM Hexane Sulphonic acid sodium salt 
(50:50) was prepared by dissolving 0.94 gm of Hexane Sulphonic acid sodium salt in 
1000 ml of HPLC grade water which further mixed with acetonitrile and filtered through 
0.45µn filter followed by degassing in ultra sonic bath for 20 min. 
4.3.5. STANDARD SOLUTION PREPARATION 
Valproic acid  and its related impurities working standard solution containing 100 μg/ml 
was prepared in a 100 ml volumetric flask by dissolving 10 mg each in 25 ml acetonitrile: 
water(50:50) and then diluting to volume with the same diluent. 
4.3.6. SAMPLE SOLUTION PREPARATION 
Valproic acid  and its related impurities sample (different batch) solution containing 100 
μg/ml was prepared in a 100 ml volumetric flask by dissolving 10 mg each in 25 ml 
acetonitrile: water(50:50) and then diluting to volume with the same diluent. 
 
9.00  10.008.007.006.005.004.003.001.00  2.000.00
Minutes
0.10
0.08
0.04
0.02
0.00
AU 0.06
 
Working Standard 
Pentanoic acid - 3.157
Valproic acid - 7.474
2(1-methyl, ethyl) Pentanoic acid - 6.728 
2- Ethyl Pentanoic acid - 5.154
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10.008.00  9.007.006.005.004.003.001.00  2.000.00
Minutes
0.10
0.08
0.04
0.02
0.00
AU
0.06
 
Sample solution 
 
Pentanoic acid - 3.157
2- Ethyl Pentanoic acid - 5.155
2(1-methyl, ethyl) Pentanoic acid - 6.727
Valproic acid - 7.471
 
Figure 4: Chromatograms of Working Standard and Sample solution. 
 
In conclusion to Method development following chromatographic clauses suits the most 
and decided as a final method for validation experiments. 
 
Mobile Phase A   : 5 mM Hexane Sulphonic acid sodium salt 
Mobile Phase B   : Acetonitrile (HPLC grade) 
Column    :  Symmetry (250 x 4.6 mm id, 5μ) 
Flow Rate   : 1.2 ml/min 
Isocratic elution at  : 50:50, v/v 
Detection               : 215 nm UV 
Diluent     : Acetonitrile: Water (1:1) 
Injection Volume  : 05 µl 
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4.4. METHOD VALIDATION 
 
Method for the determination of valproic acid and its related impurities in bulk drug is 
further validated as per ICH Q2(R1) guideline [39]. Validation of analytical method was 
performed using Valproic acid working standard and sample batch drug substance. 
 
4.4.1. SPECIFICITY  
 
The evaluation of the specificity of the method was determined against diluent 
application and each of the impurities to the drug substance. The interference of the 
diluent and each impurity was derived by injecting each individual impurities solution 
and individual drug substance. The retention time of each was taken in to consideration. 
Further the specificity of the method toward the drug was established by means of the 
interference of diluent at the retention time of the drug peak. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Impurity - I Solution preparation: 
Weight exact 10.0 mg of Pentanoic acid in 100 ml volumetric flask dissolve it in 25 ml of 
diluent followed by make up to the mark with diluent. Apply sonication to it in ultrasonic 
bath for 10 min and filter the solution with 0.22 µn membrane filter. 
 
Impurity - II Solution preparation: 
Weight exact 10.0 mg of 2-Ethyl Pentanoic acid in 100 ml volumetric flask dissolve it in 
25 ml of diluent followed by make up to the mark with diluent. Apply sonication to it in 
ultrasonic bath for 10 min and filter the solution with 20 µn membrane filter. 
 
Impurity - III Solution preparation: 
Weight exact 10.0 mg of 2-(1-Methyl, ethyl) Pentanoic acid in 100 ml volumetric flask 
dissolve it in 25 ml of diluent followed by make up to the mark with diluent. Apply 
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sonication to it in ultrasonic bath for 10 min and filter the solution with 20 µn membrane 
filter. 
 
Drug substance solution preparation: 
Weight exact 10.0 mg of valproic acid in 100 ml volumetric flask dissolve it in 25 ml of 
diluent followed by make up to the mark with diluent. Apply sonication to it in ultrasonic 
bath for 10 min and filter the solution with 20 µn membrane filter. 
 
10.009.008.007.006.005.004.003.001.00  2.000.00
Minutes
 
Diluent 
AU
0.010
0.005
0.000
-0.005
-0.010
-0.015
 
 
 
 
 
 
 
 
 
 
 
9.00  10.008.007.006.005.004.003.002.000.00  1.00
Minutes
0.050
0.040
0.020
0.010
0.000
AU0.030
 
Impurity I 
 
Pentanoic Acid - 3.165
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8.00  9.00  10.007.006.005.002.00  3.00 4.001.000.00
Minutes
0.08
0.06
0.04
0.02
0.00
AU 
 
Impurity II 
  2-Ethyl Pentanoic acid 5.171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.00  10.008.007.006.005.002.00 3.00 4.000.00  1.00
Minutes
0.080
0.070
0.060
0.050
0.030
0.020
0.010
0.000
AU0.040
 
Impurity III 
 
2(1-methyl, ethyl) Pentanoic acid - 6.753
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9.00  10.008.007.006.005.004.003.002.000.00  1.00
Minutes
0.080
0.070
0.060
0.050
0.030
0.020
0.010
0.000
AU 0.040
 
Drug Substance Valproic acid - 7.515
 
Figure 5: Chromatograms of Diluent, each impurity and drug substance 
 
From the specificity experiment and subsequently achieved above chromatograms it has 
proven that any interference was not observed from blank or any related impurities to the 
peak of interest, in addition to this peak purity was also within the acceptance criteria 
confirmed by the photo diode detector. Hence it confirms that the proposed method is 
highly specific with respect to the diluent and related impurities. 
 
4.4.2. LINEARITY & RANGE  
 
The linearity curve was prepared with 8 concentration levels (20, 40, 60, 100, 120, 140, 
160 and 180 μg/ml of valproic acid and its related impurities). These concentration levels 
were respectively corresponding to 20, 40, 60, 80, 100, 120, 140 and 160 % of standard 
solution concentration. The peak areas vs. concentration data were evaluated by linear 
regression analysis. 
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Stock Solution Preparation:  
Weight accurately 100 mg of valproic acid and Impurities A, B and C working standard, 
transfer it into 100 ml volumetric flask and dilute it up to the mark with diluent. Apply 
sonication for minimum 30 min to confirm the uniform mixture. 
 
Linearity Standard Solution Preparation: 
From Standard Stock Solution of accurate 1000 µg/ml pipette out exactly 0.2, 0.4, 0.6, 
0.8, 1.0, 1.2, 1.4 and 1.6 ml and dilute it up to 10 ml each with diluent to achieve 20-160 
µg/ml concentration of valproic acid and its impurities. 
 
 
Linearity & Range 
Calibration 
Point 
Concentration 
(µg/ml) 
Peak Area 
PA 2-EPA 2,1-MEPA VA 
STD 1 160 333435.5 951712.5 987668.5 1304670 
STD 2 140 292616.5 840231 863781.5 1141796.5 
STD 3 120 262647.5 756747 744930.5 950832 
STD 4 100 210495 613099.5 620302 810735 
STD 5 80 166381 481084.5 505692.5 668924 
STD 6 60 124962.5 372918.5 369831.5 470998 
STD 7 40 83557 256069 239321 327032.5 
STD 8 20 40096.5 120336 108449 145355 
 
 
Table 1: Linearity and Range - Concentration Vs Peak area response data 
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Chart 1: Regression Analysis chart of linearity Study 
 
Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = PA 
(Pentanoic acid), Series 2 = 2-EPA (2- Ethyl Pentanoic acid), Series 3 = 2, 1-MEPA (2(1-
methyl, ethyl) Pentanoic acid), Series 4 = VA (Valproic acid) 
Above data and the chart suggest that correlation coefficient of the Valproic acid was R2 
= 0.997 with linear regression equation y = 5966x + 12028 and R2 = 0.998, y = 2116x – 
1217 for Pentanoic acid, R2 = 0.999, y = 6062x – 8400 for 2- Ethyl Pentanoic acid, R2 = 
0.998, y = 8196x – 10154 for 2(1-methyl, ethyl) Pentanoic acid. 
Thus in conclusion the method counts to be highly linear for drug substance as well as for 
related impurities across the working concentration range. 
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4.4.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION 
 
 LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) should be more than 3.3 for LOD 
and more than 10 for LOQ. On the basis of linearity data theoretically it can be also 
calculated by the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 157. From the stock 
solution of 1000 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent, assign this solution as Solution – A. Form the 
Solution - A pipette out exact 1.0 ml to the 100 ml volumetric flask followed by dilution 
up to the mark with diluent to reach 0.1 µg/ml concentrations of each. 
 
LOQ Solution Preparation: 
Form the Solution - A pipette out exact 2.0 ml to the 100 ml volumetric flask followed by 
dilution up to the mark with diluent to achieve 0.2 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
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LOQ 
Replicates  PA 2-EPA 2,1-MEPA VA 
INJ 01 4019 12272 11171 14305 
INJ 02 4021 12595 11190 15288 
INJ 03 4091 13125 11554 14127 
INJ 04 3954 12358 10632 15346 
INJ 05 3982 13405 11276 15367 
INJ 06 3886 12401 11386 15134 
Mean 3992.16 12692.66 11201.5 14927.83 
Std dev 69.49 464.30 312.80 560.2 
% RSD 1.74 3.65 2.79 3.75 
 
Table 2: Limit of Quantification – Summary of Replicate Injections 
 
 
9.00  10.008.007.006.005.004.003.002.000.00  1.00
Minutes
0.030
0.025
0.020
 
LOD 
Pentanoic acid - 3.160
2- Ethyl Pentanoic acid - 5.149
2(1-methyl, ethyl) Pentanoic acid - 6.720 
Valproic acid - 7.466 
AU
0.010
0.005
0.000
 0.015
Figure 6: Chromatogram of Limit of Detection 
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10.008.00  9.007.006.003.00 4.00 5.002.000.00  1.00
Minutes
0.018
0.016
0.014
0.012
0.010
0.006
0.004
0.002
0.000
-0.002
AU
0.008
 
LOQ 
 
2(1-methyl, ethyl) Pentanoic acid - 6.715 
2- Ethyl Pentanoic acid - 5.139
Valproic acid - 7.448
Pentanoic acid -3.152
Figure 7: Chromatogram of Limit of Quantification 
LOQ of the analytical method can evaluated by establish linearity up to LOQ value. For 
that linearity study is extended up to LOQ value, 
 
 
 
Chart 2: Regression Analysis chart of linearity Study included with LOQ level 
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Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = PA 
(Pentanoic acid), Series 2 = 2-EPA (2- Ethyl Pentanoic acid), Series 3 = 2, 1-MEPA (2(1-
methyl, ethyl) Pentanoic acid), Series 4 = VA (Valproic acid) 
All the results of LOD and LOQ data were within the acceptance criteria, hence it can be 
conclude that the LOD and LOQ of the method was 0.1 µg/ml and 0.2 µg/ml respectively 
which correspond to 0.1% and 0.2% of working concentration. The signal to noise ratio 
for the LOD was well within the acceptance criteria it means more than 3.3 and for the 
LOQ it was more than 10.0. Furthermore the % RSD of the six replicate injection of LOQ 
preparation less than 5.0 and the data of linearity extension chart up to LOQ level also 
suggest that the Valproic Acid and its impurities can be quantified up to 0.2 µg/ml well 
precisely and accurately.  
 
4.4.4. PRECISION  
 
Precision study was established by evaluating method precision and intermediate 
precision study. Method precision of the analytical method was determined by analyzing 
six sets of sample solution preparation. Mean standard deviation and % relative standard 
deviation for the same was calculated. Intermediate precision of the analytical method 
was determined by performing same procedure as method precision on another day by 
another analyst using different make of raw materials under same experimental condition. 
Area of all six replicate sample preparations was determined and standard deviation and 
% relative standard deviation also calculated. 
 
Standard Solution Preparation: 
Standard Stock Solution prepared as per procedure on page 157 of 1000 µg/ml. pipette 
out exact 1.0 ml from this solution and dilute up to 10 ml to accomplish 100 µg/ml 
concentration.  
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Sample Solution Preparation:  
Weight accurately 100 mg of valproic acid and Impurities A, B and C sample, transfer it 
into 100 ml volumetric flask and dilute it up to the mark with diluent. Apply sonication 
for minimum 30 min to confirm the uniform mixture. 5 ml of above test stock solution 
was pipette out and transferred into 50 ml volumetric flask followed by diluted to volume 
with diluent. The concentration obtained is about 100 μg/ml of drug substance as well as 
each impurity. This solution is assign as Test Preparation Set – 01. The same procedure 
was used for preparing the six Test preparation Sets. Same approach was applied for the 
intermediate precision study on the second day with different analyst and different make 
of raw materials. 
 
METHOD PRECISION 
Replicates 
Peak Area 
PA 2-EPA 2,1-MEPA VA 
Set 01 210954 623938.5 629944 813293 
Set 02 208416.5 616521.5 623969.5 799387 
Set 03 208213 617099.5 621781 800629 
Set 04 208638.5 615928.5 622960.5 799801.5 
Set 05 210549.5 626428 631619.5 813999 
Set 06 211420.5 636014.5 636014.5 818790 
Mean 209698.7 622655.1 627714.8 807649.9 
Standard 
Deviation 1431.1 7849.7 5673.5 8665.1 
% RSD 0.7 1.3 0.9 1.1 
 
 
Table 3: Method Precision Data  
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INTERMEDIATE PRECISION 
Replicates 
Peak Area 
PA 2-EPA 2,1-MEPA VA 
Set 01 214100 653931.5 672628.5 867128.5 
Set 02 212925.5 631144 639404.5 821765 
Set 03 213801 633675.5 641733.5 823815.5 
Set 04 214931.5 635104 643164.5 824633 
Set 05 218389.5 649573 654524 838073 
Set 06 212130 623021.5 662536.5 835632.3 
Mean 214379.6 637741.6 652331.9 835174.6 
Standard 
Deviation 2189.6 11711.5 13299.4 17027.2 
% RSD 1 1.8 2 2 
 
 
Table 4: Intermediate Precision Data 
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9.00  10.008.007.006.005.004.002.00  3.000.00  1.00
Minutes
 
Method precision 
0.10 
0.08 
0.04 
0.02 
0.00 
AU
0.06 
Pentanoic acid -3.154
2- Ethyl Pentanoic acid - 5.144
2(1-methyl, ethyl) Pentanoic acid - 6.712
Valproic acid - 7.457
 
 
 
Intermediate Precision 
10.008.00  9.007.004.00 5.00 6.003.002.001.000.00
Minutes
0.10
0.08
0.04
0.02
0.00
AU 0.06
Pentanoic acid - 3.157
Valproic acid - 7.471
2(1-methyl, ethyl) Pentanoic acid - 6.727
2- Ethyl Pentanoic acid - 5.155
 
 
 
 
 
 
 
 
Figure 8: Chromatograms of Sample Solution for Method Precision and Int.Precision 
The data generated in method precision study and intermediate precision study suggest % 
RSD value of peak area for each set is less than 2.0 and overall % RSD value for all six 
set is less than 2.0 which suggest that method is highly precise for determination of all 
four components. 
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4.4.5. ACCURACY     
This Experiment can be performed by the recovery test. Recovery of the method is 
evaluated at 3 different concentration levels (corresponding to 40, 100 and 160% of test 
solution concentration) by addition of known amounts of standard to Sample preparation. 
For each concentration level, 3 sets were prepared and injected in duplicate. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 157. 
 
Sample preparations for accuracy levels are as under: 
 
Accuracy level 1 (40%)  
Test stock solution:  
40.0 mg of Valproic Acid and its related impurities working standard was accurately 
weighed and transferred into 200 ml volumetric flask. 40.0 mg Valproic Acid and its 
related impurities sample (different batch) was weighed and transferred into the same 200 
ml volumetric flask. Around 140 ml of diluent added into the volumetric flask. The 
volumetric flask was proceeding for sonication of 30 minutes with normal handshaking. 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained was 400 μg/ml of Valproic acid and its related impurities. 5.0 ml of above test 
stock solution was pipette out and transferred into 50 ml volumetric flask followed by 
diluted to volume with diluent. The concentration obtained is 40 μg/ml Valproic Acid and 
its related impurities. The same procedure was applied for preparing the three sets. 
 
Accuracy level 2 (100 %) 
Test stock solution:  
100.0 mg of Valproic acid and its related impurities working standard was accurately 
weighed and transferred into 200 ml volumetric flask. 100.0 mg of Valproic acid and its 
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related impurities sample (different batch) was weighed and transferred into the same 200 
ml volumetric flask. 140 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal handshaking. Then, the 
flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
solution was filtered through 0.22 μm nylon syringe filter. The concentration obtained 
was 1000 μg/ml of Valproic acid and its related impurities. 5.0 ml of above test stock 
solution was pipette out and transferred into 50 ml volumetric flask followed by diluted 
to volume with diluent. The concentration obtained is 100 μg/ml of Valproic acid and its 
related impurities. The same procedure was applied for preparing the three sets. 
 
Accuracy level 3 (160 %) 
Test stock solution:  
160.0 mg of Valproic acid and its related impurities working standard was accurately 
weighed and transferred into 200 ml volumetric flask. 160.0 mg of Valproic acid and its 
related impurities sample (different batch) was weighed and transferred into the same 200 
ml volumetric flask. 140 ml of diluent added into the volumetric flask. The volumetric 
flask was proceeding for sonication of 30 minutes with normal handshaking. Then, the 
flask was cooled to room temperature and diluted to volume with diluent. 10 ml of this 
solution was filtered through 0.22 μm nylon syringe filter. The concentration obtained 
was 1600 μg/ml of Valproic acid and its related impurities. 5.0 ml of above test stock 
solution was pipette out and transferred into 50 ml volumetric flask followed by diluted 
to volume with diluent. The concentration obtained is 160 μg/ml of Valproic acid and its 
related impurities. The same procedure was applied for preparing the three sets. 
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Accuracy 
Replicates 
PA 2-EPA 2,1-MEPA VA 
Area % RSD Area 
% 
RSD Area 
% 
RSD Area 
% 
RSD 
160 % set 01 340359 
0.72 
959032
0.12 
992984
0.1 
1311235
0.27 160 % set 02 336628 957779 992261 1308009
160 % set 03 335766 956822 990974 1304292
100 % set 01 212145 
0.52 
628584
0.61 
635200
0.58 
813121 
0.43 100 % set 02 210511 621502 628743 806179 
100 % set 03 210064 622601 629065 808993 
040 % set 01 83415 
0.43 
255238
0.47 
239781
0.53 
324719 
0.48 040 % set 02 83661 256322 239304 325242 
040 % set 03 84117 257625 241696 327641 
 
Table 5: Summery of Accuracy Data-01 
 
Calculation formulas for recovery study are as under: 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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From the above calculation the % Recovery was calculated which is given below. 
 
 
Recovery for Valproic Acid 
Accuracy 
Level 
Set 
No 
Amount 
Added 
(μg/ml ) 
Amount 
Found 
(μg/ml ) 
Recovery 
(%) 
Average 
Recovery 
Std. 
Dev. 
% 
RSD 
I (40%) 
1 39.95 40.23 100.7 
100.37 0.294 0.2932 40.21 40.31 100.24 
3 40.13 40.19 100.14 
II (100%) 
1 100.08 99.91 99.83 
100.04 0.180 0.1802 100.05 100.21 100.16 
3 100.12 100.24 100.12 
II (160%) 
1 160.1 160.06 99.98 
99.88 0.540 0.5412 160.17 160.75 100.36 
3 160.23 159.1 99.29 
 
Table 6: Summary of Accuracy Study – 2 
 
10.008.00 9.007.006.005.004.001.00  2.00  3.000.00
Minutes
0.16
0.14
0.12
0.10
0.06
0.04
0.02
0.00
AU0.08
 
Accuracy 160% 
Pentanoic acid - 3.154
Valproic acid - 7.450
2(1-methyl, ethyl) pentanoic acid - 6.711
2- Ethyl pentanoic acid - 5.144
 
Figure 9: Chromatogram of Accuracy level -1 (160 %) 
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Figure 10: Chromatogram of Accuracy level -2 (100 %) 
8.00  9.00 10.007.006.005.004.003.000.00  1.00  2.00
Minutes
 
Accuracy 100% 
0.10 
0.08 
0.04 
0.02 
0.00 
AU 
0.06  Pentanoic acid - 3.154
Valproic acid - 7.450
2(1-methyl,ethyl)pentanoic acid - 6.710
2- Ethyl pentanoic acid - 5.143
  
 
 
 
 
 
Accuracy 40% 
10.008.00  9.007.006.005.004.002.00  3.001.000.00
0.040 
0.010 
0.000 
AU 
0.030 
0.020 
Pentanoic acid - 3.148
2(1-methyl, ethyl) pentanoic acid - 6.702
Valproic acid - 7.444
2- Ethyl pentanoic acid - 5.134
 
 
 
 Minutes
Figure 11: Chromatogram of Accuracy level -3 (40 %) 
From the all above data and chromatograms it has been confirmed that the % recovery is 
within 98 to 102 % and this is in the limit of acceptance criteria. Additionally % RSD 
value of % recovery of replicate sets is below 2 % .consequently this suggests that 
proposed method is highly accurate. 
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4.4.6. ROBUSTNESS  
 
Robustness of the method was evaluated by assaying test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in 
proportions of Buffer (Ion-pair Reagent) : Acetonitrile (48:52 and 52:48,v/v), and change 
in column-lot. 
 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 1.1 ml/min and 1.3 ml/min each and the results were observed in terms of Peak 
Response (Peak Area) and chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 151.  A proto type chromatographic sequence of the robustness study 
is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Flow Rate 1.1 
ml/min 
2 Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 1.3 
ml/min 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
  
Table 7: Experimental UPLC sequence for the robustness study -01 
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8.00  9.00  10.007.006.005.004.002.00  3.001.000.00
Minutes
0.12
0.10
0.08
0.04
0.02
0.00
AU 
0.06
 
Robustness 01 
 
Pentanoic acid - 3.461 
2- Ethyl pentanoic acid - 5.664
Valproic acid - 8.234 
2(1-methyl, ethyl) pentanoic acid -7.405
 
Figure 12: Chromatogram of Robustness study at 1.1 ml/min flow rate 
 
 
 
 
 
 
 
 
 
 9.00  10.008.007.006.005.004.002.00  3.000.00  1.00 Minutes
 
Robustness 02 
 
AU
0.00 
0.02 
0.04 
0.06 
0.08 
0.10 
0.12 
Pentanoic acid - 2.927 
Valproic acid - 6.959 
2- Ethyl pentanoic acid - 4.788
2(1-methyl, ethyl) pentanoic acid -6.257
 
Figure 13: Chromatogram of Robustness study at flow Rate 1.3 ml/min. 
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The Peak Response and area value of test preparation wasn’t much influenced at 1.1 and 
1.3 ml/min. The above chromatograms suggest that the flow rate affects on the retention 
time of drug but it did not have any impact on the response, hence the peak area value 
remain unaffected. 
 
B) Mobile Phase Proportion Change: In this experiment the test samples were 
analyzed at the mobile phase proportion of 52:48 and 48:52, v/v (Ion-pair Reagent: 
Acetonitrile) each and the results were observed in terms of peak response, area value 
and chromatographic compatibility (System Suitability Test). Blank, Standards and 
Sample solutions were prepared as per the same procedure mentioned on page 151. 
 
 A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
52:48 
Ion Pair : Acetonitrile 
2 Sys Suit Standard 5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
48:52 
Ion Pair: Acetonitrile 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
 
 
Table 8: Experimental UPLC sequence for the robustness study – 02 
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9.00  10.008.007.006.005.004.002.00  3.000.00  1.00
Minutes
0.20
0.15
0.10
0.05
0.00
AU
 
Robustness 03 
 
Pentanoic acid - 3.308
2(1-methyl, ethyl) Pentanoic acid -7.474
2- Ethyl Pentanoic acid - 5.614
Valproic acid - 8.382 
 
Figure 14: Chromatogram of Test Preparations at ratio 52:48 v/v of mobile phase. 
 
 
 
 
 
 
 
 
 
 10.007.00 8.00  9.006.005.004.003.001.00  2.000.00 Minutes
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
AU
 
Robustness 04 
  Pentanoic acid - 3.052
Valproic acid - 6.802 
2(1-methyl, ethyl) Pentanoic acid -6.163
2- Ethyl Pentanoic acid - 4.810
Figure 15: Chromatogram of Test Preparations at ratio 48:52 v/v of mobile phase. 
The Peak Response and area value of test preparation wasn’t much influenced at ratio 
52:48 and 48:52 of mobile phase but the retention time of each component is highly 
transform. The above chromatograms suggest that the ratio affects on the retention time 
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of drug but it did not have any impact on the response, hence the peak area value remain 
unaffected. 
C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of area value (Peak Response) 
and chromatographic compatibility (System Suitability Test). Blank, Standards and 
Sample solutions were prepared as per the same procedure mentioned on page 151.  
 
9.00  10.008.007.006.005.004.002.00  3.000.00  1.00
Minutes
0.06
0.04
0.02
0.00
AU
   0.12
  Robustness 05 0.10
Valproic acid - 7.541
2(1-methyl, ethyl) Pentanoic acid - 6.781
Pentanoic Acid - 3.171
2-Ethyl Pentanoic acid - 5.188
 
0.08
 
Figure 16: Chromatogram of Test Preparations using different column lot 
 
The Peak Response and area value of test preparation wasn’t much changed with 
different column, in addition to this in this case the retention time was also remain. The 
above chromatograms suggest that diff. column does not affect on the retention time of 
drug and it did not have any impact on the response, hence the peak area value remain 
unaffected.  
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A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections
Chromatographic 
condition 
1 Blank 1 
Different Column 
Lot 
2  Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
 
Table 9: Experimental UPLC sequence for the robustness study – 03 
Summary of Robustness Study 
Robust 
Condition 
Peak  
Response 
Retention 
Time 
Variation 
(min.) 
System Suitability 
Theoretical 
Plates Asymmetry
Flow Change 
1.1 ml/min Unaffected - 0.85 19800 ±500 1.35 ± 0.20 
Flow Change 
1.3 ml/min Unaffected + 0.65 21000 ±500 1.12 ± 0.20 
MP Proportion 
Change 52:48 Unaffected - 0.88 17300 ± 300 1.24 ± 0.34 
MP Proportion 
Change 48:52 Unaffected + 0.70 20000 ±250 1.10 ± 0.10 
Column Lot 
Change Unaffected 0.05 20000 ±150 1.15 ± 0.20 
                   Where, ± sign suggest statistics of all four analyte peaks. 
Table 10: Summary of robustness study  
The data and the chromatogram given above suggest that there is no considerable 
influence of the column lot change on the result of the analysis by this method or on 
chromatographic suitability of this method. Hence, it can be conclude from this 
experiment that the method is highly robust in terms of column lot change. Overall the all 
the experiment in robustness parameter succeeded in terms of acceptance criteria hence 
the proposed method is robust for above small changes in chromatographic condition. 
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4.4.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time period, 
(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS: 
 25.00 mg of Valproic acid and its related impurities working standard were accurately 
weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was added into the 
volumetric flask and the standard substances were dissolved by sonication for ten minute. 
Then, volume of the flask was making up with diluent. The concentration obtained is 
1000 μg/ml of Valproic acid and its related impurities  
This solution was prepared on the first day of the validation and kept at the 2-4˚C 
temperature in refrigerator without any disturbance until performance of the LTSSS 
experiment. After 10 day the stock solution was bring out of the refrigerator and keep it 
as such till it attains the room temp. 5 ml of this solution was pipette out in 50 ml 
volumetric flask and dilute it up to the mark to reach 100 μg/ml of analyte This solution 
was assigned as LTSSS Standard solution. 
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Preparation of Fresh Standard Solution:  
25.00 mg of Valproic acid and its related impurities working standard was accurately 
weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was added into the 
volumetric flask and the standard substances were dissolved by sonication for ten minute. 
Then, volume of the flask was making up with diluent. The concentration obtained is 
1000 μg/ml of all components. Pipette out exactly 5 ml of this solution in 50 ml 
volumetric flask and dilute it up to the mark accurately to confirm the 100 μg/ml of drug 
substance and impurities. This solution was assigned as Fresh Standard Solution. The 
proto-type experimental sequence is given below for LTSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard 5 
3 LTSSS-01( 10 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 ( 10 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 10 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 10 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 10 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 11: Sequence for LTSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
 Mean Area Ratio = 1.05 for Pentanoic acid, 0.982 for 2- Ethyl Pentanoic acid 1.082 for 
2(1-methyl, ethyl) Pentanoic acid and 1.023 for Valproic acid.  
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Preparation of Stock Solution for STSSS or Bench Top Solution Stability:  
25.00 mg of Valproic acid and its related impurities working standard were accurately 
weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was added into the 
volumetric flask and the standard substances were dissolved by sonication for ten minute. 
Then, volume of the flask was making up with diluent. The concentration obtained is 
1000 μg/ml of all components. This solution was prepared before the 08 hour and kept on 
bench at ambient temperature without any disturbance until performance of the STSSS 
experiment. After 08 hour on the bench. 5 ml of this solution was pipette out in 50 ml 
volumetric flask and dilute it up to the mark to reach 100 μg/ml drug substance and 
impurities.  This solution was assigned as STSSS Standard solution 
Preparation of Fresh Standard Solution:  
25.00 mg of Valproic acid and its related impurities working standard were accurately 
weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was added into the 
volumetric flask and the standard substances were dissolved by sonication for one 
minute. Then, volume of the flask was making up with diluent. The concentration 
obtained is 1000 μg/ml of all components. Pipette out exactly 5 ml of this solution in 50 
ml volumetric flask and dilute it up to the mark accurately to confirm the 100 μg/ml drug 
substance and impurities. This solution was assigned as Fresh Standard Solution. 
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The proto-type experimental sequence is given below for STSSS, 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard 5 
3 STSSS-01( 8.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 8.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour) 1 
8 STSSS-03 ( 8.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 8.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 8.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for STSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 0.989 for Pentanoic acid, 1.024 for 2- Ethyl Pentanoic acid 0.995 for 
2(1-methyl, ethyl) Pentanoic acid and 0.998 for Valproic acid. 
The Mean Area Ratio is within the acceptance criteria of 0.95 to 1.05, hence it can be 
concluded from this experiment that the Stock Solution is stable for the 10 days at 2 - 4˚ 
C in refrigerator, while Standard solution is remain unaffected on bench at ambient 
temperature and in normal light for 8 hour. In addition to this it confirms the reliability of 
the data generated during the method validation.  
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4.4.8. SYSTEM SUITABILITY STUDY 
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
 
Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity  19500 ± 300 1.08 ± 0.1 1.30 
Linearity and Range  19000 ± 500 1.05± 0.1 0.29 
LOD and LOQ  10500 ± 200 1.50 ± 0.2 1.96 
Method Precision  18700 ± 300 1.13 ± 0.1 1.26 
Intermediate Precision 20100 ± 200 1.04 ± 0.1 0.45 
Accuracy 20300 ± 100 1.05 ± 0.1 0.54 
Robustness 19400 ± 600 1.07 ± 0.1 0.42 
Solution Stability 19000 ± 300 1.10 ± 0.1 1.83 
 
Table 13: Results of System Suitability Test after each Validation Experiment 
 
Where, ± sign suggest statistics of all four component peaks. 
As per guideline the Theoretical plates should be more than 5000, Asymmetry should be 
less than 2.0 and % RSD should be less than 2.0. As the data suggest the system 
suitability was within the criteria in each validation experiment. Hence the system was 
found suitable to perform the validation experiment which confirms the reliability of the 
data generated during the method validation. 
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5. CONCLUSION 
The surveillance and results obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria of ICH guideline. 
Since, all the results are with-in the limit, the developed Analytical method is considered 
as validated and suitable for probable use. 
 
6. APPLICATION OF CURRENT FINDINGS  
 
 
6.1. This method can be used for the quantification of Valproic acid in bulk drug as 
well as in pharmaceutical dosage form in routine or as a special test. 
6.2. This method can be used for the determination of process related impurities of 
valproic acid more specifically for determination of Pentanoic acid, 2- Ethyl 
Pentanoic acid, 2(1-methyl, ethyl) Pentanoic acid. 
6.3. This method has also application over the chromatographic purity of Valproic 
Acid. 
6.4. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation of valproic acid and its related compound. 
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1. INTRODUCTION 
 
Various valproic acid salts have diverse biological activity specifically it is used as 
anticonvulsant medicine from last few decades. Presently this  work describes the 
impurity analysis of magnesium salt of valproic acid and the same method of analysis can 
also applicable to Sodium, Calcium and Lithium valproate, which is proven in the present 
work, all the valproate has explicit biologically activity. Few of them are included in 
pharmacopeia while others are under advance clinical trials.  
Magnesium valproate is chemically known as Magnesium 2-propylpentanoate. 
Magnesium valproate is an anticonvulsant used in the treatment of epilepsy and bipolar 
disorder, as well as other psychiatric conditions requiring the administration of a mood 
stabilizer. Rationale Valproic acid is a psychoactive drug currently used for the treatment 
of epilepsy. Recently it has been introduced in psychiatry for the treatment of bipolar 
disorders, aggression, impulsivity, and resistant schizophrenia, although the mechanism 
by which VPA acts on these psychiatric diseases remains still unknown. 
[1][2][3][4][5][6]. Magnesium Valproate is a completely mew salt of Valproic acid and 
has not been added officially to pharmacopeia though it is getting the momentum in india 
and rest of the world because of its improved bioavailability. The molecular weight of 
Magnesium Valproate is 310.71 g/mole with molecular formula of C16H30H
CH3
CH3
O
-
O
O4Mg and its 
dissociation constant (pKa) 4.6 reported, the boiling point of  Magnesium Valproate is 
220°C and Flash point of the same 166.6°C. 
 
 
 
 
 
Figure 1: Chemical Structure of Magnesium Valproate 
CH3
CH3
Mg
+2
 O
-
O
 
Chapter – 5                                                             Determination of diverse Valproate salts and its Pharmacopeial Impurities 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                  Page 188 
 
1.1. SYNTHETIC METHOD 
The magnesium Valproate can be prepared by the following procedure, 
  
 
 
 
 
 
 
 
 
1.2. PROCESS RELATED IMPURITIES 
Preparation of magnesium valproate by different routes yields many impurities; there are 
possibilities of generation of many process related impurities depending upon the 
process route, which is also mentioned in the US patent [7]. Possible process related 
various impurities in the preparation of magnesium valproate are given bellow, 
 
 
 
 
A. R = R1 = H: Pentanoic acid (valeric acid),   
B. R = H, R1 = CH2-CH3: (2RS)-2-ethylpentanoic acid,  
C. R = H, R1 = CH (CH3)2: (2RS)-2-(1-methylethyl) Pentanoic acid,  
NC
O
CH3
O +
CH3
Br
NaOMe
CN
COOEt
CH3
CH3
Hydrolysis
Hydrolysis
-CO2
CN
COOH
CH3
CH3
CN
CH3
H
CH3
Ethyl Cyano Acetate Propyl Bromide Ethyl 2-cyano-2-propylpentanoate 2-Cyano-2-propylpentanoic acid
Alylation 
in two steps
CH3
O
OH
2-Propylpentanenitrile
CH3
Valproic Acid
Decarboxylation
Magnesium Valproate
Mg(OMe)2/Mg(OEt)2
CH3
R
R1
COOH
and enantiomers
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D. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanoic acid, 
 
 
 
 
 
E. R = R1 = H: pentanamide (valeramide),  
F. R = H, R1 = CH2-CH2-CH3: 2-propylpentanamide,  
G. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanamide, 
 
 
 
 
 
H. R = R1 = H: pentanenitrile (Valeronitrile),  
I. R = H, R1 = CH2-CH2-CH3: 2-propylpentanenitrile,  
J. R = R1 = CH2-CH2-CH3: 2, 2-dipropylpentanenitrile.  
 
Reviewing the above reaction scheme there is possibility of generation of only four 
process related impurities namely, Pentanoic Acid, 2-Ethyl Pentanoic acid, 2-(1-Methyl, 
ethyl) Pentanoic acid and Valeronitrile. These four molecules and magnesium valproate 
were considered in current work. The process related impurities will not change 
discussed in the previous chapter accept the Valeronitrile. 
 
CH3
NH2
O
R
R1
CH3
R
R1
CN
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2-Ethyl Pentanoic Acid              2-(1-Methyl, ethyl) Pentanoic acid 
Figure 2: Chemical Structure of Possible related impurities in magnesium valproate 
 
2. LITERATURE REVIEW 
The literature reviews concerning analytical method of magnesium valproate and its 
impurities, there is no method which describes the chromatographic quantification of 
magnesium valproate and its impurities. However various analytical methods are reported 
for determination of Sodium Valproate and Valproic acid in pharmaceutical dosage as 
well as in biological matrix, which provides the important reference and the initiative 
information about the molecule behavior under various chromatographic conditions. Few 
of them are mentioning below. 
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2.1. Runxi H, Caiping Y, Yuxi L have reported a method for Determination of 
magnesium and sodium valproates in serum by high   performance   liquid 
chromatography after precolumn derivatization, they derivetised both molecules by 2-
Bromo-4'-nitroacetophenone and the separation was achieved using reversed-phase C18 
column (150 mm x 4.6 mm) and methanol-water (72:25) as mobile phase. The UV 
detection was performed at 265 nm using Cyclohexane carboxylic acid as an internal 
standard [8]. 
 
2.2. Balbi A, Sottofattori E, Mazzei M and Sannita W. G has worked on Study of 
bioequivalence of magnesium and sodium valproates using HPLC method [9]. 
 
2.3. Manling H, Songling H, Bo X publish a paper for determination of magnesium 
valproate in serum by gas chromatography, they have extracted the valproic acid by 
chloroform and cyclohexanecarboxylic acid used as an internal standard [10]. 
 
2.4. Wiktor C and Beata H have  quantified the valproic acid and its salts using 
colorimetric method The method is based on the condensation of valproic chloride with 
2,4-dinitrophenylhydrazine in an alkaline  medium [11]. 
Many Methods are available for determination of Sodium valproate by HPLC in 
biological fluids. All these methods are describing the precolumn derivatization valproate 
by alpha bromoacetophenone [12] [13], Phenacyl bromide-triethylamine in acetone [14], 
9-aminophenanthrene [15], some research papers describes the detection of valproate by 
refractive index detection [16], while other suggest the fluorescence detection [17] [18]. 
One method is available which derivetised the valproate with 1-(2, 5-dihydroxyphenyl)-
2-bromoethanone and detected with coulometric electrochemical detection [19]. Few 
methods for determination for valproic acid are with photodiode array detection [20] and 
UV detection [21]. 
Overall, literature review suggests that there are many methods for analysis of valproic 
acid, valproic acid salts with or without derivatization by different regents. In addition 
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some methods with different detection technique are easily available. But up to our 
knowledge no method exists for determination of magnesium valproate and its related 
impurities. 
3. AIM OF THE PRESENT WORK 
The above literature recommends that there are no methods for the quantification of 
magnesium Valproate and its related known impurities by UPLC-PDA, the methods are 
available that deals with the bioanalytical study of valproate and some methods are with 
precolumn derivatization. Furthermore the present method has the advantage over the 
speed as well as the selectivity, it can be maximum utilize for the analysis and it could be 
also functional of quality control laboratory for routine use. The aim and scope of the 
proposed work are as under, 
  
3.1. To develop method for quantification of the drug substance with its process 
related impurities using the latest technology in liquid chromatography. 
3.2. To attain a method without precolumn or post column derivatization. 
3.3. To optimized the method at a maximum level to gain high throughput screening. 
3.4. Elaborate the technology suggesting the various applications.   
3.5. To perform analytical method validation for the proposed method as per ICH 
guideline [22]. 
 
4. EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS 
Parth Laboratories Pvt. Ltd. (Rajkot, India) provided Magnesium Valproate working 
standard and its related impurities working standards. Ammonium Di-hydrogen 
orthophosphate for HPLC, Ortho phosphoric acid (HPLC grade) and HPLC grade 
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Acetonitrile was purchased from Spectrochem Pvt Ltd. HPLC grade water used was 
purified by Milli-Q Elix-3 water purification system. 
4.2. INSTRUMENTATION  
The Waters AcquityTM UPLC chromatographic system used to perform development and 
validation. This system consist of a binary solvent manager (pump), photodiode array 
detector, sample manager(Auto sampler) and column oven connected to a multi-
instrument data acquisition and processing system Empower 2.1 version. Sartorius 
microbalance and Equiptronics branded balance and heating oven was used for the 
weighing and heating purpose while Spinco ultrasonic bath used for degassing purpose. 
4.3. METHOD DEVELOPMENT 
Analytical Method development is consist of following steps which can be shore up by 
the literature survey, previous experience and chemical nature of the reagents used in the 
development. 
4.3.1. MOBILE PHASE SELECTION 
On the basis of literature survey, several exploratory runs have been performed but 
initially proper selectivity and resolution between the drug substance and its impurities 
not achieved. After furnishing more importance to the literature it was concluded that 
since one impurity specifically 2-(1-Methyl, ethyl) Pentanoic acid is a structural isomer 
of the drug component, the 5 mM ammonium di hydrogen ortho-phosphate with pH = 3.0 
gives the maximum resolution with acetonitrile as a organic component at ratio 55:45, 
v/v, buffer: acetonitrile. 
4.3.2. COLUMN SELECTION 
Column selection is the most important part in the method development. In this case most 
suitable column chemistry was silica C18.Among the column chemistry available with us 
the Symmetry (250 mm x 4.6 mm id, 5μ particle size) gives the best consequences. 
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4.3.3. DETECTION WAVELENGTH SELECTION  
We have screened the standard solution over 190 nm to 400 nm using the advantage of 
photo diode array detector. On the basis of peak absorption maxima and peak purity 
index the 215 nm was decided as the detection wavelength which also gives the 
maximum chromatographic compatibility to the method. The absorption is shown in the 
figure 1 magnesium valproate and its related substance at each wavelength.  
3.523 Peak 1
6.362 Peak 2
8.729 Peak 3
9.313 Peak 4
9.897 Peak 5
AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
 
Figure 3: UV absorption of Magnesium valproate and its related substance 
4.3.4. MOBILE PHASE PREPARATION 
The mobile phase consist of Acetonitrile: 5 mM Ammonium di-hydrogen orthophosphate 
(pH = 3.0) (45:55) was prepared by dissolving 0.575 gm of Ammonium di-hydrogen 
orthophosphate for HPLC in 1000 ml of HPLC grade water which further mixed with 
acetonitrile at above ratio and filtered through 0.45µn filter followed by degassing in 
ultra sonic bath for 20 min. 
4.3.5. STANDARD SOLUTION PREPARATION 
Magnesium valproate and its related impurities working standard solution containing 200 
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μg/ml was prepared in a 100 ml volumetric flask by dissolving 20.0 mg each in 25 ml 
acetonitrile: water(50:50) and then diluting to volume with the same diluent. 
4.3.6. SAMPLE SOLUTION PREPARATION 
Valproic acid  and its related impurities sample (different batch) solution containing 200 
μg/ml was prepared in a 100 ml volumetric flask by dissolving 20 mg each in 25 ml 
acetonitrile: water(50:50) and then diluting to volume with the same diluent. 
 
14.00
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12.00 10.00
Minutes
0.00 8.006.004.002.00
0.08
0.06
0.02
0.00
AU
0.04
Magnesium Valproate - 10.067
Valeronitrile - 9.480 
2-(1-methyl, ethyl) Pentanoic acid - 8.862
2- Ethyl pentanoic acid - 6.441
Pentanoic acid - 3.550
 
 
 
 
 
 
 
 
 
14.0012.0010.008.006.004.002.000.00
Minutes
0.080 
0.070 
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0.050 
0.030 
0.020 
 
Sample 
0.000 
0.010 
AU0.040 
Magnesium Valproate - 10.053
Valeronitrile - 9.468
2-(1-methyl, ethyl) Pentanoic acid - 8.853
2- Ethyl pentanoic acid - 6.444
Pentanoic acid - 3.552
 
 
 
 
 
 
 
 
Figure 4: Chromatograms of Working Standard and Sample solution. 
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In conclusion to Method development following chromatographic clauses suits the most 
and decided as a final method for validation experiments. 
 
Mobile Phase A  : 5 mM Ammo. di-hydrogen orthophosphate (pH= 3.0) 
Mobile Phase B  : Acetonitrile (HPLC grade) 
Column   :  Symmetry (250 mm x 4.6 mm id, 5μ particle size) 
Flow Rate  : 1.2 ml/min 
Isocratic elution at : 55:45, v/v 
Detection   : 215 nm UV 
Diluent    : Acetonitrile: Water (1:1) 
Injection Volume : 05 µl 
 
4.4. METHOD VALIDATION 
 
Method for the determination of Magnesium Valproate and its related impurities in bulk 
drug is further validated as per ICH Q2 (R1) guideline [22]. Validation of analytical 
method was performed using Magnesium Valproate working standard and sample batch 
drug substance. 
 
4.4.1. SPECIFICITY  
 
The evaluation of the specificity of the method was determined against diluent 
application and each of the impurities to the drug substance. The interference of the 
diluent and each impurity was derived by injecting each individual impurities solution 
and individual drug substance. The retention time of each was taken in to consideration. 
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Further the specificity of the method toward the drug was established by means of the 
interference of diluent at the retention time of the drug peak. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Impurity - I Solution preparation: 
Weight exact 20.0 mg of Pentanoic acid in 100 ml volumetric flask dissolve it in 25 ml of 
diluent followed by make up to the mark with diluent. Apply sonication to it in ultrasonic 
bath for 10 min and filter the solution with 20 µn membrane filter. 
 
Impurity - II Solution preparation: 
Weight exact 20.0 mg of 2-Ethyl Pentanoic acid in 100 ml volumetric flask dissolve it in 
25 ml of diluent followed by make up to the mark with diluent. Apply sonication to it in 
ultrasonic bath for 10 min and filter the solution with 20 µn membrane filter. 
 
Impurity - III Solution preparation: 
Weight exact 20.0 mg of 2-(1-Methyl, ethyl) Pentanoic acid in 100 ml volumetric flask 
dissolve 
it in 25 ml of diluent followed by make up to the mark with diluent. Apply sonication to 
it in ultrasonic bath for 10 min and filter the solution with 20 µn membrane filter. 
 
Impurity - IV Solution preparation: 
Weight exact 20.0 mg of Valeronitrile in 100 ml volumetric flask dissolve it in 25 ml of 
diluent followed by make up to the mark with diluent. Apply sonication to it in ultrasonic 
bath for 10 min and filter the solution with 20 µn membrane filter. 
 
Drug substance solution preparation: 
Weight exact 20.0 mg of Magnesium Valproate in 100 ml volumetric flask dissolve it in 
25 ml of diluent followed by make up to the mark with diluent. Apply sonication to it in 
ultrasonic bath for 10 min and filter the solution with 20 µn membrane filter. 
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14.00
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Figure 5: Chromatogram of Diluent (Blank) of specificity 
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Figure 6: Chromatogram of Impurity - I of specificity 
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Figure 7: Chromatogram of Impurity - II of specificity 
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Figure 8: Chromatogram of Impurity - III of specificity 
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Figure 9: Chromatogram of Impurity - IV of specificity 
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Figure 10: Chromatogram of Drug Substance of specificity 
From the specificity experiment and subsequently achieved above chromatograms it has 
proven that any interference was not observed from blank or any related impurities to the 
peak of interest (Drug Substance), in addition to this peak purity was also within the 
acceptance criteria confirmed by the photo diode detector 3D view shown in Figure 11. 
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Hence it confirms that the proposed method is highly specific with respect to the diluent 
and related impurities. 
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Figure 11: Chromatogram of 3D – view of Standard preparation 
 
4.4.2. LINEARITY & RANGE  
 
The linearity curve was prepared with 8 concentration levels (50, 100, 150, 200, 250, 
300,350 and 400 μg/ml of Magnesium Valproate and its related impurities). These 
concentration levels were respectively corresponding to 25, 50, 75, 100, 125, 150, 175 
and 200 % of standard solution concentration. The peak areas vs. concentration data were 
evaluated by linear regression analysis. 
Stock Solution Preparation:  
Weight accurately 100 mg of Magnesium valproate and Impurities A, B, C and D 
working standard, transfer it into 100 ml volumetric flask and dilute it up to the mark 
with diluent. Apply sonication for minimum 30 min to confirm the uniform mixture. 
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Linearity Standard Solution Preparation: 
From Standard Stock Solution of accurate 1000 µg/ml pipette out exactly 0.5, 1.0, 1.5, 
2.0, 2.5, 3.0, 3.5 and 4.0 ml and dilute it up to 10 ml each with diluent to achieve 50-400 
µg/ml concentration of Magnesium Valproate and its impurities. 
 
 
Linearity & Range 
Calibration 
Point 
Conc. 
(µg/ml) 
Peak Area 
PA 2-EPA 2,1-MEPA VN MgVA 
STD 1 400 776962 964740 874746.5 208992 1052960.5 
STD 2 350 676439 868694.5 786092.5 174685 931101 
STD 3 300 576531 731808.5 656434.5 142753 782865.5 
STD 4 250 479838 626746.5 564543 120456.5 682671.5 
STD 5 200 383871.5 504112.5 463949.5 97594.5 550694 
STD 6 150 290725 386839.5 351090.5 68226.5 415239 
STD 7 100 193095 262759.5 230733 41332.5 286171 
STD 8 50 105910.5 138543 117196 19408.5 140814.5 
 
Table 1: Linearity and Range - Concentration Vs Peak area response data 
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Chart 1: Regression Analysis chart of linearity Study 
 
Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = PA 
(Pentanoic acid), Series 2 = 2-EPA (2- Ethyl Pentanoic acid), Series 3 = 2, 1-MEPA (2(1-
methyl, ethyl) Pentanoic acid), Series 4 = VN (Valeronitrile) Series 5 = MgVA 
(Magnesium Valproate) 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                  Page 203 
 
 
Chapter – 5                                                             Determination of diverse Valproate salts and its Pharmacopeial Impurities 
All data and the chart suggest that correlation coefficient of the Magnesium Valproate 
was R2 = 0.999 with linear regression equation y = 2528x + 24358 and R2 = 0.999, y = 
1920x + 3235 for Pentanoic acid, R2 = 0.999, y = 2374x + 26391 for 2- Ethyl Pentanoic 
acid, R2 = 0.998, y = 2165x + 18298 for 2(1-methyl, ethyl) Pentanoic acid and R2 = 0.996, 
y = 553.4x – 10834. 
Thus in conclusion the method counts to be highly linear for drug substance as well as for 
related impurities across the working concentration range. 
 
4.4.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION  
 
LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) should be more than 3.3 for LOD 
and more than 10 for LOQ. On the basis of linearity data theoretically it can be also 
calculated by the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 201. From the stock 
solution of 1000 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent, assign this solution as Solution – A. Form the 
Solution - A pipette out exact 1.0 ml to the 10 ml volumetric flask followed by dilution 
up to the mark with diluent to reach 1.0 µg/ml concentrations of each. 
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LOQ Solution Preparation: 
Form the Solution - A pipette out exact 2.0 ml to the 100 ml volumetric flask followed by 
dilution up to the mark with diluent to achieve 2.0 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
LOQ (Peak Area) 
Replicates  PA 2-EPA 2,1-MEPA VN MgVA 
INJ 01 12806 17227 16498 2331 18684 
INJ 02 11122 17649 15749 2263 19242 
INJ 03 11902 18126 16279 2383 19026 
INJ 04 12552 18675 16981 2212 19257 
INJ 05 11969 17296 15551 2221 18376 
INJ 06 12337 16977 16508 2250 18809 
Mean 12115 17658 16261 2277 18899 
Std dev 595.1 637.8 529.6 67 343.5 
% RSD 4.9 3.6 3.3 2.9 1.8 
  
Table 2: Limit of Quantification – Summary of Replicate Injections 
Minutes
 
LOQ 
12.00  14.0010.008.006.004.002.000.00
0.0030 
0.0025 
0.0020 
0.0015 
0.0005 
0.0000 
-0.0005
-0.0010
AU0.0010 
2(1-methyl, ethyl) Pentanoic acid - 8.877
Pentanoic acid -3.566
2- Ethyl Pentanoic acid - 6.458
Valeronitrile - 9.449 
Magnesium Valproate-10.089
Figure 12: Chromatogram of Limit of Quantification 
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14.00
Minutes
 
  LOD 
12.00 10.006.00 8.004.002.000.00
0.0020 
0.0015 
0.0010 
0.0000 
-0.0005
-0.0010
AU0.0005 
Magnesium Valproate-10.084
2(1-methyl, ethyl) Pentanoic acid - 8.883 
Pentanoic acid -3.562
Valeronitrile - 9.419
2- Ethyl Pentanoic acid - 6.452
 
 Figure 13: Chromatogram of Limit of Detection 
LOQ of the analytical method can evaluated by establish linearity up to LOQ value. For 
that linearity study is extended up to LOQ value, 
 
 
 
Chart 2: Regression Analysis chart of linearity Study included with LOQ level 
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Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = PA 
(Pentanoic acid), Series 2 = 2-EPA (2- Ethyl Pentanoic acid), Series 3 = 2, 1-MEPA (2(1-
methyl, ethyl) Pentanoic acid), Series 4 = VN (Valeronitrile), Series 5 = MgVA 
(Magnesium Valproate)  
All the results of LOD and LOQ data were within the acceptance criteria, hence it can be 
conclude that the LOD and LOQ of the method was 1.0 µg/ml and 2.0 µg/ml respectively 
which correspond to 0.5% and 1.0% of working concentration. The signal to noise ratio 
for the LOD was well within the acceptance criteria it means more than 3.3 and for the 
LOQ it was more than 10.0. Furthermore the % RSD of the six replicate injection of LOQ 
preparation less than 5.0 and the data of linearity extension chart up to LOQ level also 
suggest that the Magnesium Valproate and its impurities can be quantified up to 2.0 
µg/ml well precisely and accurately.  
 
4.4.4. PRECISION 
 
Precision study was established by evaluating method precision and intermediate 
precision study. 
Method precision of the analytical method was determined by analyzing six sets of 
sample solution preparation. The mean, standard deviation and % relative standard 
deviation for the peak area was calculated for all sets. Intermediate precision of the 
analytical method was determined by performing method precision on another day by 
another analyst using different make of raw materials under same experimental condition. 
The mean, standard deviation and % relative standard deviation for the peak area was 
calculated for all sets 
 
Standard Solution Preparation: 
Standard Stock Solution prepared as per procedure on page 201 of 1000 µg/ml. pipette 
out exact 2.0 ml from this solution and dilute up to 10 ml to accomplish 100 µg/ml 
concentration.  
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Sample Solution Preparation: 
 
Weight accurately 100 mg of Magnesium Valproate and Impurities A, B, C and D 
sample, transfer it into 100 ml volumetric flask and dilute it up to the mark with diluent. 
Apply sonication for minimum 30 min to confirm the uniform mixture. 
10.0 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained is about 200 
μg/ml of drug substance as well as each impurity. This solution is assign as Test 
Preparation Set – 01. The same procedure was used for preparing the six Test preparation 
Sets. Same approach was applied for the intermediate precision study on the second day 
with different analyst and different make of raw materials. 
 
Method Precision 
Replicates 
Peak Area 
PA 2-EPA 2,1-MEPA VN MgVA 
Set 01 385209.5 527573.5 471697 310497.5 552883 
Set 02 386337.5 528959.5 473234 307089 554516 
Set 03 386068 528362.5 472658.5 303503 553587 
Set 04 385676.5 527692.5 472115 304547 552556 
Set 05 387105 529537 474665.5 302392.5 553271 
Set 06 387128 530308 473820.5 300550 552945.5 
Mean 386254.1 528738.8 473031.8 304763.2 553293.1 
Std. Dev. 768.7 1071.7 1103.9 3558 694.9 
% RSD 0.2 0.2 0.2 1.2 0.1 
 
 
Table 3: Method Precision Data 
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Intermediate Precision 
Replicates 
Peak Area 
PA 2-EPA 2,1-MEPA VN MgVA 
Set 01 386383.5 529137.0 454614.0 188223.0 534053.0 
Set 02 394482.0 538686.5 463057.0 190529.0 540903.0 
Set 03 398786.5 539645.5 463832.5 192413.5 545145.5 
Set 04 386408.0 531365.0 455975.0 194440.0 536954.5 
Set 05 389809.5 535792.0 457506.5 196408.0 538447.5 
Set 06 390236.0 538215.0 458528.0 187992.5 539493.0 
Mean 391017.6 535473.5 458918.8 191667.7 539166.1 
Std. Dev. 4840.5 4298.3 3758.0 3387.7 3753.1 
% RSD 1.2 0.8 0.8 1.8 0.7 
 
Table 4: Intermediate Precision Data 
 
The data generated in method precision study and intermediate precision study suggest % 
RSD value of peak area for each set is less than 2.0 and overall % RSD value for all six 
set is less than 2.0 which suggest that method is highly precise for determination of all 
five components. The chromatograms of Method Precision and Intermediate Precision of 
test preparation is given below, 
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14.00
Minutes
 
   Method Precision 
12.00 10.006.00 8.004.002.000.00
0.08
0.06
0.02
0.00
AU
0.04
Magnesium Valproate - 10.077
Valeronitrile - 9.481
2(1-methyl, ethyl) Pentanoic acid - 8.865 
2- Ethyl pentanoic acid - 6.449
Pentanoic acid - 3.560 
 
Figure 14: Chromatogram of Test Preparation in Method Precision study 
 
14.00
Minutes
 
Int. Precision 
12.00 10.008.006.004.002.000.00
AU
0.000 
0.010 
0.020 
0.030 
0.040 
0.050 
0.060 
0.070 
0.080 
Magnesium Valproate - 10.20
Valeronitrile - 9.631
2(1-methyl, ethyl) Pentanoic acid - 8.959 
2- Ethyl pentanoic acid - 6.509
Pentanoic acid - 3.582 
 
Figure 15: Chromatogram of Test Preparation in Intermediate precision study 
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4.4.5. ACCURACY     
 
This Experiment can be performed by the recovery test. Recovery of the method is 
evaluated at 3 different concentration levels (corresponding to 50, 100 and 150% of test 
solution concentration) by addition of known amounts of Standard to Sample preparation. 
For each concentration level, 3 sets were prepared and injected in duplicate. 
 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 201. 
 
Sample preparations for accuracy levels are as under: 
 
Accuracy level 1 (50%)  
Test stock solution:  
100.0 mg of Magnesium Valproate and its related impurities working standard was 
accurately weighed and transferred into 200.0 ml volumetric flask. 100.0 mg Magnesium 
Valproate and its related impurities sample (different batch) was weighed and transferred 
into the same 200 ml volumetric flask. Around 140 ml of diluent added into the 
volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes with 
normal handshaking. Then, the flask was cooled to room temperature and diluted to 
volume with diluent. 10 ml of this solution was filtered through 0.22 μm nylon syringe 
filter. The concentration obtained is 1000 μg/ml of Magnesium Valproate and its related 
impurities. 5.0 ml of above test stock solution was pipette out and transferred into 50 ml 
volumetric flask followed by diluted to volume with diluent. The concentration obtained 
was 100 μg/ml Magnesium Valproate and its related impurities, the same procedure was 
applied for preparing the three sets. 
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Accuracy level 2 (100 %) 
Test stock solution:  
200.0 mg of Magnesium Valproate and its related impurities working standard was 
accurately weighed and transferred into 200 ml volumetric flask. 200.0 mg of Magnesium 
Valproate and its related impurities sample (different batch) was weighed and transferred 
into the same 200 ml volumetric flask. 140 ml of diluent added into the volumetric flask. 
The volumetric flask was proceeding for sonication of 30 minutes with normal 
handshaking. Then, the flask was cooled to room temperature and diluted to volume with 
diluent. 10 ml of this solution was filtered through 0.22 μm nylon syringe filter. The 
concentration obtained is 2000 μg/ml of Magnesium Valproate and its related impurities 
5.0 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained was 200 
μg/ml of Magnesium Valproate and its related impurities; the same procedure was 
applied for preparing the three sets. 
 
Accuracy level 3 (150 %) 
Test stock solution:  
300.0 mg of Magnesium Valproate and its related impurities d working standard was 
accurately weighed and transferred into 200 ml volumetric flask. 300.0 mg of Valproic 
acid sample (different batch) was weighed and transferred into the same 200 ml 
volumetric flask. 140 ml of diluent added into the volumetric flask. The volumetric flask 
was proceeding for sonication of 30 minutes with normal handshaking. Then, the flask 
was cooled to room temperature and diluted to volume with diluent. 10 ml of this solution 
was filtered through 0.22 μm nylon syringe filter. The concentration obtained is 3000 
μg/ml of Magnesium Valproate and its related impurities 
5.0 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained was 300 
μg/ml of Magnesium Valproate and its related impurities; the same procedure was 
applied for preparing the three sets. 
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Accuracy 
Repli. 
PA 2-EPA 2,1-MEPA VN MgVA 
Area % RSD Area 
% 
RSD Area 
% 
RSD Area 
% 
RSD Area 
% 
RSD 
150 %  579915 
0.72 
793794 
0.12 
689720 
0.10 
212206 
0.27 
896250 
0.27 150 %  577870 800492 689709 227354 915858 
150 %  577744 799201 693129 212368 916488 
100 %  391853 
0.52 
534251 
0.61 
458035 
0.58 
141783 
0.43 
670113 
0.43 100 %  391499 533976 454227 138034 688803 
100 %  390485 532134 452771 142411 678718 
050 %  198898 
0.43 
269047 
0.47 
236013 
0.53 
69928 
0.48 
345560 
0.48 050 %  198982 269585 237388 68644 345217 
050 %  198303 268485 235385 68814 343049 
 
Table 5: Summery of Accuracy Data-01 
 
Calculation formulas for recovery study are as under: 
 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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From the above calculation the % Recovery was calculated which is given below. 
 
 
Accuracy (% Recovery) 
Replicates PA 2-EPA 2,1-MEPA VN MgVA 
150 % SET 01 100.02 101.89 100.87 101.29 100.93 
150 % SET 02 99.87 100.23 101.2 100.97 98.72 
150 % SET 03 100.54 98.03 99.82 98.27 99.92 
100 % SET 01 101.08 98.56 98.26 99.52 101.9 
100 % SET 02 98.03 98.78 100.03 100.24 100.36 
100 % SET 03 98.43 100.08 98.48 101.39 101.42 
050 % SET 01 102 101.68 99.56 102 98.02 
050 % SET 02 98.7 99.12 101.9 98.29 99.05 
050 % SET 03 100.05 100.28 101.57 99.89 98.08 
 
Table 6: Summary of Accuracy Study – 2 
 
 
Figure 16: Chromatogram of Accuracy Level – 1 (150 %) 
 
 
 
Accuracy 150 % 
Pentanoic acid - 3.526 
2(1-methyl, ethyl) Pentanoic acid - 8.779
0.12
0.10
Valeronitrile - 9.352
0.08
AU
0.06
2- Ethyl pentanoic acid - 6.3810.04
0.02 Magnesium Valproate - 9.958
0.00
Minutes
0.00 2.00 4.00 6.00 8.00 12.00 10.00 14.00
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Figure 17: Chromatogram of Accuracy Level – 2 (100 %) 
 
Figure 18: Chromatogram of Accuracy Level – 3 (50 %) 
From the all above data and chromatograms it has been confirmed that the % recovery is 
within 98 to 102 % and this is in the limit of acceptance criteria. Additionally % RSD 
value of % recovery of replicate sets is below 2 % .consequently this suggests that 
proposed method is highly accurate for all five analyte. 
 
Accuracy 100 % 
 
2(1-methyl, ethyl) Pentanoic acid -  8.896
0.08
Valeronitrile - 9.509
0.06
AU
0.04
0.02 2- Ethyl pentanoic acid - 6.468Pentanoic acid - 3.565
Magnesium Valproate - 10.112
0.00
Minutes
0.00 2.00 4.00 6.00 8.00 12.00 10.00 14.00
14.0012.0010.008.006.004.000.00 2.00
Minutes
0.040 
0.030 
0.010 
0.000 
AU
0.020 
 
Accuracy 50 % 
 
2(1-methyl, ethyl) Pentanoic acid - 8.935
Pentanoic acid - 3.574
2- Ethyl pentanoic acid - 6.493
Magnesium Valproate - 10.16
Valeronitrile - 9.560
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4.4.6. ROBUSTNESS  
 
Robustness of the method was evaluated by analyzing test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in 
proportions of Buffer: Acetonitrile (54:46 and 56:44,v/v), and change in column-lot. 
 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 1.15 ml/min and 1.25 ml/min each and the results were observed in terms of Peak 
Response (Peak Area) and chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 195. A proto type chromatographic sequence of the robustness study 
is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Flow Rate 1.15 
ml/min 
2 Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 1.25 
ml/min 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
  
Table 7: Experimental UPLC sequence for the robustness study -01 
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14.00
Minutes
0.10
0.08
0.04
0.02
0.00
AU
0.06
 
Robustness 01 
 
12.00 10.008.006.004.000.00 2.00
Pentanoic acid - 3.706 
Magnesium Valproate - 10.476
Valeronitrile - 9.881
2(1-methyl, ethyl) Pentanoic acid - 9.217
2- Ethyl Pentanoic acid - 6.709
 
Figure 19: Chromatogram of Test preparation at 1.15 ml/min 
 
14.00
0.10
0.08
0.06
0.04
0.02
0.00
AU
 
Robustness 02 
12.00 10.00
Minutes
0.00 8.006.004.002.00
Valeronitrile - 9.141
Magnesium Valproate - 9.799
2(1-methyl, ethyl) Pentanoic acid - 8.539
2- Ethyl Pentanoic acid - 6.207Pentanoic acid - 3.421
 
         Figure 20: Chromatogram of Test preparation at 1.25 ml/min 
The Peak Response and area value of test preparation wasn’t much influenced at 1.15 and 
1.25 ml/min. The above chromatograms suggest that the flow rate affects on the retention 
time of analyte but it did not have any impact on the response so the peak area were not 
change too much hence the peak area value remain unaffected. 
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B) Mobile Phase Proportion Change: In this experiment the test samples were 
analyzed at the mobile phase proportion of 54:46 and 56:44, v/v (Buffer: Acetonitrile) 
each and the results were observed in terms of peak response, area value and 
chromatographic compatibility (System Suitability Test). Blank, Standards and Sample 
solutions were prepared as per the same procedure mentioned on page 195. 
 
A proto type chromatographic sequence of the robustness study is as under, 
 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
54:46 
Buffer : Acetonitrile 
2 Sys Suit Standard 5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
56:44 
Buffer: Acetonitrile 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
 
 
Table 8: Experimental UPLC sequence for the robustness study – 02 
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Figure 21: Chromatogram of Test preparation at 54:46 (Buffer: Acetonitrile) Proportion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Chromatogram of Test preparation at 56:44 (Buffer: Acetonitrile) Proportion  
 
The Peak Response and area value of test preparation wasn’t much influenced at ratio 
54:46 and 56:44 of mobile phase but the retention time of each component is highly 
transform. The above chromatograms suggest that the ratio affects on the retention time 
Robustness 03 
2(1-methyl, ethyl) Pentanoic acid - 8.232
0.10
0.08  Valeronitrile - 9.289
AU0.06
0.04
Magnesium Valproate – 9.2892- Ethyl Pentanoic acid - 6.0610.02 Pentanoic acid - 3.434 
0.00
Minutes
0.00 2.00 4.00 6.00 8.00 12.00 10.00 14.00
 
Robustness 04 
 
2(1-methyl, ethyl) Pentanoic acid - 9.328
0.10
0.08
Valeronitrile - 9.861 
0.06
AU
0.04
0.02 2-Ethyl Pentanoic acid - 6.712
Magnesium Valproate -10.61Pentanoic acid- 3.628
0.00
12.00 6.00 8.00 10.00 14.000.00 2.00 4.00
Minutes
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of drug but it did not have any impact on the response , hence the peak area value remain 
unaffected. 
C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of area value and 
chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 195.  A proto type chromatographic sequence of the robustness study 
is as under, 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections
Chromatographic 
condition 
1 Blank 1 
Different Column 
Lot 
2  Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
 
Table 9: Experimental UPLC sequence for the robustness study – 03 
 
 
 
Figure 23: Chromatogram of Test preparation at different column lot 
Robustness 05 
 
2(1-methyl, ethyl) Pentanoic acid -  8.884 0.10
0.08
Valeronitrile - 9.531
0.06
AU
0.04
Pentanoic acid - 3.5630.02
2- Ethyl Pentanoic acid - 6.460 Magnesium Valproate - 10.107
0.00
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00
Minutes
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The Peak Response and area value of test preparation wasn’t much changed with 
different column, in addition to this in this case the retention time was also remain. The 
above chromatograms suggest that diff. column does not affect on the retention time of 
drug and it did not have any impact on the response, hence the peak area value remain 
unaffected. 
 
Summary of Robustness Study 
Robust Condition Peak  Response 
Retention 
Time 
Variation 
(min.) 
System Suitability 
Theoretical 
Plates Asymmetry 
Flow Change 1.15 
ml/min Unaffected 0.20 20800 ±300 1.45 ± 0.32 
Flow Change 1.25 
ml/min Unaffected + 0.1 24000 ±800 1.10 ± 0.15 
MP Proportion 
Change 54:46 Unaffected - 0.12 19300 ± 500 1.28 ± 0.24 
MP Proportion 
Change 56:44 Unaffected + 0.17 22000 ±200 1.20 ± 0.20 
Column Lot 
Change Unaffected 0.09 20000 ±500 1.13 ± 0.30 
 
Table 10: Summary of robustness study  
 
Where, ± sign suggest statistics of all five analyte peaks.  
The data and the chromatogram given above suggest that there was no considerable 
influence of the column lot change on the result of the analysis by this method or on 
chromatographic suitability of this method. Hence, it can be conclude from this 
experiment that the method is highly robust in terms of column lot change. Overall the all 
the experiment in robustness parameter succeeded in terms of acceptance criteria hence 
the proposed method is robust for above small changes in chromatographic condition. 
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4.4.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time of 
period, 
(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS:  
50.00 mg of Magnesium Valproate and its related impurities working standard were 
accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substances were dissolved by sonication 
for ten minute. Then, volume of the flask was making up with diluent. The concentration 
obtained is 2000 μg/ml of Valproic acid and its related impurities. This solution was 
prepared on the first day of the validation and kept at the 2-4˚C temperature in 
refrigerator without any disturbance until performance of the LTSSS experiment. After 
11 day the stock solution was bring out of the refrigerator and keep it as such till it attains 
the room temp. 5 ml of this solution was pipette out in 50 ml volumetric flask and dilute 
it up to the mark to reach 200 μg/ml of analyte. This solution was assigned as LTSSS 
Standard solution. 
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Preparation of Fresh Standard Solution:  
50.00 mg of Magnesium Valproate and its related impurities working standard was 
accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substances were dissolved by sonication 
for ten minute. Then, volume of the flask was made up with diluent. The concentration 
obtained is 2000 μg/ml of all components. Pipette out exactly 5 ml of this solution in 50 
ml volumetric flask and dilute it up to the mark accurately to confirm the 200 μg/ml of 
drug substance and impurities. This solution was assigned as Fresh Standard Solution. 
The proto-type experimental sequence is given below for LTSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 LTSSS-01( 11 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 ( 11 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 11 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 11 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 11 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 11: Sequence for LTSSS 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 0.92 for Pentanoic acid, 0.987for 2- Ethyl Pentanoic acid 1.034 for 
2(1-methyl, ethyl) Pentanoic acid, 0.923 for Valeronitrile and 1.023 for Magnesium 
Valproate. 
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Preparation of Stock Solution for STSSS or Bench Top Solution Stability:  
50.00 mg of Magnesium Valproate and its related impurities working standard were 
accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substances were dissolved by sonication 
for ten minute. Then, volume of the flask was made up with diluent. The concentration 
obtained is 2000 μg/ml of all components. This solution was prepared before the 08 hour 
and kept on bench at ambient temperature without any disturbance until performance of 
the STSSS experiment. After 08 hour on the bench. 5 ml of this solution was pipette out 
in 50 ml volumetric flask and dilute it up to the mark to reach 200 μg/ml drug substance 
and impurities.  This solution was assigned as STSSS Standard solution 
Preparation of Fresh Standard Solution:  
50.00 mg of Magnesium Valproate and its related impurities working standard were 
accurately weighed and transferred into 25 ml volumetric flask. 20 ml of diluent was 
added into the volumetric flask and the standard substances were dissolved by sonication 
for one minute. Then, volume of the flask was made up with diluent. The concentration 
obtained is 2000 μg/ml analyte. Pipette out exactly 5 ml of this solution in 50 ml 
volumetric flask and dilute it up to the mark accurately to confirm the 200 μg/ml drug 
substance and impurities. This solution was assigned as Fresh Standard Solution. 
 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 1.012 for Pentanoic acid, 1.10 for 2- Ethyl Pentanoic acid 0.921 for 
2(1-methyl, ethyl) Pentanoic acid, 0.952 for Valeronitrile and 1.021 for Magnesium 
Valproate. 
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The proto-type experimental sequence is given below for STSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 STSSS-01( 8.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 8.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour) 1 
8 STSSS-03 ( 8.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 8.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 8.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for STSSS. 
 
The Mean Area Ratio was within the acceptance criteria of 0.90 to 1.10, hence it can be 
concluded from this experiment that the Stock Solution is stable for the 11 days at 2 - 4˚ 
C in refrigerator, while Standard solution was remain unaffected on bench at ambient 
temperature and in normal light for 8 hour. In addition to this it confirms the reliability of 
the data generated during the method validation.  
 
4.4.8. SYSTEM SUITABILITY  
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
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Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity 25100 ± 500 1.1 ± 0.1 1.1 
Linearity and Range 25000 ± 800 1.15± 0.1 0.76 
LOD and LOQ 7800 ± 500 1.50 ± 0.3 1.87 
Method Precision 25700 ± 800 1.08 ± 0.1 1.16 
Intermediate Precision 25100 ± 900 1.05 ± 0.1 1.54 
Accuracy 24300 ± 500 1.15 ± 0.1 1.23 
Robustness 22500 ± 500 1.17 ± 0.1 1.78 
Solution Stability 24000 ± 500 1.16 ± 0.1 0.76 
 
Table 13: Results of System Suitability Test after each Validation Experiment 
 
Where, ± sign suggest statistics of all four component peaks. 
 As per guideline the Theoretical plates should be more than 5000, Asymmetry should be 
less than 2.0 and % RSD should be less than 2.0. As the data suggest the system 
suitability was within the criteria in each validation experiment. Hence the system was 
found suitable to perform the validation experiment which confirms the reliability of the 
data generated during the method validation. 
 
 
5. APPLICATION OF CURRENT METHOD TO DIVERSE 
VALPROATE SALTS 
The proposed method can be also applicable for quantification of the different valproic 
acid salt, here we used the Calcium, Sodium and Lithium salts of valproate. The calcium, 
sodium and lithium salt have significant medicinal importance while sodium valproate is 
used for the treatment of epilepsy from last few decades. 
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Preparation of sample for different salts: 
50.00 mg of Calcium, Lithium and Sodium Valproate samples were accurately weighed 
and transferred into different 25 ml volumetric flask. 20 ml of diluent was added into the 
volumetric flask and the samples were dissolved by sonication for 10 minute. Then, 
volume of the flask was made up with diluent. The concentration obtained was 2000 
μg/ml analyte. Pipette out exact 1.0 ml of this solution and dilute it up to 10.0 ml with the 
diluent which contains 200 μg/ml valproate salts.  Same procedure was applied for 
preparation of the all Calcium, Lithium and Sodium Valproate samples. 
The each samples containing the 200 μg/ml calcium, Lithium and Sodium Valproate were 
injected and the suitability of the method for all samples were observed in terms of  
Resolution, Peak Response , Theoretical plates and Asymmetry. In addition to this the 
Pharmacopeial impurities of sodium valproate are Pentanoic acid, 2-Ethyl Pentanoic acid, 
2(1-methyl, ethyl) Pentanoic acid and Valeronitrile are also added in concentration 200 
μg/ml and injected separately to confirm the application of this method to diverse 
valproate. 
 
 
Figure 24: Chromatogram of Calcium Valproate Sample 
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Figure 25: Chromatogram of Lithium Valproate Sample 
 
 
        Figure 26: Chromatogram of Sodium Valproate Sample 
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Figure 27: Chromatogram of Sodium Valproate spiked with its Pharmacopeial impurities  
 
 
5.1. ASSAY DETERMINATION OF COMMERCIAL SAMPLE 
Commercially Sodium Valproate is available in 200.0 mg, 300 mg and 500 mg 
pharmaceutical dosage form. The proposed method can also applicable for commercial 
sample. 
Sample Preparation: 
200.0 mg tablet was crushed in mortal-pastel and the powder was dissolved in 100 ml of 
diluent and sonicate for 30 min to confirm proper dissolution. Pipette out 10.0 ml exact to 
100 ml volumetric flask and dilute it up to mark with diluent to achieve 200 μg/ml 
concentration of analyte. This sample is injected and results are evaluated in terms of 
chromatographic suitability, peak response. 
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 Minutes
 
Commercial Sample 
14.00 12.00 10.008.006.004.002.000.00
0.020 
0.015 
0.005 
0.000 
AU 0.010 
Sodium Valproate - 10.082
Figure 21: Chromatogram of commercial sample of Sodium Valproate. 
 
Above all data, chromatograms and the suitability result suggest that besides Magnesium 
Valproate, this method is appropriately applicable for the analysis of diverse valproate 
salts like Calcium, Lithium, and Sodium valproate in bulk drug as well as in 
pharmaceutical dosage form. 
 
 
6. CONCLUSION 
 
The observation and results obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria of ICH guideline. 
Since, all the results are with-in the limit, the developed Analytical method is considered 
as validated and suitable for probable use. 
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7. APPLICATION OF CURRENT FINDINGS  
 
 
7.1. This method can be used for the quantification of Magnesium Valproate in bulk 
drug as well as in pharmaceutical dosage form in routine or as a special test. 
7.2. This method can be used for the determination of process related impurities of 
valproic acid more specifically for determination of Pentanoic acid, 2- Ethyl 
Pentanoic acid, 2(1-methyl, ethyl) Pentanoic acid and Valeronitrile. 
7.3. This method has also application over the chromatographic purity of Magnesium 
Valproate. 
7.4. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation of Magnesium Valproate and its related 
compound. 
7.5. This method is also applicable for determination of Calcium, Lithium, and 
Sodium Valproate in bulk drug as well as in pharmaceutical dosage form. 
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1. INTRODUCTION 
 
Various chemical moieties like Benzimidazole, Phenothiazine and Benz-isoxazole etc. 
are used   to treat psychotic disease. In addition to this few Isobenzofuran, Piperidine and 
2-Quinolinone derivatives are also categorize in to antipsychotic class of drugs.  
Here some diverse antipsychotic molecules are taken into the consideration for their 
Analytical method, which is also an example of high throughput screening includes the 
simultaneous determination of nine molecules in shortest analysis time of just 5 minutes. 
They are as under; 
Venlafaxine is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI) 
[1]. It has a similar chemical structure to the opioid derivative Tramadol, and has 
the tertiary amine functional group necessary for mu-opioid receptor recognition 
(cf.lefetamine), though it is unknown whether it has an opioid agonist effect. It is 
surprisingly effective in treating depression in heroin and other addicts compared to all 
other conventional anti-depressants.  
Venlafaxine is used primarily for the treatment of major depression in adults.[2] Multiple 
double blind studies show venlafaxine's effectiveness in treating depression. Venlafaxine 
has similar efficacy to tricyclic antidepressants amitriptyline (Elavil) and imipramine and 
is better tolerated than amitriptyline. Its efficacy is similar to or better than sertraline 
(Zoloft) and fluoxetine (Prozac), depending on the criteria and rating scales used. Higher 
doses of venlafaxine are more effective, and more patients achieved remission or were 
"very much improved". The efficacy was similar if the number of patients who achieved 
"response" or were "improved" was considered. A meta-analysis comparing venlafaxine 
and combined groups of SSRI or tricyclic antidepressants showed venlafaxine's 
superiority.[3] Judged by the same criteria, venlafaxine was similar in efficacy to the 
atypical antidepressant bupropion (Wellbutrin); however, the remission rate was 
significantly lower for venlafaxine.[4] In a double-blind study, patients who did not 
respond to an SSRI were switched to venlafaxine or citalopram. Similar improvement 
was observed in both groups [5]. 
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Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) 
class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment 
in adults with major depressive disorder, generalized anxiety disorder, social anxiety 
disorder, or panic disorder. Escitalopram is the S-stereoisomer (enantiomer) of the earlier 
Lundbeck drug citalopram, hence the name escitalopram. Escitalopram is noted for its 
high selectivity of serotonin reuptake inhibition and has side effects typical for the SSRI 
class. 
Escitalopram was developed in a close cooperation between Lundbeck and Forest 
Laboratories. Its development was initiated in the summer of 1997, and the resulting new 
drug application was submitted to the U.S. FDA in March 2001. The short time (3.5 
years) it took to develop escitalopram can be attributed to the previous extensive 
experience of Lundbeck and Forest with citalopram, which has similar pharmacology.[6] 
Escitalopram is an enantiopure compound of the racemic mixture citalopram, used for the 
same indication, and for that reason it required less investment and less time to develop. 
Two years after escitalopram's launch, when the patent on citalopram expired, the 
escitalopram sales successfully made up for the loss. On May 23, 2006, the FDA 
approved a generic version of escitalopram by Teva [7]. 
Despite the similarity of escitalopram and citalopram, preclinical as well as various 
clinical studies (including double-blinded studies) have shown differentiated effects of 
citalopram and escitalopram [8] as well as a clinical superiority compared with a variety 
of other SSRIs, such as paroxetine [9], especially in severely depressed patients. A head-
to-head comparison of escitalopram with duloxetine found escitalopram to be both more 
tolerable and more effective [10], Compared with venlafaxine [11] and sertraline [12], 
escitalopram was shown to have similar efficacy.  
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. 
Fluoxetine is approved for the treatment of major depression, obsessive-compulsive 
disorder (in both adult and pediatric populations), bulimia nervosa, panic 
disorder and premenstrual dysphoric disorder [13]. Despite the availability of newer 
agents, it remains extremely popular. Fluoxetine has been approved by the FDA for the 
treatment of major depression, obsessive compulsive disorder, bulimia nervosa and panic 
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disorder[14]. Fluoxetine was shown to be effective for depression in 6-week long double-
blind controlled trials where it also alleviated anxiety and improved sleep. Fluoxetine was 
better than placebo for the prevention of depression recurrence when the patients, who 
originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of 
fluoxetine for geriatric as well as pediatric depression was also demonstrated in placebo-
controlled trials [15]. 
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  Candesarten                                 Trihexyphenidyl                               Thioridazine 
           
 
         
 
              Aripiprazole                     Trifluoperazine           Risperidone   
Figure 1: Chemical Structure of mentioned antipsychotic molecules 
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The recent research suggests that a significant part of the resistance to the SSRIs can be 
explained by the genetic variation of Pgp transporter. Paroxetine and citalopram, which 
are Pgp substrates, are actively transported from the brain by this protein. Fluoxetine is 
not a substrate of Pgp, and thus a switch from paroxetine or citalopram to fluoxetine may 
be beneficial to the non-responders [16] [17]. 
Candesartan is an angiotensin II receptor antagonist used mainly for the treatment 
of hypertension. As all angiotensin II receptor antagonists, candesartan is indicated for 
the treatment of hypertension. Results from the CHARM study in the early 2000s 
demonstrated the morbidity and mortality reduction benefits of candesartan therapy 
in congestive heart failure.[18] Thus, while ACE inhibitors are still considered first-line 
therapy in heart failure, candesartan can be used in combination with an ACE to achieve 
improved mortality and morbidity vs. an ACE alone and additionally is an alternative in 
patients intolerant of ACE inhibitor therapy.  
Risperidone is an atypical antipsychotic used to treat schizophrenia (including 
adolescent schizophrenia), schizoaffective disorder, the mixed and manic states 
associated with bipolar disorder, and irritability in children with autism. The drug was 
developed by Janssen-Cilag and first released in 1994 [19]. Risperidone was approved by 
the United States Food and Drug Administration (FDA) in 1993 for the treatment 
of schizophrenia.[20] 
This drug belongs to a class of antipsychotic drugs known as atypical antipsychotics that 
have more pronounced serotonin antagonism than dopamine antagonism, but risperidone 
is unique in this class because it retains dopamine antagonism. It has high affinity for 
D2 dopaminergic receptors. It has actions at several 5-HT (serotonin) receptor subtypes. 
These are 5-HT2C, linked to weight gain, 5-HT2A, linked to its antipsychotic action and 
relief of some of the extra pyramidal side effects (EPS) experienced with the typical 
neuroleptics. 
It reaches peak plasma levels quickly regardless of whether it is administered as a liquid 
or pill. Risperidone is metabolised fairly quickly, so the potential for nausea subsides 
usually in two to three hours. However, the active metabolite, 9-hydroxy-risperidone, 
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which has similar pharmacodynamics to risperidone, lingers in the body for much longer, 
and has been developed as an antipsychotic in its own right, called paliperidone. 
An intramuscular preparation, marketed as Risperdal Consta, can be given once every 
two weeks. It is slowly released from the injection site. This method of administration 
may be used on sanctioned patients who are declining, or consenting patients who may 
have disorganized thinking and cannot remember to take their daily doses [21] .  
Trihexyphenidyl, also known as benzhexol, is an antiparkinsonian agent of 
the antimuscarinic class - specifically at equivalent doses it has 83 per cent of the 
antimuscarinic power of atropine. It was invented in the United States in 1949, and it has 
been in clinical usage for decades. Chemically, it is a tertiary amine with alcohol, phenyl, 
and cyclohexyl moieties. The drug is available as the hydrochloride salt. The exact 
mechanism of action in parkinsonian syndromes is not precisely understood, but it is 
known that trihexyphenidyl blocks efferent impulses in parasympathetically innervated 
structures like smooth muscles (spasmolytic activity), salivary glands, and eyes 
(mydriasis). In higher doses direct central inhibition of cerebral motor centers may 
contribute. In very high doses central toxicity as seen in atropine overdose is noted. It 
binds to the M1 muscarinic receptor [22]. 
Trihexyphenidyl is used for the symptomatic treatment of Parkinson's disease in mono- 
and combination therapy. It is active in post encephalitic, arteriosclerotic, and idiopathic 
forms. The drug is also commonly used to treat extra pyramidal side effects occurring 
during antipsychotic treatment. It reduces the frequency and duration of oculogyric 
crises as well as of dyskinetic movements and spastic contractions. Excessive salivation 
may also respond. Trihexyphenidyl may improve psychotic depression and mental inertia 
frequently associated with Parkinson's disease and symptomatic problems caused by 
antipsychotic treatment. 
Thioridazine is a typical antipsychotic drug belonging to the phenothiazine drug group 
and was previously widely used in the treatment of schizophrenia and psychosis. Due to 
concerns about cardiotoxicity and retinopathy at high doses this drug is not commonly 
prescribed, reserved for patients who have failed to respond to, or have contraindications 
for, more widely used antipsychotics. A serious side effect is the potentially 
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fatal neuroleptics malignant syndrome. It exerts its actions through a central adrenergic-
blocking, a dopamine-blocking and minor anticholinergic activity. Thioridazine is known 
to kill multidrug-resistant mycobacterium and MRSA at clinical concentration [23]. 
Thioridazine is a racemic compound with two enantiomers, both of which are 
metabolized, according to Eap et al., by CYP2D6 into (S)- and (R)-thioridazine 2-
sulfoxide, better known as mesoridazine [24], and into (S)- and (R)-thioridazine-5-
sulfoxide.[25] Mesoridazine is in turn metabolized into sulforidazine [26]. Thioridazine is 
an inhibitor of CYP1A2 and CYP3A2 [27]. 
Aripiprazole is an atypical antipsychotic and antidepressant used in the treatment 
of schizophrenia, bipolar disorder, and clinical depression. It was approved by the Food 
and Drug Administration (FDA) for schizophrenia in 2002, for acute manic and mixed 
episodes associated with bipolar disorder in 2004, and as an adjunct for major depressive 
disorder in  2007 [28]. Aripiprazole has been approved by the FDA for the treatment of 
schizophrenia [29]. Aripiprazole has been approved by the FDA for the treatment of 
acute manic and mixed episodes, in both pediatric patients aged 10–17 and in adults [30]. 
Trifluoperazine is a typical antipsychotic of the phenothiazine chemical class. The 
primary indication of trifluoperazine is schizophrenia. Other official indications may vary 
country by country, but generally it is also indicated for use in agitation and patients with 
behavioural problems, severe nausea and vomiting as well as severe anxiety. Its use in 
many parts of the world has declined because of highly frequent and severe early and 
late tardive dyskinesia, a type of extra pyramidal symptom. A study suggested that 
trifluoperazine may be able to reverse addiction to opioids [31]. A multi-year UK study 
by the Alzheimer's Research Trust suggested that this and other antipsychotic drugs 
commonly given to Alzheimer's patients with mild behavioural problems often make 
their condition worse [32]. Thioridazine has central antiadrenergic [33], antidopaminergic 
[34] [35] effects. It is believed to work by blockading dopamine D1 and D2 receptor in 
the mesocortical and mesolimbic pathways, relieving or minimizing such symptoms of 
schizophrenia as hallucinations, delusions, and disorganized thought and speech [36]. 
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2.  LITERATURE REVIEW 
 
The literature reviews concerning analytical method of these nine antipsychotic drugs, 
there is no Ultra Performance Liquid Chromatographic method which describes the 
simultaneous chromatographic quantification these molecules. However various high 
performance liquid chromatographic analytical methods are reported for determination of 
those in bulk drug. Pharmaceutical dosage form and/or in biological matrix in single or in 
combination of two molecules, which provides the important reference and the initiative 
information about the molecule behavior under various chromatographic conditions. Few 
of them are mentioning below. 
 
2.1. D. V. Subba Rao, P. Radhakrishnanand, M. V. Suryanarayana and 
V. Himabindu have developed A Stability-Indicating LC Method for Candesartan 
Cilexetil using 250 mm × 4.6 mm, 5 μm particle, CN column with a 50:50 (v/v) mixture 
of phosphate buffer, pH 3.0, and acetonitrile as mobile phase. The flow rate was 
1.0 ml/min and the detection wavelength was 210 nm [37].Some other methods are also 
available in literature for the determination of candesartan single or in combination form 
and also in biological matrix [38] [39]. 
 
2.2. Ebenezer B. Asafu-Adjayea et al worked on Validation and application of a 
stability-indicating HPLC method for the in vitro determination of gastric and intestinal 
stability of venlafaxine [40] using a 5 μm Ascentis C18 column (150 mm × 4.6 mm) and 
mobile phase consisting of 30% acetonitrile in 20 mM potassium phosphate buffer (pH 
6.5) delivered isocratically at a flow rate of 1 ml/min with UV detection at 228 nm. Few 
other references are also available for analytical method of venlafaxine [41] [42]. 
 
2.3. Christine Greiner ,  Christoph Hiemke, Wolfgang Badera and Ekkehard 
Haena publish a paper for Determination of citalopram and escitalopram together with 
their active main metabolites desmethyl(es-)citalopram in human serum by column-
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switching high performance liquid chromatography (HPLC) and Spectrophotometric 
detection[43] while, Sonu Sundd Singh, Hiten Shah, Sapna Gupta, Manish Jain, 
Kuldeep Sharma, Purav Thakkar and Ruchy Shah worked on Liquid 
chromatography–electrospray ionization mass spectrometry method for the determination 
of escitalopram in human plasma and its application in bioequivalence study[44]. 
 
2.4. Sagi Morisha, Hayakawa Hideyuki, Saski Chizuko, Mukai Toshiji have 
publish a paper for a study on HPLC method with ODS column of Risperidone and 9- 
hydroxyrisperidone [45], and E Vendelin Olesen and Kristian Linnet develop a 
Simplified high-performance liquid chromatographic method for determination of 
risperidone and 9-hydroxyrisperidone in serum from patients co medicated with other 
psychotropic drugs [46]. 
 
2.5. Venkateswara Reddy, K. V. N. Suresh Reddy , J. Sreeramulu and 
G. V. Kanumula have worked  on the combination dosage form as a Simultaneous 
Determination of Olanzapine and Fluoxetine by HPLC[47] and Erturk S, Cetin 
SM, Atmaca S, Ersoy L, Baktr G publish a paper for sensitive HPLC method for the 
determination of fluoxetine and norfluoxetine in human plasma with fluorescence 
detection [48]. 
 
2.6. Many methods are available for the estimation of trihexyphenidyl in combination 
or as a single drug in pharmaceutical dosage form like Ashwin Patel, Alankar 
Shrivastava, Anurekha Jain and GK Singh have done Method Development and 
Validation for estimation of Trihexyphenidyl Hydrochloride in Tablet Dosage Forms[49] 
and Mahadik K.R, Aggarwal H and Kaul N. also worked on the development and 
validation of HPLC method for simultaneous estimation of Trihexyphenidyl 
Hydrochloride and Chlorpromazine Hydrochloride from tablet dosage form[50] 
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2.7. R. Bhushan and Deepak Gupta has achieved HPLC resolution of thioridazine 
enantiomers from pharmaceutical dosage form using cyclodextrin-based chiral stationary 
phase [51]. 
 
2.8. A. M. Al-Obaid, M. E. M. Hagga, I. E. El-Khawad, O. H. M. El-Mahi 
published a paper for Simultaneous Quantitation of Some Phenothiazine Drug Substances 
and Their Monosulphoxide Degrades by High Performance Liquid Chromatography 
[52].while some other stability indicating methods are also published for the 
determination of Trifluoperazine[53] 
 
2.9. Vijaya kumar M, Muley P.R. have describe the HPLC method for aripiprazole 
in bulk drug and in solid dosage form using the Grace Vydac (C18, 25cm, 4.6mm internal 
diameter, 5μ) column with mobile phase consisting of buffer (0.05M potassium 
phosphate pH adjusted to 3 with phosphoric acid), Methanol and Acetonitrile in the ratio 
of (50:25:25% v/v) in an isocratic mode was used. The detection wavelength was 250nm, 
flow rate 1ml/minute and Methylparaben was used as an internal standard, in the linear 
range of 25-50μg/ml. In addition to this they also did the force degradation analysis [54], 
many other liquid chromatographic methods are available in bulk drug and 
pharmaceutical dosage form [55] [56], some bioanalytical methods are also publish [57] 
[58]. 
 
3. AIM OF THE PRESENT WORK 
 
The above literature recommends that there are no methods for the determination of these 
nine most popular antipsychotic molecules by UPLC-PDA, All available methods are 
high performance liquid chromatographic methods and in single or in combination with 
one another molecule in dosage form but no methods deals with such high no. of 
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molecule in exclusive work. Furthermore the present method has the advantage over the 
speed which confirm by the shortest analysis time of just 5.0 minute and the selectivity, it 
can be maximum utilize for the analysis and it could be also functional of quality control 
laboratory for routine use. The aim and scope of the proposed work are as under,  
 
3.1. To develop method for quantification of the drug substance using the latest 
technology in liquid chromatography. 
3.2. To attain a method without precolumn or post column derivatization. 
3.3.  To optimized the method at a maximum level to gain High Throughput 
Screening. 
3.4.  Elaborate the technology suggesting the various applications.   
3.5.  To perform analytical method validation for the proposed method as per ICH 
guideline [59]. 
 
4.  EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS. 
Alembic Research Centre (Baroda, India), Torrent Research Centre (Gandhinagar, India), 
Zydus Research Centre (Ahmadabad, India), Cadila Pharma. (Ahmadabad, India) and 
Parth Laboratories Pvt. Ltd. (Rajkot, India) provided working standards and samples of 
all nine antipsychotic drugs. Ammonium Acetate (for HPLC), HPLC grade Acetonitrile 
has purchased from Spectrochem Pvt Ltd. HPLC grade water used was purified by Milli-
Q Elix-3 water purification system. 
4.2. INSTRUMENTATION  
The Waters AcquityTM UPLC chromatographic system used to perform development and 
validation. This system consists of a Binary Solvent Manager (pump), Photodiode Array 
Detector, Sample Manager (Auto sampler) and column oven connected to a multi-
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instrument data acquisition and processing system Empower 2.1 version. Sartorius 
microbalance and Equiptronics branded balance and heating oven was used for the 
weighing and heating purpose while Spinco ultrasonic bath used for degassing purpose. 
4.3.  METHOD DEVELOPMENT 
Analytical Method development is consist of following steps which can be shore up by 
the literature survey, previous experience and chemical nature of the reagents used in the 
development. 
4.3.1.  MOBILE PHASE SELECTION 
On the basis of literature survey, several exploratory runs have been performed but 
initially proper selectivity and resolution between the all drug substances were not 
achieved. After furnishing more importance to the literature, the 10 mM ammonium 
acetate gave the maximum resolution with acetonitrile as an organic component, which 
was used in gradient programming with respect to time and composition of mobile phase. 
4.3.2. COLUMN SELECTION 
Column selection is the most important part in the method development. In this case most 
suitable column chemistry was BEH (Bridge Ethane Hybrid) Silica C18.Among the 
column chemistry available with us the Acquity BEH C18 (50 mm x 2.1 mm id, 1.7μ 
particle size) gives the best consequences. 
4.3.3. DETECTION WAVELENGTH SELECTION  
We have screened the standard solution over 190 nm to 400 nm Using the advantage of 
photo diode array detector. On the basis of peak absorption maxima and peak purity 
index the 215 nm was decided as the detection wavelength which also gives the 
maximum chromatographic compatibility to the method. The absorption is shown in the 
figure 1 of all mentioned nine molecules at each wavelength.  
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Figure 2: UV absorption of all nine molecules in overlaid format 
4.3.4.  BUFFER SOLUTION PREPARATION 
10 mM Ammonium acetate was prepared by dissolving 0.385 gm of Ammonium Acetate 
for HPLC in 1000 ml of HPLC grade water which further Sonicate for 20 minutes to 
remove of all dissolve gas and filtered through 0.45µn filter.  
4.3.5. STANDARD SOLUTION PREPARATION 
Standard solution of 100 μg/ml concentration was prepared by dissolving 10.0 mg of 
each working standard in a 25 ml of acetonitrile: water (50:50) diluent then diluting it up 
to mark with the same diluent in the 100 ml volumetric flask. 
4.3.6. SAMPLE SOLUTION PREPARATION 
Sample solution of 100 μg/ml concentration was prepared by dissolving 10.0 mg of each 
Sample (Different batch) in a 25 ml of acetonitrile: water (50:50) diluent then diluting it 
up to mark with the same diluent in the 100 ml volumetric flask. 
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        Figure 3: Chromatograms of Working Standard 
 
 
 
 
 
 
 
 
 
Figure 4: Chromatograms of Sample Solution. 
 
 
 
 
 
 
Standard 
Venlafaxine - 1.222
Escitalopram - 1.441
Risperidone - 1.849
Fluoxetine Hcl - 2.149
Trihexaphenidyl - 2.498
Thioridazine - 2.978
Candesarten - 3.346 
Trifluoperazine - 3.624
Aripiprazole - 3.751 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
 
Sample 
 
Venlafaxine -1.221
Escitalopram - 1.440 
Risperidone - 1.848
Fluoxetine Hcl - 2.148
Trihexaphenidyl - 2.48
Thioridazine - 2.977
Candesarten - 3.34 
Trifluoperazine - 3.624 
Aripiprazole - 3.75 
AU 
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
0.00 0.50 1.00  1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00
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In conclusion to Method development following chromatographic clauses suits the most 
and decided as a final method for validation experiments. 
 
 
Mobile Phase A  : 10 mM Ammonium acetate  
Mobile Phase B  : Acetonitrile (HPLC grade) 
Column   :  Acquity BEH C18 (50  x 2.1 mm id, 1.7μ particle size) 
Flow Rate  : 0.3 ml/min 
Gradient elution   : As per Table 1 
Detection   : 215 nm UV 
Diluent    : Acetonitrile: Water (1:1) 
Injection Volume : 05 µl 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Gradient Programming of proposed method 
 
 
Time Flow Rate % of Buffer % of Organic Curve 
0.0 0.3 55 45 Initial 
1.75 0.3 30 70 6 
2.5 0.3 20 80 6 
3.8 0.3 20 80 6 
3.9 0.3 55 45 6 
5.0 0.3 55 45 6 
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4.4. METHOD VALIDATION 
 
Method for the simultaneous determination of nine most pertinent antipsychotic 
molecules bulk drug is further validated as per ICH Q2 (R1) guideline [59]. Validation of 
analytical method was performed using working standards and samples of different batch 
of drug substances. 
 
4.4.1. SPECIFICITY  
 
 
The evaluation of the specificity of the method was determined against diluent 
application and each of the Molecules to another drug substance, which were taken in to 
the consideration. The interference of the diluent and each molecule was derived by 
injecting each individual drug substance solution and diluent. The retention time of each 
is taken in to consideration. Further the specificity of the method toward the drug was 
established by means of the interference of diluent at the retention time of the drug peak. 
 
Blank preparation: 
Diluent was used as blank solution. 
Solution preparation: 
Weight exact 10.0 mg of each drug substance in separate 100 ml volumetric flasks and 
dissolve them in 25 ml of diluent followed by make up to the mark with diluent. Apply 
sonication to them in ultrasonic bath for 10 min and filter the solution with 0.22 µn 
membrane filter. 
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Figure 5: Chromatogram of Diluent (Blank) of Specificity Experiment 
 
 
 
 
 
 
 
 
 
 
Figure 6: Chromatogram of Aripiprazole of Specificity Experiment 
 
 
 
 
Aripiprazole 
  Aripiprazole - 3.718
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Figure 7: Chromatogram of Candesartan of Specificity Experiment 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Chromatogram of Escitalopram of Specificity Experiment 
 
 
Candesartan 
 
Candesarten - 3.314
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Figure 6: Chromatogram of Impurity - C of specificity 
Figure 9: Chromatogram of Trihexyphenidyl of Specificity Experiment 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Chromatogram of Fluoxetine HCl of Specificity Experiment 
 
 
Trihexyphenidyl 
 
Trihexaphenidyl - 2.473
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Figure 11: Chromatogram of Risperidone of Specificity Experiment 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Chromatogram of Venlafaxine of Specificity Experiment 
 
 
Risperidone 
Risperidone - 1.817
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Figure 13: Chromatogram of Thioridazine of Specificity Experiment 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Chromatogram of Trifluoperazine of Specificity Experiment 
 
From the specificity experiment and subsequently achieved above chromatograms it has 
proven that any interference was not observed from blank or individual drug substance to 
the peak of other (Drug Substance), in addition to this peak purity was also within the 
 
Thioridazine 
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acceptance criteria confirmed by the photo diode detector. The chromatogram (3D View) 
of standard solution is shown in Figure 15. Hence it confirms that the proposed method is 
highly specific with respect to the diluent and each drug molecule to the other. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Chromatogram of 3D – view of Standard preparation 
 
4.4.2. LINEARITY & RANGE  
 
The linearity curve was prepared with 8 concentration levels (25, 50, 75, 100, 125, 150, 
175 and 200 μg/ml of each of drug molecule). These concentration levels were 
respectively corresponding to 25, 50, 75, 100, 125, 150, 175 and 200 % of standard 
solution concentration.  The  peak areas vs. concentration data were evaluated by linear 
regression analysis. 
Stock Solution Preparation:  
Weight accurately 50 mg of each of drug molecule (working standard), transfer it into 
100 ml volumetric flask and dilute it up to the mark with diluent. Apply sonication for 
minimum 30 min to confirm the uniform mixture, which contains the 500 µg/ml of each 
analyte. 
0.00
0.50
1.00
1.50
2.00
AU
0.00 0.50  1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
Minutes
300.00
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Linearity Standard Solution Preparation: 
From Standard Stock Solution of accurate 500 µg/ml pipette out exactly 0.5, 1.0, 1.5, 2.0, 
2.5, 3.0, 3.5 and 4.0 ml and dilute it up to 10 ml each with diluent to achieve 25-200 
µg/ml concentration of analytes. 
 
Linearity & Range 
Conc. 
(µg/ml) 
Peak Area 
VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
200 2763493 4616776 3460782 3928028 732992.5 5061779 2968152 3824242 4232990 
175 2526992 4078238 2992471 3401789 654839 4449690 2532704 3317253 3518836 
150 2099645 3409789 2632514 2820424 551018.5 3906613 2210290 2767574 2949652 
125 1799983 2944006 2171017 2452301 466192.5 3179291 1813768 2368595 2236379 
100 1409194 2315614 1698754 1899090 359384 2475554 1495752 1829424 1778566 
75 1065454 1779818 1197696 1401743 276115 1793483 1118078 1418052 1207238 
50 712961 1182285 866862.5 978843 177643 1070339 723475 954420.5 639077 
25 337450 558111 409555 462141 94896.5 337616 391801.5 450839.5 149555 
 
Table 2: Linearity and Range - Concentration Vs Peak area response data 
 
Linearity & Range 
Analyte  R² Y = mX + c 
Venlafaxine 0.998 y = 14069x + 6584. 
Escitalopram 0.999 y = 23052x + 17255 
Risperidone 0.998 y = 17506x - 40759 
Fluoxetine 0.998 y = 19612x - 38305 
Trihexyphenidyl 0.999 y = 3706x - 2874 
Thioridazine 0.998 y = 27147x - 26975 
Candesartan 0.999 y = 14607x + 13436 
Trifluoperazine 0.999 y = 19055x - 27399 
Aripiprazole 0.997 y = 23175x - 51817 
 
Table 3: Linearity and Range – Regression analysis data 
Where R2 = Co-relation co efficient and Y = mX + c is regression analysis equation  
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All above data suggests that the value of correlation coefficient and regression analysis 
equation are well within the criteria Thus in conclusion the method counts to be highly 
linear across the definite range for all nine drug substance. 
 
4.4.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION 
  
LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) should be more than 3.3 for LOD 
and more than 10 for LOQ. On the basis of linearity data theoretically it can be also 
calculated by the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 255. From the stock 
solution of 500 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent, assign this solution as Solution – A. Form the 
Solution - A pipette out exact 40 µl to the 10 ml volumetric flask followed by dilution up 
to the mark with diluent to reach 0.02 µg/ml concentrations of each. 
LOQ Solution Preparation: 
Form the Solution - A pipette out exact 0.4 ml to the 10 ml volumetric flask followed by 
dilution up to the mark with diluent to achieve 0.2 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
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LOQ 
Replicates 
Peak Area 
VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
INJ 01 3117.0 4689.0 3652.0 4189.0 1894.0 4895.0 3683.0 3443.0 19925.0 
INJ 02 3087.0 4649.0 3643.0 4180.0 1884.0 4853.0 3646.0 3419.0 19130.0 
INJ 03 3114.0 4683.0 3636.0 4187.0 1874.0 4851.0 3641.0 3396.0 19682.0 
INJ 04 3069.0 4632.0 3650.0 4147.0 1888.0 4845.0 3644.0 3418.0 19846.0 
INJ 05 3085.0 4693.0 3611.0 4162.0 1908.0 4830.0 3659.0 3358.0 19632.0 
INJ 06 3081.0 4675.0 3602.0 4144.0 1869.0 4843.0 3731.0 3401.0 19591.0 
Mean  3092.2 4670.2 3632.3 4168.2 1886.2 4852.8 3667.3 3405.8 20301.0 
Std Dev 19.1 24.4 21.0 20.0 14.1 22.2 34.8 28.7 1130.9 
 % RSD 0.6 0.5 0.6 0.5 0.7 0.5 0.9 0.8 1.4 
  
Table 4: Limit of Quantification – Summary of Replicate Injections 
 
 
 
 
 
 
 
 
 
Figure 16: Chromatogram of Limit of Quantification 
 
 
 
LOQ 
Venlafaxine - 1.261
Escitalopram - 1.453 
Risperidone - 1.798 
Fluoxetine - 2.198 
Trihexyphenidyl - 2.453
Thioridazine - 2.952 
Candesartan - 3.358 
Trifluoperazine - 3.614 
Aripiprazole - 3.767 
AU 
-0.070
-0.060
-0.050
-0.040
-0.030
-0.020
-0.010
0.000
Minutes
0.00  0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 
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Figure 17: Chromatogram of Limit of Detection 
 
Signal to Noise ratio for LOQ and LOD is more than 10.0 and 3.3 respectively which are 
well within the acceptance criteria for each analyte. All the results of LOD and LOQ data 
were within the acceptance criteria, hence it can be conclude that the LOD and LOQ of 
the method was 0.02 µg/ml and 0.2 µg/ml respectively which correspond to 0.02% and 
0.2% of working concentration. Furthermore the % RSD of the six replicate injection of 
LOQ preparation less than 5.0 and the data of linearity extension up to LOQ level also 
suggest that the analytes can be quantified up to 0.2 µg/ml well precisely and accurately.  
 
4.4.4. PRECISION  
 
Precision study was established by evaluating method precision and intermediate 
precision study. Method precision of the analytical method was determined by analyzing 
six sets of sample solution preparation. The mean, standard deviation and % relative 
standard deviation for peak area of all sets was calculated. Intermediate precision of the 
analytical method was determined by performing method precision on another day by 
another analyst using different make of raw materials under same experimental condition. 
 
LOD 
Venlafaxine -1.257 
Escitalopram - 1.452
Risperidone - 1.798 
Fluoxetine - 2.199 
Trihexyphenidyl - 2.453
Thioridazine - 2.954 
Candesartan - 3.357
Trifluoperazine - 3.615
Aripiprazole - 3.767 
AU 
-0.070
-0.060
-0.050
-0.040
-0.030
-0.020
-0.010
0.000 
Minutes
0.00 0.50 1.00  1.50 2.00 2.50 3.00 3.50 4.00 4.50  5.00
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The mean, standard deviation and % relative standard deviation for peak area of all sets 
was calculated. 
 
Standard Solution Preparation: 
Standard Stock Solution of 500 µg/ml prepared as per procedure on page 255. Pipette out 
exact 2.0 ml from this solution and dilute it up to 10 ml to accomplish 100 µg/ml 
concentrations.  
  
Sample Solution Preparation: 
Weight accurately 50.0 mg of each analyte sample and transfer it into 100 ml volumetric 
flask and dilute it up to the mark with diluent. Apply sonication for minimum 30 min to 
confirm the uniform mixture. 
10.0 ml of above test stock solution was pipette out and transferred into 50 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained is about 100 
μg/ml of each drug substance. This solution is assign as Test Preparation Set – 01. 
The same procedure was used for preparing the six Test preparation Sets. Same approach 
was applied for the intermediate precision study on the second day with different analyst 
and different make of raw materials. 
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Method Precision 
Replicates 
Peak Area 
VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
Set 01 
1420351 2048210 1748507 1933002 877249 2363352 1609691 1855082 1733478 
1418833 2048431 1749562 1932738 882047 2364642 1611126 1857635 1734973 
Set 02 
1419992 2049257 1750234 1933773 882324 2365868 1612881 1859040 1738339 
1426573 2053084 1751621 1936027 876956 2367780 1614184 1860604 1740021 
Set 03 
1420460 2049702 1750645 1932899 881516 2366340 1613790 1860856 1742277 
1416932 2041587 1742140 1923313 875054 2354838 1604247 1848224 1727578 
Set 04 
1408900 2036316 1740217 1916556 887439 2351976 1604898 1846888 1723840 
1398934 2020218 1725400 1902772 884209 2334328 1592745 1834484 1718860 
Set 05 
1392952 2012523 1735238 1893620 806460 2324465 1591783 1832172 1722453 
1394278 2013377 1735437 1895853 822346 2326286 1595514 1836198 1727759 
Set 06 
1402930 2022597 1741025 1908276 818547 2336267 1603169 1846163 1745835 
1402261 2021473 1737639 1907238 828481 2333893 1601425 1845510 1744235 
Mean 1410283.0 2034731.3 1742305.4 1918005.6 860219.0 2349169.6 1604621.1 1848571.3 1733304.0 
Std. Dev. 11628.85 15590.45 8096.18 15941.55 31033.09 16934.77 8051.54 10306.43 9094.39 
% RSD 0.82 0.77 0.46 0.83 3.61 0.72 0.50 0.56 0.52 
 
 
Table 5: Method Precision Data  
 
Where, VNF = Venlafaxine, ESTP = Escitalopram, FLXT = Flouxitine, THPD = 
Trihexyphenidyl, TDRZ = Thioridazine, CNDST = Candesarten, TFPRZ = 
Trifluoperazine, ARPZ = Aripiprazole 
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Intermediate Precision 
Replicates 
Peak Area 
VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
Set 01 
1457177 2072628 1767287 1966059 915804 2388435 1633189 1872571 1560742 
1457275 2072455 1765265 1965679 941759 2385811 1629217 1868822 1562658 
Set 02 
1441301 2056359 1755548 1983614 919066 2368121 1618282 1861201 1535636 
1443716 2054152 1751052 1947381 910594 2366135 1619132 1856532 1543807 
Set 03 
1441298 2051229 1748114 1944156 909161 2361146 1615098 1851386 1545127 
1445329 2059603 1756882 1988834 916618 2371665 1622882 1863195 1529896 
Set 04 
1434899 2048440 1749018 1978021 918701 2362516 1617459 1858732 1535292 
1438377 2048262 1744470 1942833 911878 2358913 1612792 1850454 1550482 
Set 05 
1465311 2085028 1774968 1980903 926127 2402527 1641908 1881880 1590214 
1475347 2099111 1786732 2029693 934181 2419046 1654829 1896923 1590083 
Set 06 
1463778 2083635 1773055 2015273 924492 2399024 1644853 1878416 1579421 
1451394 2070519 1763354 1999891 924202 2382441 1632471 1867673 1562675 
Mean 1451267 2066785 1761312 1978528 921049 2380482 1628509 1867315 1557169 
Std. Dev. 12539.71 16468.81 12767.70 27483.36 9724.68 19094.75 13316.66 13565.84 20885.02 
% RSD 0.86 0.80 0.72 1.39 1.06 0.80 0.82 0.73 1.34 
 
Table 6: Intermediate Precision Data  
 
The data generated in method precision study and intermediate precision study suggest % 
RSD value of peak area for each set is less than 2.0 and overall % RSD value for all six 
set is less than 2.0 which suggest that method is highly precise for determination of all 
nine components. The Chromatograms of Method Precision and Intermediate Precision 
of test preparation is given as under, 
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Figure 18: Chromatogram of Test Preparation in Method Precision study 
 
 
 
 
 
 
 
 
 
 
            Figure 19: Chromatogram of Test Preparation in Intermediate precision study 
 
 
 
Method Precision 
Venlafaxine - 1.222
Escitalopram - 1.440
Risperidone - 1.848
Fluoxetine Hcl - 2.149
Trihexyphenidyl - 2.498
Thioridazine - 2.977
Candesarten - 3.346 
Trifluoperazine - 3.624
Aripiprazole - 3.750 
AU 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
 
Int. Precision 
Venlafaxine - 1.222 
Escitalopram - 1.442
Risperidone - 1.852 
Fluoxetine Hcl - 2.149
Trihexyphenidyl - 2.503
Thioridazine - 2.979
Candesarten - 3.340 
Trifluoperazine - 3.623
Aripiprazole - 3.747
AU 
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
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4.4.5. ACCURACY STUDY    
This Experiment can be performed by the recovery test. Recovery of the method is 
evaluated at 3 different concentration levels (corresponding to 50, 100 and 150% of test 
solution concentration) by addition of known amounts of Standard to Sample preparation. 
For each concentration level, 3 sets were prepared and injected to evaluate the study. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 255. 
 
Sample preparations for accuracy levels are as under: 
 
Accuracy level 1 (50%)  
Test stock solution:  
50.0 mg of each analyte (working standard) was accurately weighed and transferred into 
200.0 ml volumetric flask. 50.0 mg each analyte (different batch) was weighed and 
transferred into the same 200 ml volumetric flask. Around 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking.  Then, the flask was cooled to room temperature and diluted to 
volume with diluent. 10 ml of this solution was filtered through 0.22 μm nylon syringe 
filter. The concentration obtained is 500 μg/ml. 5.0 ml of above test stock solution was 
pipette out and transferred into 50 ml volumetric flask followed by diluted to volume 
with diluent. The concentration obtained is 50 μg/ml of each analyte; the same procedure 
was applied for preparing the three sets. 
 
Accuracy level 2 (100 %) 
Test stock solution:  
100.0 mg of analytes (working standards) was accurately weighed and transferred into 
200 ml volumetric flask. 100.0 mg of analytes (sample; different batch) was weighed and 
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transferred into the same 200 ml volumetric flask. 140 ml of diluent added into the 
volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes with 
normal handshaking. 
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained is 1000 μg/ml of drug substances. 5.0 ml of above test stock solution was pipette 
out and transferred into 50 ml volumetric flask followed by diluted to volume with 
diluent. The concentration obtained is 100 μg/ml. The same procedure was applied for 
preparing the three sets. 
 
Accuracy level 3 (150 %) 
Test stock solution:  
150.0 mg of analytes (working standards) was accurately weighed and transferred into 
200 ml volumetric flask. 150.0 mg of analytes (sample; different batch) was weighed and 
transferred into the same 200 ml volumetric flask. 140 ml of diluent added into the 
volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes with 
normal handshaking.  
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained is 1500 μg/ml of drug substances. 5.0 ml of above test stock solution was pipette 
out and transferred into 50 ml volumetric flask followed by diluted to volume with 
diluent. The concentration obtained is 150 μg/ml. The same procedure was applied for 
preparing the three sets. 
 
 
 
 
 
 
 
 
 
Chapter – 6                                                              UPLC method for simultaneous determination of antipsychotic molecules 
Department of Chemistry, Saurashtra University, Rajkot-360005                                                                  Page 266
 
 
 
Accuracy 
Replicates 
Peak Area 
VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
level 01 50 % 
Set 01 
711092 1025970 864374 984323 444469 1163062 817016 920779 735040 
711269 1026571 864020 983954 449568 1162343 816313 919223 739695 
level 01 50 % 
Set 02 
716460 1033169 869848 990993 454581 1170056 821029 925605 747346 
715834 1031460 867253 989606 444656 1167691 818540 921178 689724 
level 01 50 % 
Set 03 
714167 1030132 868160 988376 454102 1167031 819899 922670 749468 
712888 1027843 865740 985415 453763 1163561 817271 921101 738378 
level 02 100% 
Set 01 
1457017 2074263 1747328 2003007 935360 2385498 1635947 1875402 1561298 
1451104 2067469 1740344 1998508 931202 2380143 1631680 1867997 1571638 
level 02 100% 
Set 02 
1449496 2063411 1736975 1995756 928838 2375786 1629017 1864986 1560754 
1444936 2057286 1733166 1990860 926760 2369596 1624286 1859108 1564532 
level 02 100% 
Set 03 
1462048 2080422 1760855 2010788 934570 2394074 1640342 1877960 1568616 
1468685 2090206 1766295 2024602 933667 2409188 1651330 1883983 1587489 
level 03 150% 
Set 01 
2147540 3208474 2612448 2921356 1416107 3542871 1996452 2765177 3099708 
2154441 3221207 2617188 2932226 1407874 3557201 2000741 2772712 3093319 
level 03 150% 
Set 02 
2157465 3225947 2639758 2936649 1417551 3561907 2015904 2777815 3099010 
2258874 3251991 2638198 2927059 1426520 3549914 2011846 2773513 3091855 
level 03 150% 
Set 03 
2148561 3211921 2621731 2923349 1404631 3546838 1998161 2759471 3087575 
2147462 3210610 2621769 2919560 1404962 3543743 1993170 2759252 3065652 
 
Table 7: Accuracy Data - 01 
 
Calculation formulas for recovery study are as under: 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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From the above calculation the % Recovery was calculated which is given below. 
 
 
% Recovery 
Replicates VNF ESTP RSPRD FLXT THPD TDRZ CNDST TFPRZ ARPZ 
level 01 
50% Set 
01 
100.02 98.95 100.85 100.8 102 101.9 100.89 98.45 100.23 
level 01 
50% Set 
02 
101.72 98.9 100.67 101.2 101.95 99.47 98.45 100.65 100.58 
level 01 
50% Set 
03 
99.34 100.63 99.75 101.25 102 100.35 100.45 100.25 100.1 
level 02 
100% Set 
01 
98.75 102 98.05 98.3 101.3 100.45 98.75 99.8 99.35 
level 02 
100% Set 
02 
100 98.36 100.62 99.05 10.24 99.45 99.95 101.75 100.25 
level 02 
100% Set 
03 
101.75 101.25 100.5 99.65 99.52 99.15 99.85 101.79 100.05 
level 03 
150% Set 
01 
101.36 100.36 100.85 100.23 98.75 98.02 98.96 101.23 100.56 
level 03 
150% Set 
02 
100.25 98.56 100.54 99.25 100.34 100.24 100.94 100.64 100.54 
level 03 
150% Set 
03 
99.65 99.02 100.9 101.35 101.25 101.95 99.04 98.25 100.39 
 
Table 8: Accuracy Data – 02 
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Figure 20: Chromatogram of Accuracy Level – 1 (50 %) 
 
 
 
 
 
 
 
 
 
 
Figure 21: Chromatogram of Accuracy Level – 2 (100 %) 
 
 
 
 
Accuracy Level 01 
Venlafaxine - 1.236 
Escitalopram - 1.419 
Risperidone - 1.736 
Flouxitine HCl - 2.159
Trihexyphenidyl - 2.392
Thioridazine - 2.907
Candesarten - 3.353
Trifluoperazine - 3.586 
Aripiprazole - 3.722
AU
-0.10 
0.00
0.10
0.20
0.30
0.40
0.50
Minutes
0.00  0.50  1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50  5.00
 
Accuracy Level 02 
 
Venlafaxine - 1.218 
Escitalopram - 1.409 
Risperidone - 1.748 
Flouxitine HCl - 2.141
Trihexaphenidyl - 2.401
Thioridazine - 2.914
Candesarten - 3.342 
Trifluoperazine - 3.589
Aripiprazole - 3.722 
AU
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
0.00  0.50  1.00  1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 
 
Chapter – 6                                                              UPLC method for simultaneous determination of antipsychotic molecules 
Department of Chemistry, Saurashtra University, Rajkot-360005                                                                  Page 269
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Chromatogram of Accuracy Level – 3 (150 %) 
From the all above data and chromatograms it has been confirmed that the % recovery 
was within 98 to 102 % and this is in the limit of acceptance criteria. Additionally % 
RSD value of % recovery of replicate sets is below 2 % .consequently this suggests that 
proposed method is highly accurate for all nine analyte. 
 
4.4.6. ROBUSTNESS  
 
Robustness of the method was evaluated by assaying test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in pH of 
Buffer and change in column-lot. 
 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 0.31 ml/min and 0.29 ml/min each and the results were observed in terms of Peak 
Response (Peak Area) and chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 247.  
 
Accuracy Level 03 
 
Venlafaxine - 1.206 
Escitalopram - 1.403 
Risperidone - 1.756 
Flouxitine HCl - 2.129
Trihexaphenidyl - 2.410
Thioridazine - 2.921
Candesarten - 3.341 
Trifluoperazine - 3.596 
Aripiprazole - 3.728 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
 
Chapter – 6                                                              UPLC method for simultaneous determination of antipsychotic molecules 
Department of Chemistry, Saurashtra University, Rajkot-360005                                                                  Page 270
 
 
A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Flow Rate 0.31 
ml/min 
2 Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 0.29 
ml/min 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
  
 
Table 9: Experimental UPLC sequence for the robustness study -01 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Chromatogram of Test preparation at 0.31 ml/min 
 
 
 
 
Robustness 01 
Venlafaxine - 1.244 
Escitalopram - 1.462 
Risperidone - 1.861 
Flouxitine Hcl - 2.163
Trihexyphenidyl - 2.487
Thioridazine - 2.970
Candesarten - 3.339 
Trifluoperazine - 3.602 
Aripiprazole - 3.729 
AU 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50  5.00
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Figure 24: Chromatogram of Test preparation at 0.29 ml/min 
 
The Peak Response and area value of test preparation wasn’t much influenced at 0.31 and 
0.29 ml/min. The above chromatograms suggest that the flow rate affects on the retention 
time of analyte but it did not have any impact on the response, hence the peak area value 
remain unaffected. 
 
B) Using buffer with different pH: In this experiment the test samples were analyzed 
at the mobile phase which consist of buffer 10 mM Ammonium Acetate (pH = 6.1) and 
10 mM Ammonium Acetate (pH = 6.3). The pH of 10 mM Ammonium Acetate is around 
6.2 which can change by adding 0.1 % Ammonia or 0.1 % Acetic acid solution. Blank, 
Standards and Sample solutions were prepared as per the same procedure mentioned on 
page 247. 
 
 
 
 
Robustness 02 
 
Venlafaxine - 1.320 
Escitalopram - 1.551 
Risperidone - 1.969 
Flouxitine HCl - 2.247
Trihexyphenidyl -2.607
Thioridazine - 3.082
Candesarten - 3.427 
Trifluoperazine - 3.728 
Aripiprazole - 3.857 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
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A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Using Buffer of  pH = 6.1
2 Sys Suit Standard 5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Using Buffer of  pH = 6.3
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
 
 
Table 10: Experimental UPLC sequence for the Robustness study – 02 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Chromatogram of Test preparation using buffer of pH = 6.1 
 
 
 
 
 
Robustness 03 
 
Venlafaxine - 1.275 
Escitalopram - 1.490 
Risperidone - 1.888 
Flouxitine HCl - 2.200
Trihexyphenidyl -2.523
Thioridazine - 3.008
Candesarten - 3.383 
Trifluoperazine - 3.653 
Aripiprazole - 3.782 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00  0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50  5.00
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Figure 26: Chromatogram of Test preparation using buffer of pH= 6.3 
 
The Peak Response and area value of test preparation wasn’t much influenced at pH = 6.1 
and pH = 6.3 of buffer in mobile phase but the selectivity of each component is slightly 
transform. The above chromatograms suggest that the pH affects on the chromatographic 
selectivity of drug but it did not have any impact on the response, hence the peak area 
value remain unaffected. 
 
C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of area value and 
chromatographic compatibility (System Suitability Test).  
 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 247. 
 
 
 
 
 
 
Robustness 04 
 
Venlafaxine - 1.271
Escitalopram - 1.478 
Risperidone - 1.864 
Flouxitine HCl - 2.195
Trihexyphenidyl - 2.501
Thioridazine - 2.990
Candesarten - 3.383 
Trifluoperazine - 3.643 
Aripiprazole - 3.774 
AU
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00  4.50  5.00
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A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections
Chromatographic 
condition 
1 Blank 1 
Different Column 
Lot 
2  Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
 
 
Table 11: Experimental UPLC sequence for the Robustness study – 03 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Chromatogram of Test preparation at different column lot 
 
 
The Peak Response and area value of test preparation wasn’t much changed with 
different column, in addition to this in this case the retention time was also remain. The 
above chromatograms suggest that diff. column does not affect on the retention time of 
drug and it did not have any impact on the response, hence the peak area value remain 
unaffected. 
 
 
Robustness 05 
 
Venlafaxine - 1.272 
Escitalopram - 1.477 
Risperidone - 1.861 
Flouxitine HCl - 2.198
Trihexaphenidyl - 2.502
Thioridazine - 2.990
Candesarten - 3.381 
Trifluoperazine - 3.644 
Aripiprazole - 3.773 
AU
0.00
0.20
0.40
0.60
0.80
1.00
Minutes
0.00 0.50  1.00  1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00
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Summary of Robustness Study 
Robust 
Condition 
Peak  
Response 
Retention Time 
Variation 
(min.) 
System Suitability 
Theoretical Plates Asymmetry
Flow Change 
0.31 ml/min Unaffected -  0.05 48000 ±300 1.45 ± 0.32 
Flow Change 
0.29 ml/min Unaffected + 0.06 35000 ±800 1.10 ± 0.15 
At pH 6.1 of 
buffer soln. Unaffected - 0.1 44520 ± 500 1.28 ± 0.24 
At pH 6.3 of 
buffer soln. Unaffected + 0.1 44000 ±200 1.20 ± 0.20 
Column Lot 
Change Unaffected 0.02 45000 ±500 1.13 ± 0.30 
 
Table 12: Summary of Robustness study  
Where, ± sign suggest statistics of all nine analyte peaks.  
The data and the chromatogram given above suggest that there was no considerable 
influence of the column lot change on the result of the analysis by this method or on 
chromatographic suitability of this method. Hence, it can be conclude from this 
experiment that the method is highly robust in terms of column lot change. Overall the all 
the experiment in robustness parameter succeeded in terms of acceptance criteria hence 
the proposed method is robust for above small changes in chromatographic condition. 
 
4.4.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time of 
period. 
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(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS:  
25.00 mg of each analyte (working standard) were accurately weighed and transferred 
into 25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substances were dissolved by sonication for ten minute. Then, volume of the 
flask was made up with diluent. The concentration obtained was 1000 μg/ml of all nine 
analytes. This solution was prepared on the first day of the validation and kept at the 2-
4˚C temperature in refrigerator without any disturbance until performance of the LTSSS 
experiment. After 4 day the stock solution was bring out of the refrigerator and keep it as 
such till it attains the room temp. 5 ml of this solution was pipette out in 50 ml volumetric 
flask and dilute it up to the mark to reach 100 μg/ml of all analyte. This solution was 
assigned as LTSSS Standard solution. 
Preparation of Fresh Standard Solution:  
25.00 mg of all analyte (working standard) was accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substances were dissolved by sonication for ten minute. Then, volume of the 
flask was making up with diluent. The concentration obtained was 1000 μg/ml of all 
components. Pipette out exactly 5 ml of this solution in 50 ml volumetric flask and dilute 
it up to the mark accurately to confirm the 100 μg/ml of all drug substance. This solution 
was assigned as Fresh Standard Solution. 
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The proto-type experimental sequence is given below for LTSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 LTSSS-01( 4 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 (4 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 4 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 4 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 4 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 11: Sequence for LTSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio for all nine components are within 0.95 to 1.05. This is well within the 
acceptance criteria. 
Preparation of Stock Solution for STSSS or Bench Top Solution Stability 
25.00 mg of all analytes (working standard) were accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substances were dissolved by sonication for ten minute. Then, volume of the 
flask was made up with diluent. The concentration obtained was 1000 μg/ml of all 
components. This solution was prepared before the 08 hour and kept on bench at ambient 
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temperature without any disturbance until performance of the STSSS experiment. After 
08 hour on the bench. 5 ml of this solution was pipette out in 50 ml volumetric flask and 
dilute it up to the mark to reach 200 μg/ml drug substances. This solution was assigned as 
STSSS Standard solution 
Preparation of Fresh Standard Solution:  
25.00 mg of all analyte (working standard) were accurately weighed and transferred into 
25 ml volumetric flask. 20 ml of diluent was added into the volumetric flask and the 
standard substances were dissolved by sonication for one minute. Then, volume of the 
flask was made up with diluent. The concentration obtained was 1000 μg/ml analyte. 
Pipette out exactly 5 ml of this solution in 50 ml volumetric flask and dilute it up to the 
mark accurately to confirm the 100 μg/ml of all drug substance. This solution was 
assigned as Fresh Standard Solution. The proto-type experimental sequence is given 
below for STSSS. 
Experimental Sequence 
Sr.No. Sample Name 
No. of 
Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 STSSS-01( 8.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 8.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour)  1 
8 STSSS-03 ( 8.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 8.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 8.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for STSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
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Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio for all nine components are within 0.92 to 1.08. This is well within the 
acceptance criteria. The Mean Area Ratio is within the acceptance criteria of 0.90 to 1.10, 
hence it can be concluded from this experiment that the Stock Solution is stable for the 4 
days at 2 - 4˚ C in refrigerator, while Standard solution is remain unaffected on bench at 
ambient temperature and in normal light for 8 hour. In addition to this it confirms the 
reliability of the data generated during the method validation.  
 
4.4.8. SYSTEM SUITABILITY  
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
 
Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity  40,000± 800 1.0 ± 0.1 2.0 
Linearity and Range  38,000± 800 1.05± 0.1 1.40 
LOD and LOQ    6500 ± 200 1.50 ± 0.3 1.9 
Method Precision  42,000 ± 600 1.1 ± 0.1 1.0 
Intermediate Precision 42,000 ± 300 1.1 ± 0.1 1.05 
Accuracy 40,500 ± 700 1.05 ± 0.1 0.95 
Robustness 32500 ± 300 1.2 ± 0.1 1.95 
Solution Stability 38,000 ± 100 1.15 ± 0.1 0.5 
 
Table 13: Results of System Suitability Test after each Validation Experiment 
Where, ± sign suggest statistics of all four component peaks. 
 As per guideline the Theoretical plates should be more than 5000, Asymmetry should be 
less than 2.0 and % RSD should be less than 2.0. As the data suggest the system 
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suitability was within the criteria in each validation experiment. Hence the system was 
found suitable to perform the validation experiment which confirms the reliability of the 
data generated during the method validation. 
 
5. CONCLUSION 
The observation and results obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria of ICH guideline. 
Since, all the results are with-in the limit, the developed analytical method is considered 
as validated and suitable for probable use. 
 
6. APPLICATION OF CURRENT WORK  
 
6.1. This method can be used for the simultaneously quantification of all nine most 
pertinent antipsychotics in bulk drug as well as in pharmaceutical dosage form in 
routine or as a special test. 
6.2. This method can be used for the determination of all nine analyte individually or 
in combination dosage form. 
6.3. This method has also application over the chromatographic purity of all analytes. 
6.4. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation for all molecules. 
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1. INTRODUCTION 
 
Alpha keto-analogues of valine, leucine, isoleucine, methionine, phenylalanine, and (in 
one instance) tryptophan and histidine, along with the remaining essential amino acids, 
are used to treat severe renal failure (Chronic Uremia) [1]. Mixtures of the salts are useful 
in the treatment of renal and hepatic disorders characterized by protein intolerance 
leading to deficiencies of various essential and semi-essential amino acids in the body. 
They may also be useful in the treatment of nitrogen wasting disorders and protein 
malnutrition [2]. It is also popular that the any beneficial effects of keto acids in patients 
with chronic renal failure are only likely to occur in case it is given with low protein diet 
progrmme [3]. Homeostasis of essential amino acids and their transamination derivatives 
(ketoacids) is disturbed in haemodialysis (HD) patients. In long-term HD patients a hyper 
catabolic state is often paired with severe anemia. This can overcome with 
supplementation therapy of branched-chain compounds in HD patients [4]. According to 
the hyper filtration theory of renal diseases characterized by a decrease in the number of 
functional nephrons, increased arterial blood pressure, excessive protein intake in the 
diet, high levels of calcium (Ca) and phosphorus (P), secondary hyperparathyroidism, 
hyper triglyceridemia and/or hypercholesterolemia, proteinuria and metabolic acidosis 
are some factors that impair the prognosis of the disease.  The amount of protein in the 
diet is the most important of these factors.  A protein-restricted diet administered to 
patients with chronic renal failure results in the risk of inadequate amino acid intake.  To 
overcome this problem, the use of dysaminated alpha-keto analogues has been considered 
to reduce the risk of nitrogenemia resulting from the continuous intake of essential amino 
acids [5]. Many pharmaceutical companies are marketing these analogues in combination 
dosage form for the treatment of renal failure. 
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Figure 1: Chemical Structure of Keto-analogues of Essential Amino Acids Calcium Salt 
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2. LITERATURE REVIEW 
 
The literature reviews regarding the alpha keto amino acid calcium salt suggests that few 
analytical methods are reported for quantification in various biological fluids like blood, 
plasma and serum. The literature review for analysis of alpha ketoacids is as under, 
 
2.1. Kandar R, Zakova P, Jirosova J, Sladka M have worked on determination of 
branched chain amino acids, methionine, phenylalanine, tyrosine and alpha-keto acids in 
plasma and dried blood samples using HPLC with fluorescence detection [6]. Prior to 
separation, the amino acids (AA) were derivetised with o-phthaldialdehyde (OPA) and 
Reverse phase column chromatography (LiChroCart 125x4 Purospher RP-18e, 5µ) was 
used for separation and fluorescence detection used to monitoring of effluent. For Amino 
Acid analysis, 25 mM sodium hydrogen phosphate-methanol (90:10, v/v), pH 6.5 +/-0.1 
was used as mobile phase A and 100% methanol was used as mobile phase B. 
 
2.2 Qureshi G. Ali has developed a High - performance   liquid   chromatographic   
methods with fluorescence detection for the determination of branched-chain amino   
acids and their alpha - keto analogs in plasma samples of healthy subjects and uremic 
patients [7]. Amino acids and their keto analogs were derivetised with o-phthalaldehyde, 
2-mercaptoethanol, and o-phenylene diamine sulfate prior to HPLC. Separations were 
performed on a reversed-phase column, using a multi-step gradient system with 2 
solvents and a fluorescence detector. 
 
2.3 Nissen Steven L, Van Huysen Carol, Haymond Morey W has published a 
conference paper with the title Quantitation of branched-chain amino and alpha keto 
acids by HPLC [8]. The keto acids and amino acids were isolated from blood plasma by 
cation-exchange chromatography and amino acids were deaminated with amino acid 
oxidase and subsequently chromatographed as their respective alpha keto acids.  A C-18 
silica column and UV detector (214 nm) were used for HPLC, and the mobile phase was 
0.005 M sodium phosphate (pH 7.0) - Acetonitrile (90:10). 
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2.4. M. Fuchs, J. Engel, M. Campos et al have determined the Intracellular alpha-keto 
acid quantification by fluorescence-HPLC [9]. They give the Procedures for the analysis 
of free α-keto acids in human fluids (i.e. plasma, cerebrospinal fluid, urine, etc.) as well 
as for studying the dynamic free α-keto acid pools in differentiated tissues and organ cells 
have been the subject of growing clinical interest in the study of metabolic regulatory and 
pathophysiological phenomena. 
 
 
3. AIM OF THE PRESENT WORK 
 
On the basis of literature survey, it can be concluded  that there are no Ultra Performance 
Liquid Chromatographic methods for the quantification of Keto-analogues of Essential 
Amino Acids Calcium Salt, since the methods are available that deals with the 
bioanalytical study of analytes and some methods deals for intracellular assay. In addition 
the analytes are now widely used for the treatment of the severe renal failure like chronic 
uremia; there should be necessity to having a method for quantification of these analytes 
in bulk drug as well as in pharmaceutical dosage form. Furthermore the present method 
has the advantage over the speed as well as the selectivity and it can be maximum utilize 
for the analysis and it could be also functional of quality control laboratory for routine 
use. The aim and scope of the proposed work are as under. 
 
3.1. To develop analytical method for quantification of the drug substance simultaneously 
using the latest technology in liquid chromatography. 
3.2. To optimized the method at a maximum level to gain high throughput screening. 
3.3. Elaborate the technology suggesting the various applications.   
3.4. To perform analytical method validation for the proposed method as per ICH 
guideline [10]. 
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4. EXPERIMENTAL 
4.1. MATERIALS, CHEMICALS AND REAGENTS 
Beta Pharma. Co.Ltd. (Shanghai, China) provided the mentioned alpha keto acid calcium 
salts working standard and samples. Potassium Di-Hydrogen Ortho Phosphate for HPLC, 
Ortho Phosphoric acid (HPLC grade), HPLC grade Acetonitrile has purchased from 
Spectrochem Pvt Ltd. HPLC grade water used was purified by Milli-Q Elix-3 water 
purification system. 
4.2. INSTRUMENTATION  
The Waters AcquityTM UPLC chromatographic system used to perform development and 
validation. This system consist of a binary solvent manager (pump), photodiode array 
detector, sample manager(Auto sampler) and column oven connected to a multi-
instrument data acquisition and processing system Empower 2.1 version. Sartorius 
microbalance and Equiptronics branded balance and heating oven was used for the 
weighing and heating purpose while Spinco ultrasonic bath used for degassing purpose. 
4.3. METHOD DEVELOPMENT 
Analytical Method development is consist of following steps which can be shore up by 
the literature survey, previous experience and chemical nature of the reagents used in the 
development. 
4.3.1. MOBILE PHASE SELECTION  
On the basis of literature survey, several exploratory runs have been performed but 
initially proper selectivity and resolution between the drug molecules was not achieved. 
After furnishing more importance to the literature it was concluded that the 
chromatography of these molecules are highly dependent on the pH of the mobile phase, 
best chromatography compatibility, resolution and selectivity between the four molecule 
are achieved using 5 mM Potassium di hydrogen ortho phosphate (pH=3.0). Above all 5 
mM Potassium di hydrogen ortho phosphate (pH=3.0) and acetonitrile (HPLC grade) as 
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an organic component was used in gradient programming with respect to time and 
composition of mobile phase. 
4.3.2. COLUMN SELECTION 
Column selection is the most important part in the method development. In this case most 
suitable column chemistry was BEH (Bridge Ethane Hybrid) silica bonded with 
C8.Among the column chemistry available with us the Acquity BEH C8 (100 mm x 2.1 
mm id, 1.7μ particle size) gives the best consequences. 
4.3.3. DETECTION WAVELENGTH SELECTION  
we have screened the standard solution over 190 nm to 400 nm using the advantage of 
photo diode array detector. On the basis of peak absorption maxima and peak purity 
index the 215 nm was decided as the detection wavelength which also gives the 
maximum chromatographic compatibility to the method. The absorption is shown in the 
figure 2 for all four Alpha keto acid calcium salts at each wavelength.  
 
1.298 Alpha Keto Valine Ca SAlt
2.244 Alpha Keto Isoleucine Ca Salt
2.562 Alpha Keto Leucine Ca Salt
3.285 Alpha Keto Ph Alanine Ca Salt
211.5
323.2
211.5
316.4315.2
AU
0.00
0.20
0.40
0.60
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
 
Figure 2: UV absorption of Alpha keto acid calcium salts 
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4.3.4. BUFFER SOLUTION PREPARATION 
5 mM Potassium di hydrogen ortho phosphate was prepared by dissolving 0.34 gm of 
Potassium di hydrogen ortho phosphate for HPLC in 1000 ml of HPLC grade water, the 
pH of the buffer solution was adjusted to 3.0 using 0.1% ortho phosphoric acid (HPLC 
grade) which further Sonicate for 20 minutes to remove of all dissolve gas and filtered 
through 0.45µn mobile phase filter.  
4.3.5. DILUENT PREPARATION 
Sample diluent was prepared by mixing acetonitrile and buffer (5 mM Potassium di 
hydrogen ortho phosphate, pH = 3.0) in 05:95 ratio, which was further sonicate to 
confirm uniformity and removal of all dissolve gas. 
4.3.6. STANDARD SOLUTION PREPARATION 
Alpha keto acid calcium salts (working standard) solution containing 200 μg/ml was 
prepared in a 100 ml volumetric flask by dissolving exact 20.0 mg each in 25 ml of 
diluent and then it was made up to volume with the same diluent. 
4.3.6. SAMPLE SOLUTION PREPARATION 
Alpha keto acid calcium salts (Samples, Different Batch) solution containing 200 μg/ml 
was prepared in a 100 ml volumetric flask by dissolving exact 20.0 mg each in 25 ml of 
diluent and then it was made up to volume with the same diluent. 
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8.007.006.005.004.003.002.00
Minutes
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1.00 0.00
0.60
0.50
0.40
0.20
0.10
0.00
AU0.30
AKVCa - 1.298 
AKILCa - 2.244
AKLCa - 2.561
AKPACa - 3.285
 
Figure 3: Chromatograms of Working Standard solution. 
 
 
8.007.006.005.004.003.002.00
Minutes
 
Sample 
 
1.00 0.00
0.60
AKVCa - 1.295 
AKILCa - 2.242
AKLCa - 2.559 AKPACa - 3.280
AU
0.50
0.40
0.30
0.20
0.10
0.00
 
Figure 4: Chromatograms of Sample solution. 
 
In conclusion to Method development following chromatographic clauses suits the most 
and decided as a final method for validation experiments. 
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Mobile Phase A  : 5 mM Pott. Di hydrogen ortho phosphate (pH=3.0) 
Mobile Phase B  : Acetonitrile (HPLC grade) 
Column   :  Acquity BEH C8 (100 x 2.1 mm , 1.7μn)  
Flow Rate  : 0.4 ml/min 
       Gradient elution               : As per Table 01 
Detection   : 215 nm UV 
Diluent               : Buffer: Acetonitrile (95:05) 
Injection Volume : 05 µl 
 
 
 
Time Flow Rate % of Buffer % of Organic Curve 
0.0 0.4 95 05 Initial 
7.0 0.4 75 25 6 
7.1 0.4 95 05 6 
8.0 0.4 95 95 6 
 
 
 
 
 
 
 
Table 1: Gradient Programming of proposed method 
 
 
4.4. METHOD VALIDATION 
 
Method for the determination of valproic acid and its related impurities in bulk drug is 
further validated as per ICH Q2 (R1) guideline [10]. Validation of analytical method was 
performed using Valproic acid working standard and sample batch drug substance. 
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4.4.1. SPECIFICITY  
 
The evaluation of the specificity of the method was determined against diluent 
application and each of the drug substance. The interference of the diluent and each 
molecule was derived by injecting diluent solution and individual drug substance. The 
retention time of each was taken in to consideration. Further the specificity of the method 
toward the drug was established by means of the interference of diluent at the retention 
time of the drug peak. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
AKILCa (Alpha-Keto Isoleucine calcium salt) solution preparation: 
Weight exact 20.0 mg of Alpha-Keto Isoleucine calcium in 100 ml volumetric flask 
dissolve it in 50 ml of diluent followed by make up to the mark with diluent. Apply 
sonication to it in ultrasonic bath for 10 min and filter the solution with 0.20 µn 
membrane filter. 
 
AKLCa (Alpha-Keto Leucine calcium salt) solution preparation: 
Weight exact 20.0 mg of Alpha-Keto Leucine calcium (Working Standard) in 100 ml 
volumetric flask dissolve it in 50 ml of diluent followed by make up to the mark with 
diluent. Apply sonication to it in ultrasonic bath for 10 min and filter the solution with 20 
µn membrane filter. 
 
AKVCa (Alpha-Keto Valine calcium salt) solution preparation: 
Weight exact 20.0 mg of Alpha-Keto Valine calcium (Working Standard) in 100 ml 
volumetric flask dissolve it in 50 ml of diluent followed by make up to the mark with 
diluent. Apply sonication to it in ultrasonic bath for 10 min and filter the solution with 20 
µn membrane filter. 
 
 
Department of Chemistry, Saurashtra University, Rajkot-360005.                                                                   Page 296 
 
 
Chapter – 7                                                    UPLC Method for some Keto-analogues of Essential Amino Acids Calcium Salt  
AKPACa (Alpha-Keto Phenyl alnine calcium salt) solution preparation: 
Weight exact 20.0 mg of Alpha-Keto Phenyl alnine calcium salt in 100 ml volumetric 
flask dissolve it in 50 ml of diluent followed by make up to the mark with diluent. Apply 
sonication to it in ultrasonic bath for 10 min and filter the solution with 20 µn membrane 
filter. 
 
Blank 
Specificity 
8.007.006.005.004.003.002.001.000.00
Minutes
0.005 
0.004 
0.003 
-0.001
AU
0.002 
0.000 
0.001 
   
Figure 5: Chromatogram of Diluent in Specificity Experiment. 
 
8.007.006.005.004.003.002.00
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Specificity 
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0.10
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AU 
0.20
0.30
0.40
AKILCa - 2.231
 
    Figure 6: Chromatogram of AKILCa in Specificity Experiment. 
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8.007.006.005.004.003.002.001.000.00
Minutes
0.25
0.20
0.10
0.05
0.00
AU 0.15
 
Specificity 
 
AKLCa - 2.563
 
Figure 7: Chromatogram of AKILCa in Specificity Experiment. 
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Figure 8: Chromatogram of AKVCa in Specificity Experiment. 
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8.007.006.005.004.003.002.00
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Figure 9: Chromatogram of AKPACa in Specificity Experiment. 
 
0.00
0.10
0.20
0.30
0.40
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0.60
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Minutes
300.00
 
Figure 10: Chromatogram of 3D – view of Standard preparation 
 
From the specificity experiment and subsequently achieved above chromatograms it was 
proven that any interference was not observed from blank or individual drug substance to 
the peak of other (Drug Substance), in addition to this peak purity was also within the 
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acceptance criteria confirmed by the photo diode detector. The chromatogram (3D View) 
of standard solution is shown in Figure 10. Hence it confirms that the proposed method is 
highly specific with respect to the diluent and each drug molecule to the other. 
 
4.4.2. LINEARITY & RANGE  
 
The linearity curve was prepared with 8 concentration levels (50, 100, 150, 200, 250, 
300, 350 and 400 μg/ml of each of drug molecule). These concentration levels were 
respectively corresponding to 25, 50, 75, 100, 125, 150, 175 and 200 % of standard 
solution concentration.  The  peak areas vs. concentration data were evaluated by linear 
regression analysis. 
Stock Solution Preparation:  
Weight accurately 50 mg of each of drug molecule (working standard), transfer it into 
100 ml volumetric flask and dilute it up to the mark with diluent. Apply sonication for 
minimum 30 min to confirm the uniform mixture, which contains the 500 µg/ml of each 
analyte. 
 
Linearity Standard Solution Preparation: 
From Standard Stock Solution of accurate 500 µg/ml pipette out exactly 1.0, 2.0, 3.0, 4.0, 
5.0, 6.0, 7.0 and 8.0 ml and dilute it up to 10 ml each with diluent to achieve 50-400 
µg/ml concentration of analytes. 
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Linearity & Range 
Calibration 
Point 
Concentration 
(µg/ml) 
Peak Area 
AKVCa AKILCa AKLCa AKPACa 
STD 1 400 2346389 2318983 2442399 10165797 
STD 2 350 2068556 2043083 2122399 8955799 
STD 3 300 1744755 1727703 1791079 7570654 
STD 4 250 1443780 1432076 1483718 6261227 
STD 5 200 1166267 1155753 1199345 5035302 
STD 6 150 888223 869198 909385 3822576 
STD 7 100 580738 569577 597809 2471802 
STD 8 50 288127 280993 293220 1172463 
 
Table 2: Linearity and Range - Concentration Vs Peak area response data 
 
Where, AKVCa = Alpha-Keto Valine calcium salt, AKILCa = Alpha-Keto Isoleucine 
calcium salt, AKLCa = Alpha-Keto Leucine calcium salt, AKPACa = Alpha-Keto 
Phenyl alnine calcium salt. 
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Chart 1: Regression Analysis chart of linearity Study 
 
Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = Alpha Keto 
Valine Ca Series 2 = Alpha Keto Iso Leucine Ca, Series 3 = Alpha Keto Leucine Ca, 
Series 4 = Alpha Keto Phenyl Alanine Ca 
Above data and the chart suggest that correlation coefficient of all four analyte R2 = 0.999 
with linear regression equation y = 5879.x – 7040, y = 6094.x – 16330, y = 5829.x - 
12042 and y = 25677x – 95377 for Alpha Keto Valine Ca, Alpha Keto Iso Leucine Ca, 
Alpha Keto Leucine Ca and Alpha Keto Phenyl Alanine Ca respectively. Thus in 
conclusion the method counts to be highly linear for all four drug substance in terms of 
concentration and response. 
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4.4.3. LIMIT OF DETECTION AND LIMIT OF QUANTITATION  
 
LOD is the lowest amount of the drug content which can be detected by the proposed 
method while LOQ is the lowest amount which can be quantified by the method. The 
guideline suggest minimum signal to noise ratio (S/N) should be more than 3.3 for LOD 
and more than 10 for LOQ. On the basis of linearity data theoretically it can be also 
calculated by the given formula, 
LOD = 3.3 σ/S LOQ = 10 σ/S 
Where σ = Residual Standard Deviation of regression line and S = Slope of regression 
line. 
 
LOD Solution Preparation: 
Standard Stock Solution prepared as per procedure given on page 300. From the stock 
solution of 500 µg/ml pipette out exact 1 ml to 100 ml volumetric flask followed by 
dilution up to the mark with diluent, assign this solution as Solution – A. 
Form the Solution - A pipette out exact 1.0 ml to the 50 ml volumetric flask followed by 
dilution up to the mark with diluent to reach 0.1 µg/ml concentrations of each. 
LOQ Solution Preparation: 
Form the Solution - A pipette out exact 10.0 ml to the 50.0 ml volumetric flask followed 
by dilution up to the mark with diluent to achieve 1.0 µg/ml concentrations. Six replicate 
injections were made to prove the precision of the LOQ level. 
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LOQ 
Replicates  
Peak Area 
AKVCa AKILCa AKLCa AKPACa 
INJ 01 4019.0 12272.0 11171.0 14305.0 
INJ 02 4021.0 12595.0 11190.0 15288.0 
INJ 03 4091.0 13125.0 11554.0 14127.0 
INJ 04 3954.0 12358.0 10632.0 15346.0 
INJ 05 3982.0 13405.0 11276.0 15367.0 
INJ 06 3886.0 12401.0 11386.0 15134.0 
Mean 3992.2 12692.7 11201.5 14927.8 
Std dev 69.5 464.3 312.8 560.2 
% RSD 1.7 3.7 2.8 3.8 
 
Table 3: Limit of Quantification – Summary of Replicate Injections 
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Figure 11: Chromatogram of Limit of Quantification 
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Figure 12: Chromatogram of Limit of Detection 
LOQ of the analytical method can evaluated by establish linearity up to LOQ value. For 
that linearity study is extended up to LOQ value, 
 
  
 
   
 
 
 
 
 
 
 
 
Minutes
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0.006 
 
LOD 
 
AU
0.000 
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Chart 2: Regression Analysis chart of linearity Study included with LOQ level 
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Where, X axis = Concentration (µg/ml), Y axis = Peak Area and Series 1 = Alpha Keto 
Valine Ca Series 2 = Alpha Keto Iso Leucine Ca, Series 3 = Alpha Keto Leucine Ca, 
Series 4 = Alpha Keto Phenyl Alanine Ca 
All the results of LOD and LOQ data were within the acceptance criteria, hence it can be 
conclude that the LOD and LOQ of the method was 0.1 µg/ml and 1.0 µg/ml respectively 
which correspond to 0.05% and 0.5% of working concentration. The signal to noise ratio 
for the LOD was well within the acceptance criteria it means more than 3.3 and for the 
LOQ it was more than 10.0. Furthermore the % RSD of the six replicate injection of LOQ 
preparation less than 5.0 and the data of linearity extension chart up to LOQ level also 
suggest that all the analytes can be quantified up to 1.0 µg/ml well precisely and 
accurately.  
 
4.4.4. PRECISION  
 
Precision study was established by evaluating method precision and intermediate 
precision study. Method precision of the analytical method was determined by analyzing 
six sets of sample solution preparation. Mean, Standard deviation and % relative standard 
deviation for the same was calculated. Intermediate precision of the analytical method 
was determined by performing method precision on another day by another analyst using 
different make of raw materials under same experimental condition. Assay of all six 
replicate sample preparations was determined and mean, standard deviation and % 
relative standard deviation also calculated. 
 
Standard Solution Preparation: 
 
Standard Stock Solution prepared as per procedure on page 300 of 500 µg/ml. Pipette out 
exact 4.0 ml from this solution and dilute up to 10 ml to accomplish 200 µg/ml 
concentration.  
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Sample Solution Preparation: 
Weight accurately 100 mg Alpha Keto Valine Ca, Alpha Keto Iso Leucine Ca, Alpha 
Keto Leucine Ca and Alpha Keto Phenyl Alanine Ca samples, transfer each into 100 ml 
volumetric flask and dilute it up to the mark with diluent. Apply sonication for minimum 
30 min to confirm the uniform mixture. 
 
2.0 ml of above test stock solution was pipette out and transferred into 10 ml volumetric 
flask followed by diluted to volume with diluent. The concentration obtained was about 
200 μg/ml of each analyte. This solution is assign as Test Preparation Set – 01. 
The same procedure was used for preparing the six Test preparation Sets. Same approach 
was applied for the intermediate precision study on the second day with different analyst 
and different make of raw materials. 
 
 
Method Precision 
Replicates 
Peak Area 
AKVCa AKILCa AKLCa AKPACa 
Set 01 1146043 1138089 1172906 4972067 
Set 02 1146628 1138248 1173567 4963305 
Set 03 1144835 1135699 1171772 4968935 
Set 04 1145261 1135826 1171685 4971061 
Set 05 1135378 1127280 1160871 4928941 
Set 06 1143929 1135171 1168277 4948945 
Mean 1143679 1135052 1169846 4958876 
Std Dev. 4173.57 4021.78 4760.53 16958.80 
% RSD 0.36 0.35 0.41 0.34 
 
 
Table 4: Method Precision Data  
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Intermediate Precision 
Replicates 
Peak Area 
AKVCa AKILCa AKLCa AKPACa 
Set 01 1154477 1142143 1189608 4976333 
Set 02 1176889 1159736 1206577 5045024 
Set 03 1160183 1148087 1192839 5025204 
Set 04 1158243 1147512 1192297 4999032 
Set 05 1158427 1148724 1193548 5002863 
Set 06 1155092 1142672 1187134 4962535 
Mean 1160552 1148146 1193667 5001832 
Std Dev. 8289.73 6341.42 6758.70 30381.43 
% RSD 0.71 0.55 0.57 0.61 
 
Table 5: Intermediate Precision Data 
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Figure 13: Chromatogram of Test Preparation in Method Precision study 
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         Figure 14: Chromatogram of Test Preparation in Intermediate Precision study 
The data for the method precision study and intermediate precision study suggest %RSD 
value of peak area for each set is less than 2.0 and overall %RSD value for all six set is 
less than 2.0 which suggest that method is precise. 
 
4.4.5. ACCURACY   
This Experiment can be performed by the recovery test. Recovery of the method is 
evaluated at 3 different concentration levels (corresponding to 50, 100 and 150% of test 
solution concentration) by addition of known amounts of standard to Sample preparation. 
For each concentration level, 3 sets were prepared and injected in duplicate. 
 
Blank preparation: 
Diluent was used as blank solution. 
 
Standard preparation: 
Stock solution and standard solution has been prepared as per procedure on page 300. 
Sample preparations for accuracy levels are as under: 
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Accuracy level 1 (50%)  
Test stock solution:  
50.0 mg of each analyte (working standard) was accurately weighed and transferred into 
200 ml volumetric flask. 50.0 mg each analyte (sample, different batch) was weighed and 
transferred into the same 200 ml volumetric flask. Around 140 ml of diluent added into 
the volumetric flask. The volumetric flask was proceeding for sonication of 30 minutes 
with normal handshaking.  
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained was 500 μg/ml of each drug substance. 5.0 ml of above test stock solution was 
pipette out and transferred into 25 ml volumetric flask followed by diluted to volume 
with diluent. The concentration obtained is 100 μg/ml of each molecule. The same 
procedure was applied for preparing the three sets. 
 
Accuracy level 2 (100 %) 
Test stock solution:  
100.0 mg of each analyte (working standard) was accurately weighed and transferred into 
200 ml volumetric flask.100.0 mg each analyte (sample, different batch) was weighed 
and transferred into the same 200 ml volumetric flask. Around 140 ml of diluent added 
into the volumetric flask. The volumetric flask was proceeding for sonication of 30 
minutes with normal handshaking.  
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained was 1000 μg/ml of each drug substance. 5.0 ml of above test stock solution was 
pipette out and transferred into 25 ml volumetric flask followed by diluted to volume 
with diluent. The concentration obtained is 200 μg/ml of each molecule. The same 
procedure was applied for preparing the three sets. 
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Accuracy level 3 (150 %) 
Test stock solution:  
150.0 mg of each analyte (working standard) was accurately weighed and transferred into 
200 ml volumetric flask.150.0 mg each analyte (sample, different batch) was weighed 
and transferred into the same 200 ml volumetric flask. Around 140 ml of diluent added 
into the volumetric flask. The volumetric flask was proceeding for sonication of 30 
minutes with normal handshaking.  
Then, the flask was cooled to room temperature and diluted to volume with diluent. 10 ml 
of this solution was filtered through 0.22 μm nylon syringe filter. The concentration 
obtained was 1500 μg/ml of each drug substance. 5.0 ml of above test stock solution was 
pipette out and transferred into 25 ml volumetric flask followed by diluted to volume 
with diluent. The concentration obtained is 300 μg/ml of each molecule. The same 
procedure was applied for preparing the three sets. 
 
Calculation formulas for recovery study are as under: 
 
 
 
Where, Volume = Dilution given for preparing the solution. 
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Accuracy 
Replicates 
AKVCa AKILCa AKLCa AKPACa 
Area % RSD Area % RSD Area % RSD Area % RSD 
Level 01 50 % 
Set 01 568812 
0.51 
556780 
0.09 
582827 
0.45 
2416920 
0.52 Level 01 50 % 
Set 02 570707 557643 582584 2442173 
Level 01 50 % 
Set 03 574544 556688 580654 2428602 
Level 02 50 % 
Set 01 1150150 
0.18 
1141292
0.17 
1173801 
0.22 
4968751 
0.29 Level 02 50 % 
Set 02 1151807 1143028 1175857 4990187 
Level 02 50 % 
Set 03 1147714 1139144 1170586 4961612 
Level 03 50 % 
Set 01 1768954 
0.33 
1753653
0.25 
1801904 
0.24 
7678397 
0.28 Level 03 50 % Set 02 1758097 1748069 1795293 7638898 
Level 03 50 % 
Set 03 1760014 1745384 1793594 7643357 
 
Table 6: Accuracy Data- 01 
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% Recovery 
Replicates AKVCa AKILCa AKLCa AKPACa 
Level 01 50 % Set 01 100.25 100.98 101.36 100.24 
Level 01 50 % Set 02 99.23 99.23 99.6 101.25 
Level 01 50 % Set 03 98.15 98.35 100.12 100.58 
Level 02 50 % Set 01 100.25 98.43 100.42 100.78 
Level 02 50 % Set 02 101.45 100.25 101.95 98.15 
Level 02 50 % Set 03 102.0 101.46 98.9 102.0 
Level 03 50 % Set 01 101.45 100.78 99.36 100.3 
Level 03 50 % Set 02 101.85 101.28 100.58 98.87 
Level 03 50 % Set 03 100.5 99.3 99.98 99.58 
 
Table 7: Accuracy Data- 02 
 
8.007.006.005.004.003.002.001.000.00
Minutes
0.30
0.25
0.20
0.10
0.05
0.00
AU 
0.15
 
Accuracy Level 01 50% 
AKPACa -3.323
AKLCa - 2.581
AKILCa - 2.265 
AKVCa- 1.305 
 
   Figure 15: Chromatogram of Accuracy level -1 (50 %) 
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8.007.006.005.004.003.002.001.000.00
Minutes
0.60
0.50
0.40
0.20
0.10
0.00
AU
0.30
 
Accuracy Level 01 100% 
 
AKPACa -3.272
AKLCa - 2.557AKILCa - 2.241
AKVCa - 1.297 
 
Figure 16: Chromatogram of Accuracy level -2 (100 %) 
 
8.006.00 7.005.004.003.002.001.000.00
Minutes
0.80
0.60
0.40
0.20
0.00
AU 
 
Accuracy Level 01 150% 
 
AKPACa -3.230
AKLCa - 2.540
AKILCa - 2.225
AKVCa - 1.298 
 
Figure 17: Chromatogram of Accuracy level -3 (150 %) 
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From the all above data and chromatograms it has been confirmed that the % recovery is 
within 98 to 102 % and this is in the limit of acceptance criteria. Additionally % RSD 
value of % recovery of replicate sets is below 2 % .consequently this suggests that 
proposed method is highly accurate. 
 
4.4.6. ROBUSTNESS  
 
Robustness of the method was evaluated by assaying test solutions under slight but 
deliberate changes in analytical conditions, such as change in flow rate, change in pH of 
Buffer solution and change in column-lot. 
 
A) Flow Rate change: In this experiment the test samples were analyzed at the flow 
rate of 0.425 ml/min and 0.375 ml/min each and the results were observed in terms of 
Peak Response (Peak Area) and chromatographic compatibility (System Suitability Test). 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 293. A proto type chromatographic sequence of the robustness study 
is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Flow Rate 0.425 
ml/min 
2 Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Flow Rate 0.375 
ml/min 
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
  
Table 8: Experimental UPLC sequence for the robustness study -01 
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8.007.006.005.002.00 3.00 4.001.000.00 
Minutes
0.60
0.50
0.40
0.20
0.10
0.00
AU 0.30
 
Robustness 01 AKPA - 3.112
AKLCa - 2.421
AKILCa - 2.123
AKVCa - 1.226 
 
Figure 17: Chromatogram of Robustness study at 0.425 ml/min flow rate 
 
8.007.006.00
 
Robustness 02 
 
AKVCa- 1.369 
AKILCa- 2.341 AKLCa- 2.655
AKPACa - 3.334
AU
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
Minutes
5.004.003.002.001.000.00 
 
Figure 18: Chromatogram of Robustness study at 0.375 ml/min flow rate 
The Peak Response and area value of test preparation wasn’t much influenced at 0.425 
and 0.375 ml/min. The above chromatograms suggest that the flow rate affects on the 
retention time of drug but it did not have any impact on the response, hence the peak area 
value remain unaffected. 
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B) Using buffer with different pH: In this experiment the test samples were analyzed 
at the mobile phase which consist of buffer 5 mM Potassium di hydrogen ortho phosphate 
(pH = 3.1) and 5 mM Potassium  di hydrogen ortho phosphate (pH = 2.9). The results 
were observed in terms of Peak Response (Peak Area) and chromatographic compatibility 
(System Suitability Test).  
 
Blank, Standards and Sample solutions were prepared as per the same procedure 
mentioned on page 293.  
 
A proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr. 
No. Sample Name 
No. of 
Injections
Chromatographic 
condition 
1 Blank 1 
Using Buffer of  pH = 3.1
2 Sys Suit Standard 5 
3 Test Preparation 2 
4 Bracketing Standard 1 
5 Blank 1 
Using Buffer of  pH = 2.9
6 Sys Suit Standard 5 
7 Test Preparation 2 
8 Bracketing Standard 1 
 
 
Table 9: Experimental UPLC sequence for the Robustness study – 02 
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8.007.006.005.004.003.002.001.000.00
Minutes
0.60
0.50
0.10
0.00
 
Robustness 03 
 
AU
0.20
0.30
0.40
AKLCa - 2.554
AKILCa - 2.239
AKPA- 3.281
AKVCa - 1.301
 
Figure19: Chromatogram of Test preparation using buffer of pH = 3.1  
 
 
8.007.006.005.004.003.002.001.000.00
Minutes
0.70
0.60
0.50
0.30
 
Robustness 04 
 
0.10
0.20
0.00
AU 
0.40
AKLCa- 2.521
AKILCa- 2.218
AKPACa - 3.192
AKVCa- 1.293
 
Figure 20: Chromatogram of Test preparation using buffer of pH = 2.9  
The Peak Response and area value of test preparation wasn’t much influenced at pH = 3.1 
and pH = 2.9 of buffer in mobile phase but the selectivity of each component is slightly 
transform. The above chromatograms suggest that the pH affects on the chromatographic 
selectivity of drug but it did not have any impact on the response, hence the peak area 
value remain unaffected. 
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C) Column Lot Change: In this experiment the test samples were analyzed using 
different column lot and the results were observed in terms of area value (Peak Response) 
and chromatographic compatibility (System Suitability Test). Blank, Standards and 
Sample solutions were prepared as per the same procedure mentioned on page 293. A 
proto type chromatographic sequence of the robustness study is as under, 
 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
Chromatographic 
condition 
1 Blank 1 
Different Column 
Lot 
2  Sys Suit Standard  5 
3 Test Preparation 2 
4 Bracketing Standard 1 
 
Table 9: Experimental UPLC sequence for the robustness study – 03 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
8.007.006.005.004.003.002.001.000.00
Minutes
0.60
0.50
0.40
 
Robustness 05 
 
AKVCa - 1.301  AKILCa - 2.228
AKLCa- 2.533
AKPA - 3.218
AU 
0.30
0.20
0.10
0.00
Figure 21: Chromatogram of Test preparation at different column lot 
 
 
The Peak Response and area value of test preparation wasn’t much changed with 
different column, in addition to this in this case the retention time was also remain same. 
The data and the chromatogram given above suggest that there is no considerable 
influence of the column lot change on the result of the analysis by this method or on 
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chromatographic suitability of this method. Hence, it can be conclude from this 
experiment that the method is highly robust in terms of column lot change. 
 
Summary of Robustness Study 
Robust 
Condition Peak  Response
Retention Time 
Variation (min.)
System Suitability 
Theoretical 
Plates Asymmetry 
Flow Change 
0.425 ml/min Unaffected -  0.1 50000 ±500 1.3 ± 0.2 
Flow Change 
0.375 ml/min Unaffected + 0.08 45000 ±500 1.4 ± 0.15 
At pH 3.1 of 
buffer soln. Unaffected - 0.05 48520 ± 500 1.15 ± 0.10 
At pH 2.9 of 
buffer soln. Unaffected + 0.04 46000 ±200 1.20 ± 0.4 
Column Lot 
Change Unaffected 0.05 46000 ±100 1.15 ± 0.1 
 
Table 10: Summary of robustness study  
Where, ± sign suggest statistics of all four analyte peaks.  
Overall the all the experiment in robustness parameter succeeded in terms of acceptance 
criteria hence the proposed method is robust for above small changes in chromatographic 
condition. 
 
4.4.7. SOLUTION STABILITY 
Solution stability has the significant role in terms of the acceptability of the data 
generated during the method validation. Hence this study has to plan before starting the 
method validation and sometimes it is included in Pre Method Validation. On the basis 
of results achieved in PMV the solution stability can be planned and established in 
Method Validation. The Solution Stability can be established at two different time of 
period, 
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(A) Long Term Stock Solution Stability (LTSSS). 
(B) Short Term Standard Solution Stability (STSSS) or Bench Top Solution Stability. 
LTSSS is established by comparing the response of the standard solution prepared from 
the kept stock solution at 2-4˚C for long time (in days) and fresh stock solution. While 
the STSSS is or bench top solution stability is established by comparing the response the 
standard solution kept on the bench for the short time (in hours) and freshly prepared 
standard solution. 
Preparation of Stock Solution for LTSSS:  
50.00 mg of each alpha keto acid (working standard) were accurately weighed and 
transferred into 100 ml volumetric flask. 50 ml of diluent was added into the volumetric 
flask and the standard substances were dissolved by sonication for ten minute. Then, 
volume of the flask was making up with diluent. The concentration obtained was 500 
μg/ml. This solution was prepared on the first day of the validation and kept at the 2-4˚C 
temperature in refrigerator without any disturbance until performance of the LTSSS 
experiment. After 4 day the stock solution was bring out of the refrigerator and keep it as 
such till it attains the room temp. 10 ml of this solution was pipette out in 25 ml 
volumetric flask and dilute it up to the mark to reach 200 μg/ml of analytes. This solution 
was assigned as LTSSS Standard solution. 
 
Preparation of Fresh Standard Solution:  
50.00 mg of each alpha keto acid working standard was accurately weighed and 
transferred into 100 ml volumetric flask. 50 ml of diluent was added into the volumetric 
flask and the standard substances were dissolved by sonication for ten minute. Then, 
volume of the flask was making up with diluent. The concentration obtained was 500 
μg/ml of all components. Pipette out exactly 10 ml of this solution in 25 ml volumetric 
flask and dilute it up to the mark accurately to confirm the 200 μg/ml of drug substance 
and impurities. This solution was assigned as Fresh Standard Solution. 
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Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 LTSSS-01( 04 day) 1 
4 Fresh Standard-01( 0 day) 1 
6 LTSSS-02 ( 04 day) 1 
7 Fresh Standard-02 ( 0 day) 1 
8 LTSSS-03 ( 04 day) 1 
9 Fresh Standard-03 ( 0 day) 1 
10 LTSSS-04 ( 04 day) 1 
11 Fresh Standard-04 ( 0 day) 1 
12 LTSSS-05 ( 04 day) 1 
13 Fresh Standard-05 ( 0 day) 1 
14 Bracketing Standard 1 
 
Table 11: Sequence for LTSSS. 
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
Mean Area Ratio = 1.05 for Alpha keto valine Ca, 0.99 for Alpha keto leucine Ca, 0.98 
for Alpha keto isoleucine Ca and 1.086 for Alpha keto phenyl alanine Ca.  
Preparation of Stock Solution for LTSSS:  
50.00 mg of each alpha keto acid (working standard) were accurately weighed and 
transferred into 100 ml volumetric flask. 50 ml of diluent was added into the volumetric 
flask and the standard substances were dissolved by sonication for ten minute. Then, 
volume of the flask was making up with diluent. The concentration obtained was 500 
μg/ml. This solution was prepared before the 08 hour and kept on bench at ambient 
temperature without any disturbance until performance of the STSSS experiment. After 
08 hour on the bench. 5 ml of this solution was pipette out in 50 ml volumetric flask and 
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dilute it up to the mark to reach 200 μg/ml drug substances. This solution was assigned as 
STSSS Standard solution 
Preparation of Fresh Standard Solution:  
50.00 mg of each alpha keto acid working standard was accurately weighed and 
transferred into 100 ml volumetric flask. 50 ml of diluent was added into the volumetric 
flask and the standard substances were dissolved by sonication for ten minute. Then, 
volume of the flask was making up with diluent. The concentration obtained was 500 
μg/ml of all components. Pipette out exactly 10 ml of this solution in 25 ml volumetric 
flask and dilute it up to the mark accurately to confirm the 200 μg/ml of drug substance. 
This solution was assigned as Fresh Standard Solution.  
The proto-type experimental sequence is given below for STSSS. 
Experimental Sequence 
Sr.No. Sample Name No. of Injections 
1 Blank 1 
2 System Suitability Standard  5 
3 STSSS-01( 8.0 hour) 1 
4 Fresh Standard-01( 0.0 hour) 1 
6 STSSS-02 ( 8.0 hour) 1 
7 Fresh Standard-02 ( 0.0 hour) 1 
8 STSSS-03 ( 8.0 hour) 1 
9 Fresh Standard-03 (0.0 hour) 1 
10 STSSS-04 ( 8.0 hour) 1 
11 Fresh Standard-04 (0.0 hour) 1 
12 STSSS-05 ( 8.0 hour) 1 
13 Fresh Standard-05 (0.0 hour) 1 
14 Bracketing Standard 1 
 
Table 12: Sequence for STSSS.  
The Mean peak area ratio of five LTSSS standard injections and Fresh Standard solution 
was calculated. 
Mean Area Ratio = Mean Area of LTSSS Standard/ Mean Area of Fresh Standard 
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Mean Area Ratio = 0.98 for Alpha keto valine Ca, 0.95 for Alpha keto leucine Ca, 1.04 
for Alpha keto isoleucine Ca and 0.995 for Alpha keto phenyl alanine Ca.  
The Mean Area Ratio is within the acceptance criteria of 0.95 to 1.05, hence it can be 
concluded from this experiment that the Stock Solution is stable for the 10 days at 2 - 4˚ 
C in refrigerator, while standard solution was remain unaffected on bench at ambient 
temperature and in normal light for 8 hour. In addition to this it confirms the reliability of 
the data generated during the method validation.  
 
4.4.8. SYSTEM SUITABILITY  
A system suitability test for the chromatographic system was performed before each 
validation experiment. Five replicate injections of standard preparation were injected and 
asymmetry, theoretical plate and % RSD of peak area were determined for same. Only 
after the system suitability results were in acceptance criteria the experiments were 
precede further. 
 
Summary of System Suitability Test 
Experiment Name Theoretical Plates Asymmetry % RSD 
Specificity 45000 ± 300 1.30 ± 0.2 0.95 
Linearity and Range 40000 ± 500 1.25± 0.3 0.60 
LOD and LOQ 6500 ± 200 1.60 ± 0.2 1.96 
Method Precision 48000 ± 300 1.20 ± 0.1 0.50 
Intermediate Precision 47500 ± 200 1.15 ± 0.1 0.65 
Accuracy 40200 ± 100 1.25 ± 0.1 0.80 
Robustness 35000 ± 600 1.40 ± 0.1 1.50 
Solution Stability 39000 ± 300 1.25 ± 0.1 1.30 
 
Table 13: Results of System Suitability Test after each Validation Experiment 
Where, ± sign suggest statistics of all four component peaks. 
As per guideline the Theoretical plates should be more than 5000, Asymmetry should be 
less than 2.0 and % RSD should be less than 2.0. As the data suggest the system 
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suitability was within the criteria in each validation experiment.  Hence the system was 
found suitable to perform the validation experiment which confirms the reliability of the 
data generated during the method validation. 
 
5. CONCLUSION 
The surveillance and results obtained from each validation experiment including 
specificity, linearity and range, LOD and LOQ, precision, accuracy, robustness, solution 
stability and system suitability lies well inside the acceptance criteria of ICH guideline. 
Since, all the results are with-in the limit, the developed Analytical method is considered 
as validated and suitable for probable use. 
 
6. APPLICATION OF CURRENT FINDINGS  
 
6.1. This method can be used for the simultaneously quantification of Alpha keto 
valine Ca, Alpha keto leucine Ca, Alpha keto isoleucine Ca and Alpha keto 
phenyl alanine Ca in bulk drug in routine or as a special test. 
6.2. This method has also application over the chromatographic purity of all four 
analyte. 
6.3. By optimizing certain chromatographic parameter it can be also used for the 
reaction monitoring of preparation of all four compounds. 
6.4. This method can be used for the determination of all analyte individually or in 
combination pharmaceutical dosage form. 
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SUMMARY 
 
The work represented in the thesis entitled “ANALYTICAL METHOD 
DEVELOPMENT AND THEIR VALIDATION FOR BIOACTIVE MOLECULES 
AND APIS” is divided into seven chapters which can be summarized as under. 
Chapter – 1 includes the historical review as well as introduction to various types of 
chromatography and its application. Further the basic principal, function and operational 
overview of the High Performance Liquid Chromatography (HPLC) and Ultra 
Performance Liquid Chromatography has discussed. Addition to this the Analytical 
Method Validation, its requirement and all the experimental parameter of it covered in 
this segment of thesis. 
Chapter – 2 deals with the stability indicating Reversed Phase High Performance 
Liquid Chromatographic method for determination of aripiprazole in bulk drug and 
pharmaceutical dosage form which has the significance over total analysis time of just 10 
minutes and validation of the method is also included here as per ICH guideline. 
Chapter – 3   comprises of an Ultra Performance Liquid Chromatographic (UPLC) 
method for determination of aripiprazole with faster method with total analysis time of 
just 3 minutes, which illustrates the technology transfer from high performance LC to 
ultra performance LC successfully. Additionally comparative study of validation results 
of both methods is also conferred in this part. 
Chapter – 4 encompasses an Isocratic Ion Pair Method for quantification of Valproic 
Acid and its related impurities by Ultra Performance Liquid Chromatography. This 
work describes the successful use of ion pair reagent in liquid chromatography to 
overcome the low resolution setback. It also includes the impurity analysis of valproic 
acid namely; pentanoic acid, 2- ethyl pentanoic acid and 2-(1-Methyl, ethyl) Pentanoic 
acid. 
Chapter – 5 contains a method for determination of some diverse valproates salts like 
magnesium valproate, sodium valproate, lithium valproate, calcium valproate and its 
Pharmacopeial impurities in bulk drug and in dosage form. It illustrates the method for 
magnesium valproate and its process related impurities and the same is applicable for the 
other biologically significant salts of valproic acid. In addition to this, it also confirms 
that the same is applicable for determination of active content in pharmaceutical dosage 
form. 
Chapter – 6 conferring for the method for simultaneous analysis of nine most pertinent 
antipsychotic molecules of recent time, this covers Venlafaxine, Escitalopram, 
Fluoxetine, Candesarten, Trihexyphenidyl, Thioridazine, Aripiprazole, 
Trifluoperazine and Risperidone. This effort demonstrates the high throughput 
screening of nine analytes in just 5 minute run time. This clearly signifies the advantage 
of latest technology in liquid chromatography. Further this work also includes the 
analysis of these molecules simultaneously as well as individually in bulk drug and in 
pharmaceutical dosage form. 
Chapter – 7 covers the method development and validation for quantitative analysis of 
some keto-analogues of essential amino acids calcium salt, which currently in Indian and 
abroad market used in severe renal failure. It includes the simultaneous quantification of 
3-Methyl oxopentanoate calcium salt, 4-Methyl oxopentanoate calcium salt, 2-Oxo-
3-phenyl propanoate calcium salt and 3- Methyl-2-oxobutanoate by Ultra 
Performance Liquid Chromatography with total analysis time of just 8 minutes. Being 
the aliphatic highly polar compounds the method was difficult to identify. However, it 
successfully developed and validated. This attempt was exemplifies the high throughput 
screening of these analytes in bulk drug and the current findings are functional in 
pharmaceutical dosage form as well. 
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CONFERENCES/SEMINARS/WORKSHOPS ATTENDED 
 
1. “An International Symposium for Organic Pharmaceuticals”, jointly organized by Central 
Drug Research Institute, Lucknow & Indian Society of Chemists & Biologist held 
(ISCBC-2010) at CDRI- Lucknow on 15th-18th January, 2010.  
2. Two days National Workshop on Patents & IPR related Updates, Jointly organized by 
Technology Information, Forecasting Assessment Council (TIFAC)- New Delhi, Gujarat 
Council on Science and Technology (GUJCOST) Gandhinagar & Natioanal Facility for 
Drug Discovery Programme, Saurashtra University, Rajkot on 19-20th September, 2009.  
3. National workshop on Spectroscopy & Stereo chemistry held at Department of 
Chemistry, Saurashtra University, Rajkot on 18th- 20th March, 2009.  
4. National workshop on updates in Process & Medicinal Chemistry held at Department of 
chemistry, Saurashtra University, Rajkot on 3rd- 4th March, 2009.  
5. “National Workshop on E-Resources in Chemical Synthesis & Natural Products” held at 
Department of Chemistry, Saurashtra University, Rajkot on 2nd-3rd March, 2006.  
6. “National Workshop on Nanotechnology: Opportunities & Challenges” jointly organized 
by Saurashtra University Rajkot and Gujarat Council of Science & Technology 
(GUJCOST), Gandhinagar,  held at Rajkot, October 17, 2005. 
7. Internal Auditor Training on GLP conducted by Confederation of Indian Industry by  S K 
Kakkar (Principal Counselor & Head, CII Institute of Quality) 
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